BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies., ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. [PMID: 34458905 DOI: 10.1093/eurheartj/ehab484] [Cited by in Crossref: 625] [Cited by in F6Publishing: 714] [Article Influence: 625.0] [Reference Citation Analysis]
Number Citing Articles
1 Gasull Molinera V, Divison Garrote J, Díaz Rodríguez A, Frías Vargas M. Superando las barreras en el abordaje del paciente crónico. Medicina de Familia SEMERGEN 2023;49:101874. [DOI: 10.1016/j.semerg.2022.101874] [Reference Citation Analysis]
2 Misra DP, Hauge EM, Crowson CS, Kitas GD, Ormseth SR, Karpouzas GA. Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:. Rheumatic Disease Clinics of North America 2023;49:19-43. [DOI: 10.1016/j.rdc.2022.07.004] [Reference Citation Analysis]
3 Kim C, Lee CM, Lee S, Yoo JE, Lee H, Park HE, Han K, Choi S. The Association of Smoking Status and Clustering of Obesity and Depression on the Risk of Early–Onset Cardiovascular Disease in Young Adults: A Nationwide Cohort Study. Korean Circ J 2023;53. [DOI: 10.4070/kcj.2022.0179] [Reference Citation Analysis]
4 Shah NP, Page C, Green CL, Gao M, Cavalier J, Mcgarrah RW, Dewald TA, Sangvai D, Patel MR, Pagidipati NJ. Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients. The American Journal of Cardiology 2023;186:91-99. [DOI: 10.1016/j.amjcard.2022.10.033] [Reference Citation Analysis]
5 Kim BS, Shin J. Post-Pregnancy Hypertension in Women With a History of Hypertensive Disorders of Pregnancy. Cardiometab Syndr J 2023;3. [DOI: 10.51789/cmsj.2023.3.e4] [Reference Citation Analysis]
6 Marcellaud E, Jost J, Tchalla A, Magne J, Aboyans V. Statins in Primary Prevention in People Over 80 Years. The American Journal of Cardiology 2023;187:62-73. [DOI: 10.1016/j.amjcard.2022.10.015] [Reference Citation Analysis]
7 Borghi C. Coffee and blood pressure: exciting news! Blood Pressure 2022;31:284-287. [DOI: 10.1080/08037051.2022.2136621] [Reference Citation Analysis]
8 John Chapman M, Preston Mason R. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid. Pharmacology & Therapeutics 2022;240:108237. [DOI: 10.1016/j.pharmthera.2022.108237] [Reference Citation Analysis]
9 Ferrières J, Farnier M, Bruckert E, Vimont A, Durlach V, Ferrari E, Gallo A, Boccara F, Ferrières D, Béliard S, Angoulvant D, Aouchiche K, Beliard S, Boccara F, Bruckert E, Cariou B, Carreau V, Carrie A, Charrieres S, Cottin Y, Di Filippo M, Dourmap C, Ducluzeau P, Durlach V, Farnier M, Ferrari E, Ferrieres D, Ferrieres J, Gallo A, Hankard R, Inamo J, Kalmykova O, Krempf M, Lemale J, Moulin P, Paillard F, Peretti N, Perrin A, Pradignac A, Pucheu Y, Rabes JP, Reynaud R, Rigalleau V, Schiele F, Sultan A, Tounian P, Valero R, Verges B, Yelnik C, Ziegler O. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia. Atherosclerosis Plus 2022;50:17-24. [DOI: 10.1016/j.athplu.2022.08.001] [Reference Citation Analysis]
10 Patti G, Cavallari I, Cesaro A, Gragnano F, Riva L, Fimiani F, Cuccia C, Fresco C, Calabrò P, Leonardi S, Marcucci R, Rubboli A. Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.107137] [Reference Citation Analysis]
11 Eisenberger L, Mayr B, Beck M, Venek V, Kranzinger C, Menzl A, Jahn I, Sareban M, Oberhoffer-fritz R, Niebauer J, Böhm B. Development and validation of a 1-km cardio-trekking test to estimate cardiorespiratory fitness in healthy adults. Preventive Medicine Reports 2022;30:102039. [DOI: 10.1016/j.pmedr.2022.102039] [Reference Citation Analysis]
12 Arnold C, Hennrich P, Wensing M. Patient-reported continuity of care and the association with patient experience of cardiovascular prevention: an observational study in Germany. BMC Prim Care 2022;23:176. [DOI: 10.1186/s12875-022-01788-7] [Reference Citation Analysis]
13 Jacobsen AP, Khiew YC, Duffy E, O'connell J, Brown E, Auwaerter PG, Blumenthal RS, Schwartz BS, Mcevoy JW. Climate change and the prevention of cardiovascular disease. American Journal of Preventive Cardiology 2022;12:100391. [DOI: 10.1016/j.ajpc.2022.100391] [Reference Citation Analysis]
14 De los Ríos-ibarra MO, Leiva-pons JL, Rodríguez-reyes H, Alcocer-gamba MA, Cortés-lawrenz J, Vizcaíno-rios FM, Barragán-luna J, Farjat-ruiz JI, Virgen-carrillo LR, Padilla-padilla F, Pavia-lópez A, Morales-villegas EC, Ward NC, Lugo-gavidia LM. Risk stratification and lipid evaluation in mexican patients, evidence of lipid and cardiovascular analysis in REMECAR. The mexican registry of cardiovascular diseases (REMECAR group). Atherosclerosis Plus 2022;50:32-39. [DOI: 10.1016/j.athplu.2022.08.002] [Reference Citation Analysis]
15 Jakobs K, Lautan L, Lucassen P, Janzing J, van Lieshout J, Biermans MCJ, Bischoff EWMA. Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners. Eur J Gen Pract 2022;28:191-9. [PMID: 35796600 DOI: 10.1080/13814788.2022.2092093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pelliccia A, Borrazzo C, Maestrini V, D’ascenzi F, Caselli S, Lemme E, Squeo MR, Di Giacinto B. Determinants of LV mass in athletes: the impact of sport, constitutional traits and cardiovascular risk factors. Eur J Appl Physiol 2022. [DOI: 10.1007/s00421-022-05098-9] [Reference Citation Analysis]
17 Jancsó Z, Csenteri O, Szőllősi GJ, Vajer P, Andréka P. Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary. BMC Prim Care 2022;23:305. [DOI: 10.1186/s12875-022-01922-5] [Reference Citation Analysis]
18 Hayek A, Marquis-gravel G. Lipid lowering in primary prevention: time to focus on young patients. Heart 2022. [DOI: 10.1136/heartjnl-2022-321972] [Reference Citation Analysis]
19 Neves JS, Fontes-carvalho R, Borges-canha M, Leite AR, von Hafe M, Vale C, Martins S, Guimarães JT, Carvalho D, Leite-moreira A, Azevedo A. Association of thyroid function, within the euthyroid range, with cardiovascular risk: The EPIPorto study. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1067801] [Reference Citation Analysis]
20 Banach M, Surma S, Reiner Z, Katsiki N, Penson PE, Fras Z, Sahebkar A, Paneni F, Rizzo M, Kastelein J. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022). Cardiovasc Diabetol 2022;21:263. [DOI: 10.1186/s12933-022-01684-5] [Reference Citation Analysis]
21 Conrad N, Mcinnes IB, Mcmurray JJV, Sattar N. Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management? Ann Rheum Dis 2022. [DOI: 10.1136/ard-2022-223315] [Reference Citation Analysis]
22 Graham IM, Di Angelantonio E, Huculeci R, Graham IM, Di Angelantonio E, De Bacquer D, Ference B, Halle M, Huculeci R, Mcevoy J, Timmis A, Vardas P, Visseren F, on behalf of the European Society of Cardiology’s Cardiovascular Risk Collaboration (CRC). New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines. Curr Cardiol Rep 2022. [DOI: 10.1007/s11886-022-01790-6] [Reference Citation Analysis]
23 Popiolek-kalisz J. The Impact of Dietary Flavonols on Central Obesity Parameters in Polish Adults. Nutrients 2022;14:5051. [DOI: 10.3390/nu14235051] [Reference Citation Analysis]
24 Huy LD, Truong NLT, Hoang NY, Nguyen NTH, Nguyen TTP, Dang LT, Hsu YE, Huang C, Chang Y, Shih C, Carbone ET, Yang S, Duong TV. Insight into global research on health literacy and heart diseases: A bibliometric analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1012531] [Reference Citation Analysis]
25 Rinkūnienė E, Petrulionytė E, Dženkevičiūtė V, Petrulionienė Ž, Senulytė A, Puronaitė R, Laucevičius A. Prevalence of Cardiovascular Risk Factors in Middle-Aged Lithuanian Men Based on Body Mass Index and Waist Circumference Group Results from the 2006–2016 Lithuanian High Cardiovascular Risk Prevention Program. Medicina 2022;58:1718. [DOI: 10.3390/medicina58121718] [Reference Citation Analysis]
26 Sautner J, Eichbauer-sturm G, Gruber J, Lunzer R, Puchner R. Empfehlungen der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation zu Ernährung und Lebensstil bei Gicht und Hyperurikämie – Update 2022. Z Rheumatol 2022. [DOI: 10.1007/s00393-022-01286-2] [Reference Citation Analysis]
27 Boini S, Bourgkard E, Ferrières J, Esquirol Y. What do we know about the effect of night-shift work on cardiovascular risk factors? An umbrella review. Front Public Health 2022;10. [DOI: 10.3389/fpubh.2022.1034195] [Reference Citation Analysis]
28 Aguiar C, Araujo F, Rubio-mercade G, Carcedo D, Paz S, Castellano JM, Fuster V. Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study. JHEOR 2022. [DOI: 10.36469/jheor.2022.39768] [Reference Citation Analysis]
29 Aguiar C, Araujo F, Rubio-mercade G, Carcedo D, Paz S, Castellano JM, Fuster V. Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study. Journal of Health Economics and Outcomes Research 2022;9. [DOI: 10.36469/001c.39768] [Reference Citation Analysis]
30 Bułdak Ł, Machnik G, Skudrzyk E, Bołdys A, Maligłówka M, Kosowski M, Basiak M, Bułdak RJ, Okopień B. Exenatide prevents statin-related LDL receptor increase and improves insulin secretion in pancreatic beta cells (1.1E7) in a protein kinase A-dependent manner. JAB 2022. [DOI: 10.32725/jab.2022.015] [Reference Citation Analysis]
31 Kozela M, Polak M, Stepaniak U, Bobak M, Pająk A. Changes in Socioeconomic Status as Predictors of Cardiovascular Disease Incidence and Mortality: A 10-Year Follow-Up of a Polish-Population-Based HAPIEE Cohort. IJERPH 2022;19:15411. [DOI: 10.3390/ijerph192215411] [Reference Citation Analysis]
32 Zou Y, Li Q, Zhu Y, Pan J, Gao J, Lin J, Wu T, Zhang Q, Zheng H, Mo Y, Ma J, Dai L. Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis. Eur J Med Res 2022;27:260. [DOI: 10.1186/s40001-022-00888-5] [Reference Citation Analysis]
33 Gok Metin Z, Izgu N, Gulbahar Eren M, Eroglu H. Theory‐based nursing interventions in adults with coronary heart disease: A systematic review and meta‐analysis of randomized controlled trials. J of Nursing Scholarship 2022. [DOI: 10.1111/jnu.12839] [Reference Citation Analysis]
34 Bahat G, Ozkok S, Petrovic M. Treating Hypertension in Older Adults in Light of the Recent STEP Trial: Can We Implement the Findings in Geriatric Practice? Drugs Aging 2022. [DOI: 10.1007/s40266-022-00984-5] [Reference Citation Analysis]
35 Gavina C, Carvalho DS, Pardal M, Afonso-silva M, Grangeia D, Dinis-oliveira RJ, Araújo F, Taveira-gomes T. Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data. JCM 2022;11:6825. [DOI: 10.3390/jcm11226825] [Reference Citation Analysis]
36 Włodarek D, Dobrowolski H. Fantastic Foods and Where to Find Them—Advantages and Disadvantages of Nutri-Score in the Search for Healthier Food. Nutrients 2022;14:4843. [DOI: 10.3390/nu14224843] [Reference Citation Analysis]
37 Bengtsson J, Elsenburg LK, Andersen GS, Larsen ML, Rieckmann A, Rod NH. Childhood adversity and cardiovascular disease in early adulthood: a Danish cohort study. European Heart Journal 2022. [DOI: 10.1093/eurheartj/ehac607] [Reference Citation Analysis]
38 Malo S, Maldonado L, Rabanaque MJ, Gimeno-miguel A, Castel-feced S, Lallana MJ, Aguilar-palacio I. Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.980391] [Reference Citation Analysis]
39 Rizzoni D, Agabiti-rosei C, De Ciuceis C, Boari GEM. Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score. High Blood Press Cardiovasc Prev 2022. [DOI: 10.1007/s40292-022-00551-4] [Reference Citation Analysis]
40 Colombijn JMT, Idema DL, van der Braak K, Spijker R, Meijvis SCA, Bots ML, Hooft L, Verhaar MC, Vernooij RWM. Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map. Syst Rev 2022;11:238. [DOI: 10.1186/s13643-022-02108-x] [Reference Citation Analysis]
41 Spoladore R, Daus F, Pezzini S, Milani M, Limonta A, Savonitto S. The point on the electronic cigarette more than 10 years after its introduction. European Heart Journal Supplements 2022;24:I148-I152. [DOI: 10.1093/eurheartjsupp/suac105] [Reference Citation Analysis]
42 Menezes HJ, D' Souza SRB, Padmakumar R, Babu AS, Rao RR, Kamath VG, Kamath A, Grace SL. Technology‐based Comprehensive Cardiac Rehabilitation Therapy (TaCT) for women with cardiovascular disease in a middle‐income setting: A randomized controlled trial protocol. Research in Nursing & Health 2022. [DOI: 10.1002/nur.22276] [Reference Citation Analysis]
43 Ferrari R, Cimaglia P, Rapezzi C, Tavazzi L, Guardigli G. Cardiovascular prevention: sometimes dreams can come true. European Heart Journal Supplements 2022;24:H3-H7. [DOI: 10.1093/eurheartjsupp/suac057] [Reference Citation Analysis]
44 Gielen S, Wienbergen H, Reibis R, Koenig W, Weil J, Landmesser U. Kommentar zu den neuen Leitlinien (2021) der Europäischen Gesellschaft für Kardiologie (ESC) zur kardiovaskulären Prävention. Kardiologie 2022. [DOI: 10.1007/s12181-022-00580-2] [Reference Citation Analysis]
45 Hassan D, Versmissen J, Hek K, van Dijk L, van den Bemt PMLA. Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices. BMC Prim Care 2022;23:280. [DOI: 10.1186/s12875-022-01894-6] [Reference Citation Analysis]
46 Zhu L, Fang Y, Gao B, Jin X, Zheng J, He Y, Huang J. Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease. BMC Cardiovasc Disord 2022;22:474. [DOI: 10.1186/s12872-022-02932-y] [Reference Citation Analysis]
47 Doganer YC, Aydogan U, Kaplan U, Gormel S, Rohrer JE, Yuksel UC. Statin adherence in patients with high cardiovascular risk: a cross-sectional study. Postgraduate Medicine 2022. [DOI: 10.1080/00325481.2022.2144030] [Reference Citation Analysis]
48 Wolff G, Lin Y, Akbulut C, Brockmeyer M, Parco C, Hoss A, Sokolowski A, Westenfeld R, Kelm M, Roden M, Schlesinger S, Kuss O. Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes. ESC Heart Failure 2022. [DOI: 10.1002/ehf2.14213] [Reference Citation Analysis]
49 Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, Townsend RR, Tsioufis C, Weber MA, Weber T, Böhm M. Hypertension management in patients with cardiovascular comorbidities. European Heart Journal 2022. [DOI: 10.1093/eurheartj/ehac395] [Reference Citation Analysis]
50 Klose G, Gouni-berthold I, März W. Stellenwert primärer Fettstoffwechselstörungen im Kontext aktueller Dyslipidämie-Leitlinien und aktueller Innovationen in der Lipidtherapie. J Klin Endokrinol Stoffw 2022. [DOI: 10.1007/s41969-022-00178-9] [Reference Citation Analysis]
51 Tolkunova K, Usoltsev D, Moguchaia E, Boyarinova M, Kolesova E, Erina A, Voortman T, Vasilyeva E, Kostareva A, Shlyakhto E, Konradi A, Rotar O, Artomov M. TRANSGENERATIONAL EFFECT OF EARLY CHILDHOOD FAMINE EXPOSURE IN THE COHORT OF LENINGRAD SIEGE SURVIVORS’ OFFSPRING.. [DOI: 10.1101/2022.11.04.22281954] [Reference Citation Analysis]
52 Viamonte SG, Joaquim A, Alves A, Vilela E, Capela A, Ferreira C, Costa AJ, Teixeira M, Duarte B, Rato N, Tavares A, Santos M, Ribeiro F. Adherence, safety and satisfaction of a cardio-oncology rehabilitation program framework versus community exercise training for cancer survivors: findings from the CORE trial.. [DOI: 10.21203/rs.3.rs-2213384/v1] [Reference Citation Analysis]
53 Østergaard HB, Read SH, Sattar N, Franzén S, Halbesma N, Dorresteijn JA, Westerink J, Visseren FL, Wild SH, Eliasson B, van der Leeuw J. Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes. CJASN 2022. [DOI: 10.2215/cjn.05020422] [Reference Citation Analysis]
54 Al‐smadi AM, Ashour AF, Fitzsimons D, Slater P, O'neill B, Ajlouni W, Shajrawi AM. High levels of risk factors and poor secondary prevention for coronary heart disease patients in public hospitals: A descriptive repeated measures study. Int J of Nursing Practice 2022. [DOI: 10.1111/ijn.13111] [Reference Citation Analysis]
55 Deng L, Wu Q, Ding F, Liu Y, Shen J, Lin Y, Shi K, Zeng B, Wu L, Tong H. The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1020744] [Reference Citation Analysis]
56 Davenport A. Why is intra-dialytic hypotension the commonest complication of outpatient dialysis treatments? Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.10.031] [Reference Citation Analysis]
57 Pedro-botet J, Barrios V, Sánchez-margalet V, Tamargo J, Arrieta F, Gámez JM, Gimeno-orna JA, Escobar C, Gómez-doblas JJ, Pérez A. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]. Endocrinología, Diabetes y Nutrición (English ed ) 2022. [DOI: 10.1016/j.endien.2022.11.009] [Reference Citation Analysis]
58 Cebollada J, Buisan C. Therapeutic role of colchicine in reducing cardiovascular risk associated with inflammation. Endocrinología, Diabetes y Nutrición (English ed ) 2022. [DOI: 10.1016/j.endien.2022.09.001] [Reference Citation Analysis]
59 Fu Y, Price C, Haining S, Gaffney B, Julien D, Whitty P, Newton JL. Cardiovascular-related conditions and risk factors in primary care for deprived communities before and during the COVID-19 pandemic: an observational study in Northern England. BMJ Open 2022;12:e066868. [DOI: 10.1136/bmjopen-2022-066868] [Reference Citation Analysis]
60 Csenteri O, Jancsó Z, Szöllösi GJ, Andréka P, Vajer P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart 2022;9:e002087. [DOI: 10.1136/openhrt-2022-002087] [Reference Citation Analysis]
61 Lechner I, Reindl M, Reinstadler SJ. Acute coronary syndrome without standard modifiable cardiovascular risk factors (SMuRF): More questions than answers. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.11.005] [Reference Citation Analysis]
62 Crea F. Sodium–glucose co-transporter 2 inhibition: the saga continues. European Heart Journal 2022;43:4215-4218. [DOI: 10.1093/eurheartj/ehac590] [Reference Citation Analysis]
63 Donfrancesco C, Di Lonardo A, Lo Noce C, Buttari B, Profumo E, Vespasiano F, Vannucchi S, Galletti F, Onder G, Gulizia MM, Galeone D, Bellisario P, Palmieri L. Trends of blood pressure, raised blood pressure, hypertension and its control among Italian adults: CUORE Project cross-sectional health examination surveys 1998/2008/2018. BMJ Open 2022;12:e064270. [DOI: 10.1136/bmjopen-2022-064270] [Reference Citation Analysis]
64 Sigamani A, Gupta R. Revisiting Secondary Prevention in Coronary Heart Disease. Indian Heart Journal 2022. [DOI: 10.1016/j.ihj.2022.11.011] [Reference Citation Analysis]
65 Brotons C, Moral-peláez I, Vicuña J, Ameixeiras C, Fernández-lavandera C, Sánchez-chaparro MÁ. Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2. Clínica e Investigación en Arteriosclerosis 2022. [DOI: 10.1016/j.arteri.2022.09.003] [Reference Citation Analysis]
66 German CA, Baum SJ, Ferdinand KC, Gulati M, Polonsky TS, Toth PP, Shapiro MD. Defining Preventive Cardiology: A Clinical Practice Statement from the American Society for Preventive Cardiology. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100432] [Reference Citation Analysis]
67 Chen R, Zhao H, Yan H. Long-term Management of Patients with Myocardial Infarction: An Updated Review. Cardiology Discovery 2022;Publish Ahead of Print. [DOI: 10.1097/cd9.0000000000000073] [Reference Citation Analysis]
68 Young L, Brown EE, Martin SS. Homozygous Familial Hypercholesterolemia. JACC: Case Reports 2022. [DOI: 10.1016/j.jaccas.2022.10.005] [Reference Citation Analysis]
69 Fernández Olmo MR, Cordero Fort A, Torres Llergo J, Marzal Martín D, Baquero Alonso M, Martínez Quesada M, Palau Sampio P, Campuzano Ruiz R. Selección de lo mejor del año en 2022 en riesgo vascular y rehabilitación cardiaca. REC: CardioClinics 2022. [DOI: 10.1016/j.rccl.2022.10.002] [Reference Citation Analysis]
70 Al Rifai M, Ahmed AI, Alahdab F, Al-mallah MH. Clinical utility of coronary artery computed tomography angiography- What we know and What's new? Progress in Cardiovascular Diseases 2022. [DOI: 10.1016/j.pcad.2022.10.013] [Reference Citation Analysis]
71 Cepas-guillén PL, Laffond A, Lozano Granero C, López Lluva MT. III CardioMIR: el Congreso de los Jóvenes Cardiólogos. REC: CardioClinics 2022. [DOI: 10.1016/j.rccl.2022.10.010] [Reference Citation Analysis]
72 Jiménez López-guarch C, Barreiro-pérez M, Cecconi A, Fernández-golfín C, Galián-gay L, Martínez-monzonís A, Jiménez-borreguero LJ. Selección de lo mejor del año 2022 en imagen cardiaca. REC: CardioClinics 2022. [DOI: 10.1016/j.rccl.2022.09.003] [Reference Citation Analysis]
73 Ambaliya HC, Gupta R, Chahar C, Tyagi L, Chaturvedi H, Khedar RS. Smartphone-Enabled Retinal Arteriovenous Imaging and Correlation with Coronary SYNTAX Score. Indian Heart Journal 2022. [DOI: 10.1016/j.ihj.2022.11.005] [Reference Citation Analysis]
74 Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol 2022. [PMID: 36316574 DOI: 10.1038/s41569-022-00797-4] [Reference Citation Analysis]
75 Inggriani MP, Musthafa A, Puspitawati I, Fachiroh J, Dewi FST, Hartopo AB. Increased endothelin-1 levels in coronary artery disease with diabetes mellitus in an Indonesian population. Can J Physiol Pharmacol 2022. [DOI: 10.1139/cjpp-2022-0011] [Reference Citation Analysis]
76 Waissengein B, Abu Ata B, Merimsky O, Shamai S, Wolf I, Arnold JH, Bar-on T, Banai S, Khoury S, Laufer-perl M. The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors. Clin Res Cardiol 2022. [DOI: 10.1007/s00392-022-02118-8] [Reference Citation Analysis]
77 Teoule J, Woll C, Sütterlin M, Filsinger B. Versorgungsrealität von Frauen nach hypertensiver Schwangerschaftserkrankung – eine monozentrische fragebogenbasierte Analyse. Z Geburtshilfe Neonatol 2022. [DOI: 10.1055/a-1956-4358] [Reference Citation Analysis]
78 Ahmadi MN, Clare PJ, Katzmarzyk PT, del Pozo Cruz B, Lee I, Stamatakis E. Vigorous physical activity, incident heart disease, and cancer: how little is enough? European Heart Journal 2022. [DOI: 10.1093/eurheartj/ehac572] [Reference Citation Analysis]
79 Qureshi N, Antoniou S, Cornel JH, Schiele F, Perrone-filardi P, Brachmann J, Sidelnikov E, Villa G, Ferguson S, Rowlands C, González-juanatey JR. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction. Adv Ther 2022. [DOI: 10.1007/s12325-022-02344-6] [Reference Citation Analysis]
80 Wang P, Liu M, Zhuang X, Guo Y, Xiong Z, He L, Cai X, Chen Z, Peng L, Liao X. Association of Metabolically Healthy Obesity in Young Adulthood with Myocardial Structure and Function.. [DOI: 10.21203/rs.3.rs-2097823/v1] [Reference Citation Analysis]
81 Giachi A, Cugno M, Gualtierotti R. Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1012661] [Reference Citation Analysis]
82 Stegmüller F, Dinter J, Ritzer B, Seth C, Stadler L, Esefeld K, Halle M. [Sports cardiology : Which sport can be recommended for heart diseases?]. Herz 2022. [PMID: 36278977 DOI: 10.1007/s00059-022-05141-7] [Reference Citation Analysis]
83 Koo CY, Zheng H, Tan LL, Foo L, Hausenloy DJ, Chng W, Lee SC, Richards AM, Ling L, Lim SL, Lee C, Chan MY. Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction. Biomedicines 2022;10:2681. [DOI: 10.3390/biomedicines10112681] [Reference Citation Analysis]
84 Bonekamp NE, Visseren FLJ, Ruigrok Y, Cramer MJM, de Borst GJ, May AM, Koopal C. Leisure-time and occupational physical activity and health outcomes in cardiovascular disease. Heart 2022. [DOI: 10.1136/heartjnl-2022-321474] [Reference Citation Analysis]
85 Zeitouni M, Sulman D, Silvain J, Kerneis M, Guedeney P, Barthelemy O, Brugier D, Sabouret P, Procopi N, Collet J, Montalescot G. Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines. Heart 2022. [DOI: 10.1136/heartjnl-2022-321688] [Reference Citation Analysis]
86 Özbiçer S, Yüksel G, Deniz Urgun Ö. Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes. Diab Vasc Dis Res 2022;19:14791641221136203. [PMID: 36270638 DOI: 10.1177/14791641221136203] [Reference Citation Analysis]
87 Dąbek J, Sierka O. Knowledge of Silesia adult inhabitants regarding preventive vaccinations effect on cardiovascular diseases. BMC Public Health 2022;22:1949. [PMID: 36266647 DOI: 10.1186/s12889-022-14337-9] [Reference Citation Analysis]
88 Lupsa BC, Kibbey RG, Inzucchi SE. Ketones: the double-edged sword of SGLT2 inhibitors? Diabetologia 2022. [PMID: 36255460 DOI: 10.1007/s00125-022-05815-1] [Reference Citation Analysis]
89 Landowska M, Żebrowska A, Fajer K, Adamek P, Kruk A, Kałuża B, Franek E. Atherosclerosis Risk Factors in Patients with Reactive Hypoglycemia. Diabetes Metab Syndr Obes 2022;15:3133-42. [PMID: 36246517 DOI: 10.2147/DMSO.S371706] [Reference Citation Analysis]
90 Ray KK, Ference BA, Séverin T, Blom D, Nicholls SJ, Shiba MH, Almahmeed W, Alonso R, Daccord M, Ezhov M, Olmo RF, Jankowski P, Lanas F, Mehta R, Puri R, Wong ND, Wood D, Zhao D, Gidding SS, Virani SS, Lloyd-jones D, Pinto F, Perel P, Santos RD. World Heart Federation Cholesterol Roadmap 2022. gh 2022;17:75. [DOI: 10.5334/gh.1154] [Reference Citation Analysis]
91 Špacírová Z, Kaptoge S, García-Mochón L, Rodríguez Barranco M, Sánchez Pérez MJ, Bondonno NP, Tjønneland A, Weiderpass E, Grioni S, Espín J, Sacerdote C, Schiborn C, Masala G, Colorado-Yohar SM, Kim L, Moons KGM, Engström G, Schulze MB, Bresson L, Moreno-Iribas C, Epstein D. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease. Eur J Health Econ 2022. [PMID: 36239877 DOI: 10.1007/s10198-022-01533-y] [Reference Citation Analysis]
92 Sorensen C, Lehmann E, Holder C, Hu J, Krishnan A, Münzel T, Mb R, Rn S. Reducing the health impacts of ambient air pollution. BMJ 2022;379:e069487. [PMID: 36223913 DOI: 10.1136/bmj-2021-069487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kyriakoulis KG, Dimakakos E, Kyriakoulis IG, Catalano M, Spyropoulos AC, Schulman S, Douketis J, Falanga A, Maraveyas A, Olinic D, Belch J, Gerotziafas G, Syrigos K, Kollias A; COVID-19 Thrombosis Collaborative Group, Endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Division of Angiology/Vascular Medicine/and ESVM-European Society of Vascular Medicine and Supported by the Balkan Working Group. Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials. JCM 2022;11:5997. [DOI: 10.3390/jcm11205997] [Reference Citation Analysis]
94 Berra CC, Manfrini R, Mirani M, Bucciarelli L, Zakaria AS, Piccini S, Ghelardi R, Lunati ME, Rodovalho S, Bifari F, Fiorina P, Folli F. AWARE. A web application to rapidly assess cardiovascular risk in Type 2 Diabetes Mellitus.. [DOI: 10.21203/rs.3.rs-2134695/v1] [Reference Citation Analysis]
95 Zeljković A, Ardalić D, Vekić J, Antonić T, Vladimirov S, Rizzo M, Gojković T, Ivanišević J, Mihajlović M, Vujčić S, Cabunac P, Spasojević-kalimanovska V, Miković Ž, Stefanović A. Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome. Metabolites 2022;12:959. [DOI: 10.3390/metabo12100959] [Reference Citation Analysis]
96 Dulin AJ, Park JW, Scarpaci MM, Dionne LA, Sims M, Needham BL, Fava JL, Eaton CB, Kanaya AM, Kandula NR, Loucks EB, Howe CJ. Examining relationships between perceived neighborhood social cohesion and ideal cardiovascular health and whether psychosocial stressors modify observed relationships among JHS, MESA, and MASALA participants. BMC Public Health 2022;22:1890. [PMID: 36221065 DOI: 10.1186/s12889-022-14270-x] [Reference Citation Analysis]
97 Gosse P, boulestreau R, Doublet J, gaudissard J, cremer A. Arterial Stiffness (From Monitoring of QKD Interval) Predict the Occurrence of Cardiovascular Events and Total Mortality.. [DOI: 10.21203/rs.3.rs-2072189/v1] [Reference Citation Analysis]
98 van Broekhoven A, Mohammadnia N, Silvis MJM, Los J, Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW, Nidorf SM, Budgeon CA, Byrnes E, Bax WA, Tijssen JGP, de Kleijn DPV, Thompson PL, El Messaoudi S, Cornel JH. The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial. Clin Drug Investig 2022. [PMID: 36208364 DOI: 10.1007/s40261-022-01209-8] [Reference Citation Analysis]
99 van der Bijl P, Kuneman J, Bax JJ. Coronary artery calcium scoring in the general population. Eur Heart J Cardiovasc Imaging 2022:jeac201. [PMID: 36208189 DOI: 10.1093/ehjci/jeac201] [Reference Citation Analysis]
100 Mirrakhimov E, Zakirov U, Abilova S, Asanbaev A, Bektasheva E, Asanaliev N, Uulu YM, Alibaeva N, Neronova K, Kerimkulova A, Lunegova O, Altymysheva A, Wang W, Beaney T, Poulter NR. May Measurement Month 2019: analysis of blood pressure screening in Bishkek, Kyrgyzstan. Eur Heart J Suppl 2022;24:F19-21. [PMID: 36225280 DOI: 10.1093/eurheartjsupp/suac042] [Reference Citation Analysis]
101 Miglinas M, Ševčenko V, Račaitė A, Žakauskienė U, Vickienė A, Miglinė V, Wang W, Beaney T, Poulter NR, Macioniene E. May Measurement Month 2017-2019: an analysis of blood pressure screening results from Lithuania. Eur Heart J Suppl 2022;24:F22-4. [PMID: 36225270 DOI: 10.1093/eurheartjsupp/suac043] [Reference Citation Analysis]
102 Kotlyarov S, Kotlyarova A. Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases. Front Nutr 2022;9:998291. [PMID: 36276836 DOI: 10.3389/fnut.2022.998291] [Reference Citation Analysis]
103 Crivelli-Meyer A, Giannini O, Bianchetti MG, Simonetti GD. Adults remember their birth weight, an important anamnestic item for cardiovascular and renal disease risk stratification. Front Cardiovasc Med 2022;9:1007524. [PMID: 36277773 DOI: 10.3389/fcvm.2022.1007524] [Reference Citation Analysis]
104 Tromp TR, Cuchel M. New algorithms for treating homozygous familial hypercholesterolemia. Curr Opin Lipidol 2022. [PMID: 36206078 DOI: 10.1097/MOL.0000000000000853] [Reference Citation Analysis]
105 Fatima K, Ahmed W, Fatimi AS, Mahmud O, Mahar MU, Ali A, Aamir SR, Nasim MT, Islam MB, Maniya MT, Azim D, Marsia S, Almas T. Evaluating the safety and efficacy of daprodustat for anemia of chronic kidney disease: a meta-analysis of randomized clinical trials. Eur J Clin Pharmacol 2022. [PMID: 36195739 DOI: 10.1007/s00228-022-03395-y] [Reference Citation Analysis]
106 Van Minh H, Van Huy T, Long DPP, Tien HA. Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA). J Clin Hypertens (Greenwich) 2022;24:1121-38. [PMID: 36196473 DOI: 10.1111/jch.14580] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Mortensen MB. Recalibrating 10-Year Risk Models Using Population-Based Data: Not Without Caveats. J Am Coll Cardiol 2022;80:1343-5. [PMID: 36175053 DOI: 10.1016/j.jacc.2022.08.006] [Reference Citation Analysis]
108 Shi M, Zhu X, Cheang I, Zhu Q, Guo Q, Liao S, Gao R, Li X. Associations of thiocyanate, nitrate, and perchlorate exposure with dyslipidemia: a cross-sectional, population-based analysis. Environ Sci Pollut Res Int 2022. [PMID: 36194328 DOI: 10.1007/s11356-022-23296-y] [Reference Citation Analysis]
109 Mordi I, Trucco E. The eyes as a window to the heart: looking beyond the horizon. Br J Ophthalmol 2022:bjo-2022-322517. [PMID: 36195458 DOI: 10.1136/bjo-2022-322517] [Reference Citation Analysis]
110 Olszewski R, Ćwiklińska K, Maślińska M, Kwiatkowska B. Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis. Reumatologia 2022;60:266-74. [PMID: 36186830 DOI: 10.5114/reum.2022.119043] [Reference Citation Analysis]
111 Radhoe SP, Boersma E, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML, Brugts JJ. The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials. Cardiovasc Drugs Ther 2022. [PMID: 36194352 DOI: 10.1007/s10557-022-07384-2] [Reference Citation Analysis]
112 Ramík Z, Václavík J, Jadrníčková P, Obrová J, Stromská J. Comprehensive approach to a patient with arterial hypertension and dyslipidemia. Vnitr Lek 2022;68:376-386. [DOI: 10.36290/vnl.2022.078] [Reference Citation Analysis]
113 Cybulska AM, Schneider-Matyka D, Bosiacki M, Chlubek D, Panczyk M, Grochans E. The Levels of Bioelements in Postmenopausal Women with Metabolic Syndrome. Nutrients 2022;14:4102. [PMID: 36235758 DOI: 10.3390/nu14194102] [Reference Citation Analysis]
114 Murphy F, Byrne G. Promoting kidney health in cardiovascular disease: part one. British Journal of Cardiac Nursing 2022;17:1-12. [DOI: 10.12968/bjca.2022.0083] [Reference Citation Analysis]
115 Lopez-Santi R, Piskorz D, Garcia-Zamora S, Martinez D, Demaria DM, Renna N, Forte E, Ibarrola M, Igolnikof D, Lorenzatti A, Alexander B, Baranchuk A, Sosa-Liprandi A, Martinez F, Kaski JC. The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice - The VIPFARMA ISCP Project. Curr Probl Cardiol 2022;:101434. [PMID: 36198357 DOI: 10.1016/j.cpcardiol.2022.101434] [Reference Citation Analysis]
116 Ihm SH, Park JH, Kim JY, Kim JH, Kim KI, Lee EM, Lee HY, Park S, Shin J, Kim CH. Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum. Clin Hypertens 2022;28:38. [PMID: 36180964 DOI: 10.1186/s40885-022-00218-1] [Reference Citation Analysis]
117 Stergiou GS, Ntineri A, Menti A, Kalpourtzi N, Vlachopoulos C, Liberopoulos EN, Rallidis L, Richter D, Gavana M, Vantarakis A, Chlouverakis G, Hajichristodoulou C, Trypsianis G, Voulgari PV, Alamanos Y, Karakosta A, Touloumi G. Twenty-first Century Epidemiology of Dyslipidemia in Greece: EMENO National Epidemiological Study. Hellenic Journal of Cardiology 2022. [DOI: 10.1016/j.hjc.2022.10.002] [Reference Citation Analysis]
118 Cebollada J, Buisan C. PAPEL TERAPÉUTICO DE LA COLCHICINA EN LA REDUCCIÓN DEL RIESGO CARDIOVASCULAR ASOCIADO A LA INFLAMACIÓN. Endocrinología, Diabetes y Nutrición 2022;69:551-553. [DOI: 10.1016/j.endinu.2022.09.001] [Reference Citation Analysis]
119 Gupta K, Al Rifai M, Hussain A, Minhas AMK, Patel J, Kalra D, Samad Z, Virani SS. South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent? Progress in Cardiovascular Diseases 2022. [DOI: 10.1016/j.pcad.2022.10.001] [Reference Citation Analysis]
120 Nejatian MM, Lan NS, Yeap BB, Dwivedi G, Fegan PG, Ihdayhid AR. Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes. Diabetes Research and Clinical Practice 2022;192:110093. [DOI: 10.1016/j.diabres.2022.110093] [Reference Citation Analysis]
121 Guzman-Vilca WC, Quispe-Villegas GA, Carrillo-Larco RM. Predicted heart age profile across 41 countries: A cross-sectional study of nationally representative surveys in six world regions. EClinicalMedicine 2022;52:101688. [PMID: 36313150 DOI: 10.1016/j.eclinm.2022.101688] [Reference Citation Analysis]
122 Viamonte SG, Joaquim AV, Alves A, Vilela E, Capela A, Ferreira C, Duarte B, Rato ND, Tavares AI, Santos M, Ribeiro F. Impact of a COmprehensive cardiac REhabilitation framework among high cardiovascular risk cancer survivors: Protocol for the CORE trial. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.09.075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Orozco-beltrán D, Brotons Cuixart C, Banegas Banegas JR, Gil Guillén VF, Cebrián Cuenca AM, Martín Rioboó E, Jordá Baldó A, Vicuña J, Navarro Pérez J. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022. Atención Primaria 2022;54:102444. [DOI: 10.1016/j.aprim.2022.102444] [Reference Citation Analysis]
124 Birtcher KK, Allen LA, Anderson JL, Bonaca MP, Gluckman TJ, Hussain A, Kosiborod M, Mehta LS, Virani SS. 2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2022.08.754] [Reference Citation Analysis]
125 Iliou MC. Récupération physique et psychologique après infarctus du myocarde. Quels enjeux ? La Presse Médicale Formation 2022. [DOI: 10.1016/j.lpmfor.2022.10.015] [Reference Citation Analysis]
126 Pizzarelli G, Gennai S, Leone N, Covic T, Moratto R, Silingardi R. Transcranial doppler detects micro emboli in patients with asymptomatic carotid stenoses undergoing endarterectomy. Journal of Vascular Surgery 2022. [DOI: 10.1016/j.jvs.2022.10.003] [Reference Citation Analysis]
127 Gonzalez-jaramillo N, Eser P, Casanova F, Bano A, Franco OH, Windecker S, Räber L, Wilhelm M. Prognostic impact of physical activity patterns after percutaneous coronary intervention. Protocol for a prospective longitudinal cohort. The PIPAP study. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.976539] [Reference Citation Analysis]
128 Alekyan BG, Karapetyan NG, Chupin AV, Zotikov AE, Varava AB, Knish JB, Sedgaryan MA. Long-Term Results of the Treatment of Patients With Chronic Ischemia of the Lower Limbs in Combination With Ischemic Heart Disease. Kardiologiia 2022;62:37-43. [DOI: 10.18087/cardio.2022.9.n1941] [Reference Citation Analysis]
129 Sokolyuk АК, Tkachuk ІМ, Tkalenko ОМ. Комплексний аналіз показників захворюваності на хвороби системи кровообігу військовослужбовців Збройних Сил України. UJMM 2022;3:132-140. [DOI: 10.46847/ujmm.2022.3(3)-132] [Reference Citation Analysis]
130 Гома ТВ, Болдырева КС. Оценка сердечно-сосудистого возраста у медицинских работников. Атеросклероз 2022;18:250-252. [DOI: 10.52727/2078-256x-2022-18-3-250-252] [Reference Citation Analysis]
131 Kim BS, Lee Y, Park JK, Lim YH, Shin JH. Association of the Estimated Pulse Wave Velocity with Cardio-Vascular Disease Outcomes among Men and Women Aged 40-69 Years in the Korean Population: An 18-Year Follow-Up Report on the Ansung-Ansan Cohort in the Korean Genome Environment Study. J Pers Med 2022;12:1611. [PMID: 36294750 DOI: 10.3390/jpm12101611] [Reference Citation Analysis]
132 Novaković M, Rajkovič U, Košuta D, Tršan J, Fras Z, Jug B. Effects of Cardiac Rehabilitation and Diet Counselling on Adherence to the Mediterranean Lifestyle in Patients after Myocardial Infarction. Nutrients 2022;14:4048. [DOI: 10.3390/nu14194048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Hu Y, Chen X, Hu M, Zhang D, Yuan S, Li P, Feng L. Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects. Chin Med 2022;17:113. [PMID: 36175900 DOI: 10.1186/s13020-022-00666-9] [Reference Citation Analysis]
134 Eser P, Gonzalez-jaramillo N, Weber S, Fritsche J, Femiano R, Werner C, Casanova F, Bano A, Franco OH, Wilhelm M. Objectively measured adherence to physical activity among patients with coronary artery disease: Comparison of the 2010 and 2020 World Health Organization guidelines and daily steps. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.951042] [Reference Citation Analysis]
135 Chieng D, Canovas R, Segan L, Sugumar H, Voskoboinik A, Prabhu S, Ling LH, Lee G, Morton JB, Kaye DM, Kalman JM, Kistler PM. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank. Eur J Prev Cardiol 2022:zwac189. [PMID: 36162818 DOI: 10.1093/eurjpc/zwac189] [Reference Citation Analysis]
136 Twomey P. Thoughts on hypertriglyceridaemia in clinical practice. J Clin Pathol 2022:jcp-2022-208513. [PMID: 36167730 DOI: 10.1136/jcp-2022-208513] [Reference Citation Analysis]
137 Hegde NN, Mathew N, Thachathodiyl R, Menon JC. Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1004473] [Reference Citation Analysis]
138 Mitchenko OI, Timokhova KO, Chulaievska NM. Diagnostic Features and Selection of Hypolipidemic Therapy in Patients with Coronary Artery Disease with “Possible” Familial Hypercholesterolemia. ujcvs 2022;30:50-59. [DOI: 10.30702/ujcvs/22.30(03)/mt041-5059] [Reference Citation Analysis]
139 Davydova IV, Kryvorchuk IG, Siromakha SO, Lymanska AY, Kravets OM. Intima-Media Thickness in Women with the History of Hypertensive Disorders of Pregnancy as a Risk Marker of the Occurrence of Cardiovascular Pathology in Advanced Reproductive and Perimenopausal Age. ujcvs 2022;30:29-34. [DOI: 10.30702/ujcvs/22.30(03)/dk032-2934] [Reference Citation Analysis]
140 Chen SY, Kong XQ, Zhang KF, Luo S, Wang F, Zhang JJ. DPP4 as a Potential Candidate in Cardiovascular Disease. J Inflamm Res 2022;15:5457-69. [PMID: 36147690 DOI: 10.2147/JIR.S380285] [Reference Citation Analysis]
141 R Thompson D, F Ski C, M Clark A, M Dalal H, S Taylor R. Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation? Card Fail Rev. [DOI: 10.15420/cfr.2022.16] [Reference Citation Analysis]
142 Xia J, Wang X, Zhou J, Wang D, Pang Y, Xu X, Sang Z, Zhang Y, Zhang J, Wu S, Xiao Z, Hou L. Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1009674] [Reference Citation Analysis]
143 Han E, Fritzer-szekeres M, Szekeres T, Gehrig T, Gyöngyösi M, Bergler-klein J. Comparison of High-Sensitivity C-Reactive Protein vs C-reactive Protein for Cardiovascular Risk Prediction in Chronic Cardiac Disease. The Journal of Applied Laboratory Medicine 2022. [DOI: 10.1093/jalm/jfac069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Chudzińska M, Wołowiec Ł, Banach J, Rogowicz D, Grześk G. Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference? JCDD 2022;9:317. [DOI: 10.3390/jcdd9100317] [Reference Citation Analysis]
145 Gerdts E, Sudano I, Brouwers S, Borghi C, Bruno RM, Ceconi C, Cornelissen V, Diévart F, Ferrini M, Kahan T, Løchen ML, Maas AHEM, Mahfoud F, Mihailidou AS, Moholdt T, Parati G, de Simone G. Sex differences in arterial hypertension. Eur Heart J 2022:ehac470. [PMID: 36136303 DOI: 10.1093/eurheartj/ehac470] [Reference Citation Analysis]
146 Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Ann Rheum Dis 2022:annrheumdis-2022-222259. [PMID: 36137735 DOI: 10.1136/ard-2022-222259] [Reference Citation Analysis]
147 Pan X, Chen X, Ren L, Li Z, Chen S, Wan C. Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations. International Journal of Clinical Practice 2022;2022:1-9. [DOI: 10.1155/2022/2235994] [Reference Citation Analysis]
148 Polak M, Nowicki GJ, Naylor K, Piekarski R, Ślusarska B. The Prevalence of Depression Symptoms and Their Socioeconomic and Health Predictors in a Local Community with a High Deprivation: A Cross-Sectional Studies. Int J Environ Res Public Health 2022;19:11797. [PMID: 36142069 DOI: 10.3390/ijerph191811797] [Reference Citation Analysis]
149 Mele F, Gendarini C, Pantoni L. The use of dual antiplatelet therapy for ischemic cerebrovascular events. Neurol Sci 2022. [DOI: 10.1007/s10072-022-06395-z] [Reference Citation Analysis]
150 Kunimura A, Miura K, Segawa H, Torii S, Kondo K, Hisamatsu T, Kadota A, Fujiyoshi A, Yano Y, Nakagawa Y, Okamura T, Ueshima H; SESSA research group. Relationship between Serum Proprotein Convertase Subtilisin/Kexin Type 9 Concentration and Prevalence of Coronary Artery Calcium in a Community-Based Sample of Japanese Men. J Atheroscler Thromb 2022. [PMID: 36123046 DOI: 10.5551/jat.63549] [Reference Citation Analysis]
151 Cortigiani L, Azzolina D, Ciampi Q, Lorenzoni G, Gaibazzi N, Rigo F, Gherardi S, Bovenzi F, Gregori D, Picano E. Machine Learning Algorithms for Prediction of Survival by Stress Echocardiography in Chronic Coronary Syndromes. JPM 2022;12:1523. [DOI: 10.3390/jpm12091523] [Reference Citation Analysis]
152 Sechtem U, Seitz A, Ong P, Bekeredjian R. Management des chronischen Koronarsyndroms. Herz. [DOI: 10.1007/s00059-022-05137-3] [Reference Citation Analysis]
153 McKinn S, Batcup C, Cornell S, Freeman N, Doust J, Bell KJL, Figtree GA, Bonner C. Decision Support Tools for Coronary Artery Calcium Scoring in the Primary Prevention of Cardiovascular Disease Do Not Meet Health Literacy Needs: A Systematic Environmental Scan and Evaluation. Int J Environ Res Public Health 2022;19:11705. [PMID: 36141978 DOI: 10.3390/ijerph191811705] [Reference Citation Analysis]
154 Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V; SECURE Investigators. Polypill Strategy in Secondary Cardiovascular Prevention. N Engl J Med 2022;387:967-77. [PMID: 36018037 DOI: 10.1056/NEJMoa2208275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
155 Lee T, Hwang S, Seo DM, Shin HC, Kim HS, Kim J, Uh Y. Identification of Cardiovascular Disease-Related Genes Based on the Co-Expression Network Analysis of Genome-Wide Blood Transcriptome. Cells 2022;11:2867. [DOI: 10.3390/cells11182867] [Reference Citation Analysis]
156 Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. [DOI: 10.1038/s41581-022-00616-6] [Reference Citation Analysis]
157 Lin P, Shen N, Yin F, Guo S. Sea cucumber-derived compounds for treatment of dyslipidemia: A review. Front Pharmacol 2022;13:1000315. [DOI: 10.3389/fphar.2022.1000315] [Reference Citation Analysis]
158 Rittger H, Leistner DM, Hardt R, Dörr M, Hambrecht R, Reibis R, Schellong S, Schirmer SH, Wolf A, Simm A, Müller-werdan U, Landmesser U. Cholesterinsenkende Therapie bei älteren Patienten. Kardiologie 2022. [DOI: 10.1007/s12181-022-00575-z] [Reference Citation Analysis]
159 Scicchitano P. Impact of psychological status on cardiovascular diseases: Is it time for upgrading risk score charts? Atherosclerosis 2022:S0021-9150(22)01416-2. [PMID: 36127169 DOI: 10.1016/j.atherosclerosis.2022.09.002] [Reference Citation Analysis]
160 Sabio JM, Garcia-de Los Ríos C, Medina-Casado M, Del Mar Del Águila-García M, Cáliz-Cáliz R, Díaz-Chamorro A. High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function. Rheumatol Int 2022. [PMID: 36094601 DOI: 10.1007/s00296-022-05204-2] [Reference Citation Analysis]
161 Caselli C, Di Giorgi N, Ragusa R, Lorenzoni V, Smit J, El Mahdiui M, Buechel RR, Teresinska A, Pizzi MN, Roque A, Poddighe R, Knuuti J, Schütte M, Parodi O, Pelosi G, Scholte A, Rocchiccioli S, Neglia D; SMARTool Investigators. Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS). Vascul Pharmacol 2022;146:107098. [PMID: 36100166 DOI: 10.1016/j.vph.2022.107098] [Reference Citation Analysis]
162 Detopoulou P, Dedes V, Syka D, Tzirogiannis K, Panoutsopoulos GI. Mediterranean Diet, a Posteriori Dietary Patterns, Time-Related Meal Patterns and Adiposity: Results from a Cross-Sectional Study in University Students. Diseases 2022;10:64. [PMID: 36135220 DOI: 10.3390/diseases10030064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
163 Lugo-Gavidia LM, Nolde JM, Carnagarin R, Burger D, Chan J, Robinson S, Bosio E, Matthews VB, Schlaich MP. Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation. Int J Mol Sci 2022;23:10524. [PMID: 36142436 DOI: 10.3390/ijms231810524] [Reference Citation Analysis]
164 Michelsen HÖ, Henriksson P, Wallert J, Bäck M, Sjölin I, Schlyter M, Hagström E, Kiessling A, Held C, Hag E, Nilsson L, Schiopu A, Zaman MJ, Leosdottir M. Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study. Int J Cardiol 2022:S0167-5273(22)01322-5. [PMID: 36089158 DOI: 10.1016/j.ijcard.2022.09.012] [Reference Citation Analysis]
165 Feng Z, Tong WK, Tang Z. Longitudinal trends in the prevalence and treatment of depression among adults with cardiovascular disease: An analysis of national health and nutrition examination survey 2009–2020. Front Psychiatry 2022;13:943165. [DOI: 10.3389/fpsyt.2022.943165] [Reference Citation Analysis]
166 Toth PP, Bray S, Villa G, Palagashvili T, Sattar N, Stroes ESG, Worth GM. Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein Cholesterol. J Am Heart Assoc 2022;:e025551. [PMID: 36073669 DOI: 10.1161/JAHA.122.025551] [Reference Citation Analysis]
167 Shalnova SA, Metelskaya VA, Kutsenko VA, Yarovaya EB, Kapustina AV, Muromtseva GA, Svinin GE, Balanova YA, Imaeva AE, Evstifeeva SE, Vilkov VG, Barbarash OL, Belova OA, Grinshtein YI, Efanov AY, Kalachikova ON, Kulakova NV, Rotar OP, Trubacheva IA, Duplyakov DV, Libis RA, Viktorova IA, Redko AN, Yakushin SS, Boytsov SA, Shlyakhto EV, Drapkina OM. Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;18:366-375. [DOI: 10.20996/1819-6446-2022-07-01] [Reference Citation Analysis]
168 Spirito A, Cohen R, Mehran R. Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed? J Am Heart Assoc 2022;11:e027297. [PMID: 36056727 DOI: 10.1161/JAHA.122.027297] [Reference Citation Analysis]
169 Sawami K, Tanaka A, Node K. Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists. Cardiovasc Diabetol 2022;21:176. [PMID: 36068534 DOI: 10.1186/s12933-022-01611-8] [Reference Citation Analysis]
170 De Backer G, De Bacquer D. SCORE 2: een nieuw model om het risico op cardiovasculaire ziekten in te schatten. Tijdschr Geneesk 2022. [DOI: 10.47671/tvg.78.22.076] [Reference Citation Analysis]
171 Dahlmann AC, Konradsen H, Risom SS, Rasmussen TB. Prevalence of constipation and associated factors among patients with heart disease: A cross-sectional survey. NSF 2022;12:1-13. [DOI: 10.18261/nsf.12.4.4] [Reference Citation Analysis]
172 Bartuś S, Siłka W, Kasprzycki K, Sabatowski K, Malinowski KP, Rzeszutko Ł, Chyrchel M, Bryniarski L, Surdacki A, Bartuś K, Januszek R. Experience with Optical Coherence Tomography Enhanced by a Novel Software (Ultreon™ 1.0 Software)—The First One Hundred Cases. Medicina 2022;58:1227. [DOI: 10.3390/medicina58091227] [Reference Citation Analysis]
173 Sulman D, Zeitouni M, Silvain J, Kerneis M, Guedeney P, Barthélémy O, Brugier D, Sabouret P, Lattuca B, Mertens E, Posson J, Procopi N, Salloum T, Collet J, Montalescot G. ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2. European Heart Journal - Cardiovascular Pharmacotherapy 2022;8:633-643. [DOI: 10.1093/ehjcvp/pvac021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Agewall S. Prevention is still the key to success. European Heart Journal - Cardiovascular Pharmacotherapy 2022;8:537-538. [DOI: 10.1093/ehjcvp/pvac046] [Reference Citation Analysis]
175 Sementsova NA, Chesnikova AI, Safronenko VA, Skarzhinskaya NS. Estimation of vascular stiffness in patients with arterial hypertension and atherosclerosis of the lower limb arteries taking into account hypolipidemic therapy. Med vestn Ûga Ross 2022;13:127-136. [DOI: 10.21886/2219-8075-2022-13-3-127-136] [Reference Citation Analysis]
176 Bergman E, Vepsäläinen H, Erkkola M, Laaksonen M, Kautiainen H, Penttinen MA, Rautava P, Korhonen PE. Healthy and Unhealthy Food Consumption in Relation to Quality of Life among Finnish Female Municipal Employees: A Cross-Sectional Study. Nutrients 2022;14:3630. [PMID: 36079887 DOI: 10.3390/nu14173630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-lingen C, Garfias-veitl T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U. Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 2). Kardiologie 2022;16:411-432. [DOI: 10.1007/s12181-022-00574-0] [Reference Citation Analysis]
178 Cosín-sales J, Campuzano Ruiz R, Díaz Díaz JL, Escobar Cervantes C, Fernández Olmo MR, Gómez-doblas JJ, Mostaza JM, Pedro-botet J, Plana Gil N, Valdivielso P. Protocolo del observatorio de las dislipemias: Tratamiento de la hipercolesterolemia en España, contexto e identificación de medidas de mejora en práctica clínica habitual. Clínica e Investigación en Arteriosclerosis 2022;34:253-260. [DOI: 10.1016/j.arteri.2022.02.001] [Reference Citation Analysis]
179 Galvis-acevedo S, Rivas-escobar D, Arias-castillo L, García-perdomo HA. Enfermedad cardiovascular aterosclerótica y sexualidad. Revista Urología Colombiana / Colombian Urology Journal 2022;31:e121-e129. [DOI: 10.1055/s-0042-1746202] [Reference Citation Analysis]
180 Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, Mason JC, Rahimi K, Mcmurray JJV, Verbakel JY. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. The Lancet 2022;400:733-43. [DOI: 10.1016/s0140-6736(22)01349-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
181 Niezgoda JT, Przerwa F, Kukowka A, Aleksandrzak J, Kotrych K, Uzar I. Role of natural fatty acids in prophylaxis and treatment of cardiovascular diseases. Herba Polonica 2022;68:27-35. [DOI: 10.2478/hepo-2022-0017] [Reference Citation Analysis]
182 Pamminger M, Mayr A. Kardiovaskuläre Folgen des Rauchens. Radiologie 2022;62:763-771. [DOI: 10.1007/s00117-022-01027-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Ruyssen-witrand A. Prévenir les complications cardiovasculaires dans les rhumatismes inflammatoires chroniques. Revue du Rhumatisme Monographies 2022;89:245-251. [DOI: 10.1016/j.monrhu.2022.05.006] [Reference Citation Analysis]
184 Ambrosetti M, Hansen D. Exercise training for cardiovascular patients: Push me across the threshold! International Journal of Cardiology Cardiovascular Risk and Prevention 2022;14:200133. [DOI: 10.1016/j.ijcrp.2022.200133] [Reference Citation Analysis]
185 Krempf M. Les nouveaux traitements du cholestérol. Pratiques en nutrition 2022. [DOI: 10.1016/j.pranut.2022.09.004] [Reference Citation Analysis]
186 Vilela EM, Fontes-carvalho R. Reply to Letter to the editor regarding the article: “Inflammation and ischemic heart disease: The next therapeutic target?”. Revista Portuguesa de Cardiologia 2022;41:811-812. [DOI: 10.1016/j.repc.2022.07.001] [Reference Citation Analysis]
187 de Hartog-keyzer JM, Pedersen SS, El Messaoudi S, Nijveldt R, Pop VJ. Psychological distress is independently related to new coronary events at 8 years' follow-up in elderly primary care patients with hypertension. Journal of Psychosomatic Research 2022;160:110980. [DOI: 10.1016/j.jpsychores.2022.110980] [Reference Citation Analysis]
188 Cosín-sales J, Campuzano Ruiz R, Díaz Díaz JL, Escobar Cervantes C, Fernández Olmo MR, Gómez-doblas JJ, Mostaza JM, Pedro-botet J, Plana Gil N, Valdivielso P. Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practice. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:253-260. [DOI: 10.1016/j.artere.2022.08.003] [Reference Citation Analysis]
189 Prieto-díaz M, Méndez-rodríguez E, Murillo-garcía D, Escobar-cervantes C, Pallarés-carratalá V, Díaz-rodríguez A, Escribano-serrano J, Polo-garcía J, Cinza-sanjurjo S. Utilidad de una aplicación web interactiva en la mejora del control de los factores de riesgo cardiovascular. Proyecto Control-RCV. Medicina de Familia SEMERGEN 2022;48:411-422. [DOI: 10.1016/j.semerg.2022.04.007] [Reference Citation Analysis]
190 Adachi T, Tsunekawa Y, Tanimura D. Association among mild cognitive impairment, social frailty, and clinical events in elderly patients with cardiovascular disease. Heart Lung 2022;55:82-8. [PMID: 35500433 DOI: 10.1016/j.hrtlng.2022.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
191 Gorostidi M, Gijón-conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E, Oliveras A, Santamaría R, Segura J, Molinero A, Pérez-manchón D, Abad M, Abellán J, Armario P, Banegas J, Camafort M, Catalina C, Coca A, Divisón J, Domenech M, Martell N, Martín-rioboó E, Morales-olivas F, Pallarés V, Pérez de Isla L, Prieto M, Redón J, Ruilope L, García-donaire J. Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Hipertensión y Riesgo Vascular 2022. [DOI: 10.1016/j.hipert.2022.09.002] [Reference Citation Analysis]
192 Lira MT. Estratificación de riesgo cardiovascular: conceptos, análisis crítico, desafíos e historia de su desarrollo en Chile. Revista Médica Clínica Las Condes 2022;33:534-544. [DOI: 10.1016/j.rmclc.2022.08.003] [Reference Citation Analysis]
193 Wittboldt S, Leosdottir M, Ravn Fischer A, Ekman B, Bäck M. Exercise-based cardiac rehabilitation after acute myocardial infarction in Sweden - standards, costs, and adherence to European guidelines (The Perfect-CR study). Physiother Theory Pract 2022;:1-11. [PMID: 36047009 DOI: 10.1080/09593985.2022.2114052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Levin MG, Rader DJ. Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: progress toward clinical implementation. Best Practice & Research Clinical Endocrinology & Metabolism 2022. [DOI: 10.1016/j.beem.2022.101702] [Reference Citation Analysis]
195 Werren M, Valent F, Di Chiara A. Effectiveness of home-rehabilitation in patients after an acute coronary syndrome and myocardial revascularization. International Journal of Cardiology Cardiovascular Risk and Prevention 2022;14:200131. [DOI: 10.1016/j.ijcrp.2022.200131] [Reference Citation Analysis]
196 Dedov II, Shestakova MV, Mayorov AY, Mokrysheva NG, Vikulova OK, Galstyan GR, Kuraeva TL, Peterkova VA, Smirnova OM, Starostina EG, Surkova EV, Sukhareva OY, Tokmakova AY, Shamkhalova MS, Jarek-martynova IR, Artemova EV, Beshlieva DD, Bondarenko ON, Volevodz NN, Gomova IS, Grigoryan OR, Dzhemilova ZN, Esayan RM, Ibragimova LI, Kalashnikov VY, Kononenko IV, Laptev DN, Lipatov DV, Melnikova OG, Mikhina MS, Michurova MS, Motovilin OG, Nikonova TV, Rozhivanov RV, Sklyanik IA, Shestakova EA. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition. Diabetes mellitus 2022;24:1-148. [DOI: 10.14341/dm12802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
197 Müller-Werdan U. [Cardiovascular prevention in old age-Cardiovascular prevention of ageing?]. Z Gerontol Geriatr 2022. [PMID: 36044072 DOI: 10.1007/s00391-022-02111-w] [Reference Citation Analysis]
198 Qiao Y, Zou Y, Guo S. Low-density lipoprotein particles in atherosclerosis. Front Physiol 2022;13:931931. [DOI: 10.3389/fphys.2022.931931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Anugula D, Cardoso R, Grandhi GR, Blankstein R, Nasir K, Al-Mallah M, Shah DJ, Cainzos-Achirica M. Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading? Curr Atheroscler Rep 2022. [PMID: 36040566 DOI: 10.1007/s11883-022-01051-5] [Reference Citation Analysis]
200 Arrobas Velilla T, Brea Á, Valdivielso P. Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study. Front Genet 2022;13:971651. [DOI: 10.3389/fgene.2022.971651] [Reference Citation Analysis]
201 Dybvik JS, Svendsen M, Aune D. Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke: a systematic review and meta-analysis of prospective cohort studies. Eur J Nutr 2022. [PMID: 36030329 DOI: 10.1007/s00394-022-02942-8] [Reference Citation Analysis]
202 Park D, Kang D, Ahn J, Yun S, Yoon Y, Hur S, Lee CH, Kim W, Kang SH, Park CS, Lee B, Suh J, Yoon JH, Choi JW, Kim K, Choi SW, Lee SN, Park S. Routine Functional Testing or Standard Care in High-Risk Patients after PCI. N Engl J Med. [DOI: 10.1056/nejmoa2208335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Pengo MF, Gozal D, Martinez-garcia MA. Should we treat with continuous positive airway pressure severe non-sleepy obstructive sleep apnea individuals without underlying cardiovascular disease? Sleep 2022. [DOI: 10.1093/sleep/zsac208] [Reference Citation Analysis]
204 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022:ehac244. [PMID: 36017568 DOI: 10.1093/eurheartj/ehac244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
205 Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van Der Meer P, Wojakowski W, Zacharowski K, Knuuti J, Kristensen SD, Aboyans V, Ahrens I, Antoniou S, Asteggiano R, Atar D, Baumbach A, Baumgartner H, Böhm M, Borger MA, Bueno H, Čelutkienė J, Chieffo A, Cikes M, Darius H, Delgado V, Devereaux PJ, Duncker D, Falk V, Fauchier L, Habib G, Hasdai D, Huber K, Iung B, Jaarsma T, Konradi A, Koskinas KC, Kotecha D, Landmesser U, Lewis BS, Linhart A, Løchen ML, Maeng M, Manzo-Silberman S, Mindham R, Neubeck L, Nielsen JC, Petersen SE, Prescott E, Rakisheva A, Saraste A, Sibbing D, Siller-Matula J, Sitges M, Stankovic I, Storey RF, Ten Berg J, Thielmann M, Touyz RM; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022:ehac270. [PMID: 36017553 DOI: 10.1093/eurheartj/ehac270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
206 Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group . 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022:ehac262. [PMID: 36017572 DOI: 10.1093/eurheartj/ehac262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
207 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging 2022:jeac106. [PMID: 36017575 DOI: 10.1093/ehjci/jeac106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
208 Kambic T, Šarabon N, Lainscak M, Hadžić V. Combined resistance training with aerobic training improves physical performance in patients with coronary artery disease: A secondary analysis of a randomized controlled clinical trial. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.909385] [Reference Citation Analysis]
209 Feuchtner G, Beyer C, Barbieri F, Spitaler P, Dichtl W, Friedrich G, Widmann G, Plank F. The Atherosclerosis Profile by Coronary Computed Tomography Angiography (CTA) in Symptomatic Patients with Coronary Artery Calcium Score Zero. Diagnostics 2022;12:2042. [DOI: 10.3390/diagnostics12092042] [Reference Citation Analysis]
210 Lin J, Mars N, Fu Y, Ripatti P, Kiiskinen T, Finngen, Tukiainen T, Ripatti S, Pirinen M. Integration of biomarker polygenic risk score improves prediction of coronary heart disease in UK Biobank and FinnGen.. [DOI: 10.1101/2022.08.22.22279057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
211 Vitola B, Trusinskis K, Mintale I, Kalnina M, Erglis A. Coronary Artery Disease in Women: Lessons Learned from Single-Center SPECT Registry and Future Directions for INOCA Patients. Medicina 2022;58:1139. [DOI: 10.3390/medicina58091139] [Reference Citation Analysis]
212 Groenendyk JW, Greenland P, Khan SS. Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review. JAMA Intern Med 2022. [PMID: 35994254 DOI: 10.1001/jamainternmed.2022.3171] [Reference Citation Analysis]
213 Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Melnichenko AA, Grechko AV, Orekhov AN. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.959285] [Reference Citation Analysis]
214 Parry R, Majeed K, Pixley F, Hillis GS, Francis RJ, Schultz CJ. Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review. Eur Heart J Cardiovasc Imaging 2022:jeac167. [PMID: 35993316 DOI: 10.1093/ehjci/jeac167] [Reference Citation Analysis]
215 Kozakova M, Morizzo C, Jamagidze G, Chiappino D, Palombo C. Comparison between Carotid Distensibility-Based Vascular Age and Risk-Based Vascular Age in Middle-Aged Population Free of Cardiovascular Disease. J Clin Med 2022;11:4931. [PMID: 36013170 DOI: 10.3390/jcm11164931] [Reference Citation Analysis]
216 Ihdayhid AR, Lan NSR, Williams M, Newby D, Flack J, Kwok S, Joyner J, Gera S, Dembo L, Adler B, Ko B, Chow BJW, Dwivedi G. Evaluation of an artificial intelligence coronary artery calcium scoring model from computed tomography. Eur Radiol. [DOI: 10.1007/s00330-022-09028-3] [Reference Citation Analysis]
217 Sharma SK, Makkar JS, Bana A, Sharma K, Kasliwal A, Sidana SK, Degawat PR, Bhagat KK, Chaurasia AK, Natani V, Sharma SK, Gupta R. Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based registry. Indian Heart J 2022:S0019-4832(22)00127-4. [PMID: 35995321 DOI: 10.1016/j.ihj.2022.08.003] [Reference Citation Analysis]
218 Zamyatin KA, Nozdrachev DI, Kakadzhikova DG, Golovanova UV, Varaksin GA. Assessment of the quality of mobile applications for smoking cessation and its potential for the modification of psychosocial and behavioral risk factors for cardiovascular disease. Russ J Cardiol 2022;27:5190. [DOI: 10.15829/1560-4071-2022-5190] [Reference Citation Analysis]
219 Rossini E, Biscetti F, Rando MM, Nardella E, Cecchini AL, Nicolazzi MA, Covino M, Gasbarrini A, Massetti M, Flex A. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? IJMS 2022;23:9326. [DOI: 10.3390/ijms23169326] [Reference Citation Analysis]
220 Nozdrachev DI, Solovieva MN, Zamyatin KA. Effectiveness of mindfulness-based therapy, stress reduction in hypertension and prehypertension: a systematic review. Russ J Cardiol 2022;27:5189. [DOI: 10.15829/1560-4071-2022-5189] [Reference Citation Analysis]
221 Chrissini MK, Panagiotakos DB. Acute Myocardial Infarction in Young Patients and its Correlation with Obesity Status at Pre-adolescent Stage: A Narrative Review. TOCMJ 2022;16:e187419242206200. [DOI: 10.2174/18741924-v16-e2206200] [Reference Citation Analysis]
222 Anderson JL, Le VT, Bair TL, Muhlestein JB, Knowlton KU, Horne BD. Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience. JCM 2022;11:4797. [DOI: 10.3390/jcm11164797] [Reference Citation Analysis]
223 Cavallari I, Nobile E, De Filippis A, Veneziano F, Maddaloni E, Ussia GP, Grigioni F. Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes. Diabetes Res Clin Pract 2022;191:110043. [PMID: 35985427 DOI: 10.1016/j.diabres.2022.110043] [Reference Citation Analysis]
224 Champion S, Clark RA, Tirimacco R, Tideman P, Gebremichael L, Beleigoli A. The Impact of the SARS-CoV-2 Virus (COVID-19) Pandemic and the Rapid Adoption of Telehealth for Cardiac Rehabilitation and Secondary Prevention Programs in Rural and Remote Australia: A Multi-Method Study. Heart Lung Circ 2022:S1443-9506(22)01006-X. [PMID: 35987722 DOI: 10.1016/j.hlc.2022.07.006] [Reference Citation Analysis]
225 Jamialahmadi T, Reiner Ž, Alidadi M, Kroh M, Almahmeed W, Ruscica M, Sirtori C, Rizzo M, Santos RD, Sahebkar A, Aga SS. The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/8435133] [Reference Citation Analysis]
226 Obrová J, Jadrníčková P, Václavík J. What's new in 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice? Vnitr Lek 2022;68:295-302. [DOI: 10.36290/vnl.2022.063] [Reference Citation Analysis]
227 Zheng J, Wang J, Zhang Y, Xia J, Guo H, Hu H, Shan P, Li T. The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019. Front Public Health 2022;10:891929. [DOI: 10.3389/fpubh.2022.891929] [Reference Citation Analysis]
228 Moslehi N, Rahimi Sakak F, Mahdavi M, Mirmiran P, Azizi F. Visceral adiposity-related dietary patterns and the risk of cardiovascular disease in Iranian adults: A population-based cohort study. Front Nutr 2022;9:812701. [PMID: 35967797 DOI: 10.3389/fnut.2022.812701] [Reference Citation Analysis]
229 Fan G, Zhang S, Wu Q, Song Y, Jia A, Li D, Yue Y, Wang Q. A machine learning-based approach for low-density lipoprotein cholesterol calculation using age, and lipid parameters. Clin Chim Acta 2022;535:53-60. [PMID: 35970405 DOI: 10.1016/j.cca.2022.08.007] [Reference Citation Analysis]
230 Vergallo R, Liuzzo G. Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages? Eur Heart J 2022:ehac443. [PMID: 35962625 DOI: 10.1093/eurheartj/ehac443] [Reference Citation Analysis]
231 Biffi A, Fernando F, Palermi S, Sirico F, Bonatesta L, Cavarretta E, D'Ascenzi F, Niebauer J. Cardiovascular disease prevention in the worksite: Where are we? Int J Cardiol 2022:S0167-5273(22)01194-9. [PMID: 35964848 DOI: 10.1016/j.ijcard.2022.08.026] [Reference Citation Analysis]
232 Sagris D, Harrison SL, Lip GYH. Lipids and atrial fibrillation: New insights into a paradox. PLoS Med 2022;19:e1004067. [DOI: 10.1371/journal.pmed.1004067] [Reference Citation Analysis]
233 Lindgren M, Nielsen SJ, Björklund E, Pivodic A, Perrotta S, Hansson EC, Jeppsson A, Martinsson A. Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study. European Heart Journal - Cardiovascular Pharmacotherapy 2022;8:529-536. [DOI: 10.1093/ehjcvp/pvac006] [Reference Citation Analysis]
234 Torosyan N, Visrodia P, Torbati T, Minissian MB, Shufelt CL. Dyslipidemia in midlife women: Approach and considerations during the menopausal transition. Maturitas 2022;166:14-20. [PMID: 36027726 DOI: 10.1016/j.maturitas.2022.08.001] [Reference Citation Analysis]
235 Hu X, Qin H, Yan Y, Wu W, Gong S, Wang L, Jiang R, Zhao Q, Sun Y, Wang Q, Wang S, Zhao H, Liu J, Yuan P. Exosomal circular RNAs: Biogenesis, effect, and application in cardiovascular diseases. Front Cell Dev Biol 2022;10:948256. [DOI: 10.3389/fcell.2022.948256] [Reference Citation Analysis]
236 Georgoulis M, Georgousopoulou EN, Chrysohoou C, Pitsavos C, Panagiotakos DB. Longitudinal Trends, Determinants, and Cardiometabolic Impact of Adherence to the Mediterranean Diet among Greek Adults. Foods 2022;11:2389. [DOI: 10.3390/foods11162389] [Reference Citation Analysis]
237 Lugo-Gavidia LM, Burger D, Nolde JM, Carnagarin R, Chan J, Bosio E, Matthews VB, Schlaich MP. Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes. J Hypertens 2022. [PMID: 35950995 DOI: 10.1097/HJH.0000000000003248] [Reference Citation Analysis]
238 Papazoglou AS, Farmakis IT, Zafeiropoulos S, Moysidis DV, Karagiannidis E, Stalikas N, Kartas A, Stamos K, Sofidis G, Doundoulakis I, Giannopoulos G, Giannakoulas G, Sianos G. Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors. Front Cardiovasc Med 2022;9:934946. [PMID: 35935615 DOI: 10.3389/fcvm.2022.934946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Resolution of the III International menopause expert forum. RE 2022. [DOI: 10.18370/2309-4117.2022.65.80-88] [Reference Citation Analysis]
240 Maki KC, Dicklin MR. Is there an optimal diet for primordial prevention of atherosclerosis? Eur Heart J 2022:ehac434. [PMID: 35938853 DOI: 10.1093/eurheartj/ehac434] [Reference Citation Analysis]
241 Crea F. The burden of cardiovascular risk factors: a global perspective. Eur Heart J 2022;43:2817-20. [PMID: 35933110 DOI: 10.1093/eurheartj/ehac430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Zujko ME, Waśkiewicz A, Witkowska AM, Cicha-Mikołajczyk A, Zujko K, Drygas W. Dietary Total Antioxidant Capacity-A New Indicator of Healthy Diet Quality in Cardiovascular Diseases: A Polish Cross-Sectional Study. Nutrients 2022;14:3219. [PMID: 35956397 DOI: 10.3390/nu14153219] [Reference Citation Analysis]
243 Marilly E, Cottin J, Cabrera N, Cornu C, Boussageon R, Moulin P, Lega JC, Gueyffier F, Cucherat M, Grenet G. SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits. Diabetologia 2022. [PMID: 35925319 DOI: 10.1007/s00125-022-05773-8] [Reference Citation Analysis]
244 Chi C, Fu H, Li YH, Zhang GY, Zeng FY, Ji QX, Shen QR, Wang XJ, Li ZC, Zhou CC, Sun DY, Fu JT, Wu WB, Zhang PP, Zhang JB, Liu J, Shen FM, Li DJ, Wang P. Exerkine fibronectin type-III domain-containing protein 5/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability. Eur Heart J 2022:ehac431. [PMID: 35929617 DOI: 10.1093/eurheartj/ehac431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
245 Cazac GD, Lăcătușu CM, Mihai C, Grigorescu ED, Onofriescu A, Mihai BM. New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis. Life (Basel) 2022;12:1189. [PMID: 36013368 DOI: 10.3390/life12081189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Cascos E, Sitges M. La inevitable levedad de la ecocardioscopia: trabajo en equipo, formación y control de calidad son imprescindibles. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2022.07.018] [Reference Citation Analysis]
247 Ahmadi MN, Lee I, Hamer M, del Pozo Cruz B, Chen LJ, Eroglu E, Lai Y, Ku PW, Stamatakis E. Changes in physical activity and adiposity with all-cause, cardiovascular disease, and cancer mortality. Int J Obes. [DOI: 10.1038/s41366-022-01195-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
248 Ortega Martínez de Victoria E, Doménech CV. Riesgo cardiovascular en diabetes tipo 1 y tipo 2: Diferencias, similitudes y reflexiones. Endocrinología, Diabetes y Nutrición 2022;69:455-457. [DOI: 10.1016/j.endinu.2022.07.001] [Reference Citation Analysis]
249 Jimeno Sánchez J, Chabbar Boudet M, Morlanes Gracia P, Laita Monreal S, López Perales C, Cuko G, Albarrán Martín C, Garza Benito F. Intervención antitabaco en fase aguda del síndrome coronario agudo: ¿existe beneficio adicional en pacientes incluidos en un programa de rehabilitación cardiaca? Journal of Healthcare Quality Research 2022. [DOI: 10.1016/j.jhqr.2022.06.005] [Reference Citation Analysis]
250 Marchiori E, Rodionov RN, Peters F, Magnussen C, Nordanstig J, Gombert A, Spanos K, Jarzebska N, Behrendt C. SGLT2 Inhibitors and Peripheral Vascular Events. Heart Failure Clinics 2022. [DOI: 10.1016/j.hfc.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Svendsen K, Olsen T, Vinknes KJ, Mundal LJ, Holven KB, Bogsrud MP, Leren TP, Igland J, Retterstøl K. Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.08.015] [Reference Citation Analysis]
252 Caldeira D, Franco F, Bravo Baptista S, Cabral S, Cachulo MDC, Dores H, Peixeiro A, Rodrigues R, Santos M, Timóteo AT, Vasconcelos J, Gonçalves L. Air pollution and cardiovascular diseases: A position paper. Revista Portuguesa de Cardiologia 2022;41:709-717. [DOI: 10.1016/j.repc.2022.05.006] [Reference Citation Analysis]
253 Ganz M. Lipoproteinsenkende Therapie bei Diabetes mellitus. Diabetes aktuell 2022;20:212-216. [DOI: 10.1055/a-1851-0140] [Reference Citation Analysis]
254 Juárez Olmos V, Severo Sánchez A, Zamora Auñón P, López-fernández T. Cardio-oncology at present: a pending challenge. Revista Española de Cardiología (English Edition) 2022;75:695-696. [DOI: 10.1016/j.rec.2022.05.010] [Reference Citation Analysis]
255 Weingärtner O, Marx N, Klose G, Laufs U. [Therapeutic options to reduce LDL-cholesterol beyond statins]. Dtsch Med Wochenschr 2022;147:1001-12. [PMID: 35915886 DOI: 10.1055/a-1516-2631] [Reference Citation Analysis]
256 Sudano I. Hypertension and Hypercholesterolemia: Let’s Make Therapy Easy and Efficient. Praxis 2022;111:558-563. [DOI: 10.1024/1661-8157/a003894] [Reference Citation Analysis]
257 Ghisi GLDM, Kin SMR, Price J, Beckie TM, Mamataz T, Naheed A, Grace SL. Women-Focused Cardiovascular Rehabilitation: An International Council of Cardiovascular Prevention and Rehabilitation Clinical Practice Guideline. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.06.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Kageyama S, Serruys PW, Garg S, Ninomiya K, Masuda S, Kotoku N, Colombo A, Mack MJ, Banning AP, Morice M, Witkowski A, Curzen N, Burzotta F, James S, van Geuns R, Davierwala PM, Holmes DR, Wood DA, Mcevoy JW, Onuma Y. Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Bañeras J, Iglesies-grau J, Téllez-plaza M, Arrarte V, Báez-ferrer N, Benito B, Campuzano Ruiz R, Cecconi A, Domínguez-rodríguez A, Rodríguez-sinovas A, Ujueta F, Vozzi C, Lamas GA, Navas-acién A. Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment. Revista Española de Cardiología (English Edition) 2022. [DOI: 10.1016/j.rec.2022.05.030] [Reference Citation Analysis]
260 Kjeldsen EW, Thomassen JQ, Rasmussen KL, Nordestgaard BG, Tybjærg-hansen A, Frikke-schmidt R. Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: A tool for implementation of healthy diets. The Lancet Regional Health - Europe 2022;19:100419. [DOI: 10.1016/j.lanepe.2022.100419] [Reference Citation Analysis]
261 Amiot-carlin MJ. Profils alimentaires et pathologies cardiovasculaires. Cahiers de Nutrition et de Diététique 2022. [DOI: 10.1016/j.cnd.2022.07.002] [Reference Citation Analysis]
262 Wang M, Peter SS, Chu CD, Tuot DS, Chen JH. Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression. JAMA Netw Open 2022;5:e2225797. [PMID: 35984661 DOI: 10.1001/jamanetworkopen.2022.25797] [Reference Citation Analysis]
263 Victoria EOMD, Doménech CV. Cardiovascular risk in type 1 and type 2 diabetes: Differences, similarities and insights. Endocrinología, Diabetes y Nutrición (English ed ) 2022;69:455-457. [DOI: 10.1016/j.endien.2022.08.004] [Reference Citation Analysis]
264 Bubnova MG. Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics 2022;13:31-42. [DOI: 10.17816/22217185.2022.1.201750] [Reference Citation Analysis]
265 Henein MY, Vancheri S, Longo G, Vancheri F. The Impact of Mental Stress on Cardiovascular Health—Part II. JCM 2022;11:4405. [DOI: 10.3390/jcm11154405] [Reference Citation Analysis]
266 Ruscica M, Sirtori CR, Carugo S, Banach M, Corsini A. Bempedoic Acid: for Whom and When. Curr Atheroscler Rep 2022. [PMID: 35900636 DOI: 10.1007/s11883-022-01054-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Orsi E, Solini A, Bonora E, Vitale M, Garofolo M, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Laviola L, Morano S, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Acta Diabetol 2022. [PMID: 35902419 DOI: 10.1007/s00592-022-01942-8] [Reference Citation Analysis]
268 Leitão C, Pereira SO, Marques C, Cennamo N, Zeni L, Shaimerdenova M, Ayupova T, Tosi D. Cost-Effective Fiber Optic Solutions for Biosensing. Biosensors (Basel) 2022;12:575. [PMID: 36004971 DOI: 10.3390/bios12080575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
269 Dammen T, Tunheim K, Munkhaugen J, Papageorgiou C. The Attention Training Technique Reduces Anxiety and Depression in Patients With Coronary Heart Disease: A Pilot Feasibility Study. Front Psychol 2022;13:948081. [DOI: 10.3389/fpsyg.2022.948081] [Reference Citation Analysis]
270 Ruiz-bustillo S, Badosa N, Cabrera-aguilera I, Ivern C, Llagostera M, Mojón D, Vicente M, Ribas N, Recasens L, Martí-almor J, Cladellas M, Farré N. An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.916031] [Reference Citation Analysis]
271 Wieczorek E, Ćwiklińska A, Jankowski M. Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment. Clin Chem Lab Med 2022;60:1145-59. [PMID: 35687325 DOI: 10.1515/cclm-2022-0189] [Reference Citation Analysis]
272 Citarella A, Cammarota S, Bernardi FF, Caliendo L, D'Andrea A, Fimiani B, Fogliasecca M, Pacella D, Pagnotta R, Trama U, Zito GB, Cillo M, Vercellone A. Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy. J Clin Med 2022;11:4344. [PMID: 35893434 DOI: 10.3390/jcm11154344] [Reference Citation Analysis]
273 Verma KP, Inouye M, Meikle PJ, Nicholls SJ, Carrington MJ, Marwick TH. New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the Week. J Am Coll Cardiol 2022;80:373-87. [PMID: 35863853 DOI: 10.1016/j.jacc.2022.05.015] [Reference Citation Analysis]
274 Miller M, Tokgozoglu L, Parhofer KG, Handelsman Y, Leiter LA, Landmesser U, Brinton EA, Catapano AL. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements. Expert Review of Cardiovascular Therapy. [DOI: 10.1080/14779072.2022.2103541] [Reference Citation Analysis]
275 Banach M, Catapano AL, Cicero AFG, Escobar C, Foger B, Katsiki N, Latkovskis G, Rakowski M, Reiner Z, Sahebkar A, Sikand G, Penson PE, On Behalf Of The International Lipid Expert Panel Ilep. Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel. Pharmacol Res 2022;183:106370. [PMID: 35901940 DOI: 10.1016/j.phrs.2022.106370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Shufelt CL, Mora S, Manson JE. Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women. JAMA 2022. [PMID: 35877108 DOI: 10.1001/jama.2022.11951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Garcia-lunar I, van der Ploeg HP, Fernández Alvira JM, van Nassau F, Castellano Vázquez JM, van der Beek AJ, Rossello X, Fernández-ortiz A, Coffeng J, van Dongen JM, Mendiguren JM, Ibáñez B, van Mechelen W, Fuster V. Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial. European Heart Journal 2022. [DOI: 10.1093/eurheartj/ehac378] [Reference Citation Analysis]
278 Sarafidis P, Ferro CJ, Ortiz A. Hypernatremia and subclinical chronic kidney disease. European Heart Journal 2022. [DOI: 10.1093/eurheartj/ehac367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Scoditti E, Tumolo MR, Garbarino S. Mediterranean Diet on Sleep: A Health Alliance. Nutrients 2022;14:2998. [DOI: 10.3390/nu14142998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
280 Tardif JC, Pfeffer MA, Kouz S, Koenig W, Maggioni AP, McMurray JJV, Mooser V, Waters DD, Grégoire JC, L'Allier PL, Jukema WJ, White HD, Heinonen T, Black DM, Laghrissi-Thode F, Levesque S, Guertin MC, Dubé MP; dal-GenE Investigators. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. Eur Heart J 2022:ehac374. [PMID: 35856777 DOI: 10.1093/eurheartj/ehac374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
281 Ties D, van der Ende YM, Pundziute G, van der Schouw YT, Bots ML, Xia C, van Ooijen PMA, Pelgrim GJ, Vliegenthart R, van der Harst P. Pre-screening to guide coronary artery calcium scoring for early identification of high-risk individuals in the general population. European Heart Journal - Cardiovascular Imaging 2022. [DOI: 10.1093/ehjci/jeac137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Kimenai DM, Pirondini L, Gregson J, Prieto D, Pocock SJ, Perel P, Hamilton T, Welsh P, Campbell A, Porteous DJ, Hayward C, Sattar N, Mills NL, Shah ASV. Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease. Circulation 2022;146:240-8. [PMID: 35748241 DOI: 10.1161/CIRCULATIONAHA.122.060042] [Reference Citation Analysis]
283 Bojanić I, Bjerkeset O, Williams LJ, Berk M, Sund ER, Sletvold H. Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway. Drugs Real World Outcomes 2022. [PMID: 35856136 DOI: 10.1007/s40801-022-00321-7] [Reference Citation Analysis]
284 Petsini F, Ntzouvani A, Detopoulou M, Papakonstantinou VD, Kalogeropoulos N, Fragopoulou E, Nomikos T, Kontogianni MD, Antonopoulou S. Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial. Foods 2022;11:2105. [PMID: 35885348 DOI: 10.3390/foods11142105] [Reference Citation Analysis]
285 Eyuboglu M, Celik A. Empagliflozin has favourable effect on frontal plane QRS-T angle in diabetic patients with cardiovascular disease. J Clin Pharm Ther 2022. [PMID: 35839522 DOI: 10.1111/jcpt.13734] [Reference Citation Analysis]
286 Roman D, Timar B, Avram V, Braha A, Saftescu S, Negru Ș, Timar R. The Role of Nut and Seed Consumption in Colorectal Cancer: A Narrative Review. Medicina 2022;58:932. [DOI: 10.3390/medicina58070932] [Reference Citation Analysis]
287 Iannuzzo G, Cuomo G, Di Lorenzo A, Tripaldella M, Mallardo V, Iaccarino Idelson P, Sagnelli C, Sica A, Creta M, Baltar J, Crocetto F, Bresciani A, Gentile M, Calogero A, Giallauria F. Dyslipidemia in Transplant Patients: Which Therapy? JCM 2022;11:4080. [DOI: 10.3390/jcm11144080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Sierra-galan LM, Bhatia M, Alberto-delgado AL, Madrazo-shiordia J, Salcido C, Santoyo B, Martinez E, Soto ME. Cardiac Magnetic Resonance in Rheumatology to Detect Cardiac Involvement Since Early and Pre-clinical Stages of the Autoimmune Diseases: A Narrative Review. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.870200] [Reference Citation Analysis]
289 Martins J, Rossouw HM, Pillay TS. How should low-density lipoprotein cholesterol be calculated in 2022? Curr Opin Lipidol 2022. [PMID: 35942811 DOI: 10.1097/MOL.0000000000000833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Yaneva-Sirakova T, Traykov L. Mortality rate of high cardiovascular risk patients with mild cognitive impairment. Sci Rep 2022;12:11961. [PMID: 35831445 DOI: 10.1038/s41598-022-15823-1] [Reference Citation Analysis]
291 Zelenskaya EM, Donirova OS, Voronina EN, Kovaleva AY, Protasov KV, Lifshits GI. ASSOCIATION OF SNP <i>CYP2C19</i> AND CLINICAL PARAMETERS IN RUSSIAN AND BURYAT PATIENTS AFTER TAKING CLOPIDOGREL AFTER CORONARY STENTING. jour 2022;2:61-70. [DOI: 10.18705/2782-3806-2022-2-3-61-70] [Reference Citation Analysis]
292 Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I, Lecumberri R, Niessner A, Pabinger I, Szmit S, Trinchero A, Ten Cate H, Rocca B. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer. HemaSphere 2022;6:e750. [DOI: 10.1097/hs9.0000000000000750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Badescu MC, Badulescu OV, Scripcariu DV, Butnariu LI, Bararu-Bojan I, Popescu D, Ciocoiu M, Gorduza EV, Costache II, Rezus E, Rezus C. Myocardial Ischemia Related to Common Cancer Therapy-Prevention Insights. Life (Basel) 2022;12:1034. [PMID: 35888122 DOI: 10.3390/life12071034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
294 Agnoletti D, Fogacci F, Di Micoli A, Borghi C, Cicero AFG. A case of liver injury during lipid-lowering therapy. Phytother Res 2022. [PMID: 35821650 DOI: 10.1002/ptr.7536] [Reference Citation Analysis]
295 Falter M, Scherrenberg M, Driesen K, Pieters Z, Kaihara T, Xu L, Caiani EG, Castiglioni P, Faini A, Parati G, Dendale P. Smartwatch-Based Blood Pressure Measurement Demonstrates Insufficient Accuracy. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.958212] [Reference Citation Analysis]
296 Sautner J, Eichbauer-Sturm G, Gruber J, Lunzer R, Puchner RJ. 2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia. Wien Klin Wochenschr 2022. [PMID: 35817987 DOI: 10.1007/s00508-022-02054-7] [Reference Citation Analysis]
297 Rosengren A. Salt: the sweet spot? Eur Heart J 2022:ehac336. [PMID: 35808993 DOI: 10.1093/eurheartj/ehac336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Dikilitas O, Schaid DJ, Tcheandjieu C, Clarke SL, Assimes TL, Kullo IJ. Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations. Curr Cardiol Rep 2022. [PMID: 35796859 DOI: 10.1007/s11886-022-01734-0] [Reference Citation Analysis]
299 Maierean S, Webb R, Banach M, Mazidi M. The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events. European Heart Journal Open 2022;2. [DOI: 10.1093/ehjopen/oeac039] [Reference Citation Analysis]
300 Muhandiramge J, Zalcberg JR, van Londen GJ, Warner ET, Carr PR, Haydon A, Orchard SG. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology. Curr Oncol Rep 2022. [PMID: 35796941 DOI: 10.1007/s11912-022-01309-w] [Reference Citation Analysis]
301 Navar AM, Fonarow GC, Pencina MJ. Time to Revisit Using 10-Year Risk to Guide Statin Therapy. JAMA Cardiol 2022. [PMID: 35793080 DOI: 10.1001/jamacardio.2022.1883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Kirkpatrick CF, Willard KE, Maki KC. Keto is Trending: Implications for Body Weight and Lipid Management. Curr Cardiol Rep 2022. [PMID: 35794438 DOI: 10.1007/s11886-022-01731-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Galyavich AS, Baleeva LV, Galeeva ZM, Sabirzyanova AA. Effective drug modification of risk factors in a patient with coronary artery disease: a case report. Cardiovasc Ther Prev 2022;21:3221. [DOI: 10.15829/1728-8800-2022-3221] [Reference Citation Analysis]
304 Xu Y, Chang AR, Inker LA, Mcadams‐demarco M, Grams ME, Shin J. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation. JAHA. [DOI: 10.1161/jaha.122.025723] [Reference Citation Analysis]
305 Mayr B, Egger A, Reich B, Droese S, Niebauer J. Sustainability of physical work capacity two years post outpatient cardiac rehabilitation. Clin Rehabil 2022;:2692155221111921. [PMID: 35791498 DOI: 10.1177/02692155221111921] [Reference Citation Analysis]
306 Geisler T, Poli S, Huber K, Rath D, Aidery P, Kristensen SD, Storey RF, Ball A, Collet JP, Berg JT. Resumption of Antiplatelet Therapy after Major Bleeding. Thromb Haemost 2022. [PMID: 35785817 DOI: 10.1055/s-0042-1750419] [Reference Citation Analysis]
307 Rizvi AA, Popovic DS, Papanas N, Pantea Stoian A, Al Mahmeed W, Sahebkar A, Janez A, Rizzo M. Current and emerging drugs for the treatment of atherosclerosis: the evidence to date. Expert Rev Cardiovasc Ther 2022. [PMID: 35786159 DOI: 10.1080/14779072.2022.2094771] [Reference Citation Analysis]
308 Hassanein M, Akbar MAJ, Al-Shamiri M, Amir A, Amod A, Chudleigh R, Elhadd T, Heshmat H, Jibani M, Al Saleh YM. Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies. Diabetes Ther 2022;13:1253-80. [PMID: 35679010 DOI: 10.1007/s13300-022-01282-4] [Reference Citation Analysis]
309 Brotons C, Camafort M, Castellanos MDM, Clarà A, Cortés O, Diaz Rodriguez A, Elosua R, Gorostidi M, Hernández AM, Herranz M, Justo S, Lahoz C, Niño P, Pallarés-carratalá V, Pedro-botet J, Pérez AP, Royo-bordonada MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:219-228. [DOI: 10.1016/j.artere.2022.06.007] [Reference Citation Analysis]
310 Bañeras J, Iglesies-grau J, Téllez-plaza M, Arrarte V, Báez-ferrer N, Benito B, Campuzano Ruiz R, Cecconi A, Domínguez-rodríguez A, Rodríguez-sinovas A, Ujueta F, Vozzi C, Lamas GA, Navas-acién A. Medioambiente y salud cardiovascular: causas, consecuencias y oportunidades en prevención y tratamiento. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2022.05.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Torosyan N, Aziz D, Quesada O. Long-term sequelae of adverse pregnancy outcomes. Maturitas 2022. [DOI: 10.1016/j.maturitas.2022.06.012] [Reference Citation Analysis]
312 Sérgio Neves J, Newman C, Bostrom JA, Buysschaert M, Newman JD, Luiz Medina J, Goldberg IJ, Bergman M. Management of Dyslipidemia and Atherosclerotic Cardiovascular Risk in Prediabetes. Diabetes Res Clin Pract 2022;:109980. [PMID: 35787415 DOI: 10.1016/j.diabres.2022.109980] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Evans M, Chandramouli AS, Faurby M, Matthiessen KS, Mogensen PB, Verma S. Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET). Diabetes Obes Metab 2022;24:1300-9. [PMID: 35504854 DOI: 10.1111/dom.14703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 García RV, García JEP, Navasa WD, Salmerón DM, Mateos DB. Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Brotons C, Camafort M, Castellanos MDM, Clarà A, Cortés O, Diaz Rodriguez A, Elosua R, Gorostidi M, Hernández AM, Herranz M, Justo S, Lahoz C, Niño P, Pallarés-carratalá V, Pedro-botet J, Pérez Pérez A, Royo-bordonada MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021. Clínica e Investigación en Arteriosclerosis 2022;34:219-228. [DOI: 10.1016/j.arteri.2022.03.003] [Reference Citation Analysis]
316 Sarzani R, Laureti G, Gezzi A, Spannella F, Giulietti F. Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient. Ther Adv Chronic Dis 2022;13:20406223221102754. [PMID: 35769133 DOI: 10.1177/20406223221102754] [Reference Citation Analysis]
317 Yu S, Zhang Y, Peng W, Zhao D, Shi H, Zhang S, Huo Y, Xu Y, Ge J. Cardiovascular health status in Chinese Cardiologists: China Cardiologist Heart Survey II. Cardiology Plus 2022;7:125-131. [DOI: 10.1097/cp9.0000000000000022] [Reference Citation Analysis]
318 Réa D, Messas E, Mirault T, Nicolini FE. Recommandations 2022 du groupe Fi-LMC pour la gestion du risque d’événements cardiovasculaires sous ponatinib dans la leucémie myéloïde chronique. Bulletin du Cancer 2022;109:862-872. [DOI: 10.1016/j.bulcan.2022.04.003] [Reference Citation Analysis]
319 Igarashi A, Maruyama-Sakurai K, Kubota A, Akiyama H, Yajima T, Kohsaka S, Miyata H. Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan. Diabetes Ther 2022;13:1367-81. [PMID: 35710646 DOI: 10.1007/s13300-022-01270-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Norhammar A, Bodegard J, Eriksson JW, Haller H, Linssen GCM, Banerjee A, Karasik A, Mamouris P, Tangri N, Taveira-Gomes T, Maggioni AP, Botana M, Thuresson M, Okami S, Yajima T, Kadowaki T, Birkeland KI; CaReMe Cardiorenal Investigators. Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries. Diabetes Obes Metab 2022;24:1277-87. [PMID: 35322567 DOI: 10.1111/dom.14698] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
321 Goldsborough E, Osuji N, Blaha MJ. Assessment of Cardiovascular Disease Risk. Endocrinology and Metabolism Clinics of North America 2022. [DOI: 10.1016/j.ecl.2022.02.005] [Reference Citation Analysis]
322 Pedro-botet J, Barrios V, Sánchez-margalet V, Tamargo J, Arrieta F, Gámez JM, Gimeno-orna JA, Escobar C, Gómez-doblas JJ, Pérez A. Tratamiento de la hipertrigliceridemia con icosapento de etilo en pacientes de alto/muy alto riesgo cardiovascular. Documento de consenso de la Sociedad Española de Cardiología y Sociedad Española de Diabetes. Endocrinología, Diabetes y Nutrición 2022. [DOI: 10.1016/j.endinu.2022.03.004] [Reference Citation Analysis]
323 Sánchez de la Nava AM, Gómez-cid L, Ríos-muñoz GR, Fernández-santos ME, Fernández AI, Arenal Á, Sanz-ruiz R, Grigorian-shamagian L, Atienza F, Fernández-avilés F. Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic. BioTech 2022;11:23. [DOI: 10.3390/biotech11030023] [Reference Citation Analysis]
324 Cicero AFG, Fogacci F, Rizzoli E, Giovannini M, D'Addato S, Borghi C; Brisighella Heart Study Group. Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up. Nutr Metab Cardiovasc Dis 2022:S0939-4753(22)00282-4. [PMID: 35843791 DOI: 10.1016/j.numecd.2022.06.017] [Reference Citation Analysis]
325 Casian M, Jurcut C, Dima A, Mihai A, Stanciu S, Jurcut R. Cardiovascular Disease in Primary Sjögren's Syndrome: Raising Clinicians' Awareness. Front Immunol 2022;13:865373. [PMID: 35757738 DOI: 10.3389/fimmu.2022.865373] [Reference Citation Analysis]
326 Antoniou V, Davos CH, Kapreli E, Batalik L, Panagiotakos DB, Pepera G. Effectiveness of Home-Based Cardiac Rehabilitation, Using Wearable Sensors, as a Multicomponent, Cutting-Edge Intervention: A Systematic Review and Meta-Analysis. JCM 2022;11:3772. [DOI: 10.3390/jcm11133772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
327 Nollet L, Van Gils M, Fischer S, Campens L, Karthik S, Pasch A, De Zaeytijd J, Leroy BP, Devos D, De Backer T, Coucke PJ, Vanakker OM. Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum. JCM 2022;11:3727. [DOI: 10.3390/jcm11133727] [Reference Citation Analysis]
328 Jones LK, Sturm AC, Gionfriddo MR. Translating guidelines into practice via implementation science: an update in lipidology. Curr Opin Lipidol 2022. [PMID: 35779062 DOI: 10.1097/MOL.0000000000000835] [Reference Citation Analysis]
329 Santo K. Can Digital Health Solutions Fill in the Gap for Effective Guideline Implementation in Cardiovascular Disease Prevention: Hope or Hype? Curr Atheroscler Rep 2022. [PMID: 35761153 DOI: 10.1007/s11883-022-01050-6] [Reference Citation Analysis]
330 Allagbé I, Zeller M, Thomas D, Airagnes G, Limosin F, Boussadi A, Chagué F, Faou AL. Cardiovascular Risk Among Patients Who Smoke: Risk Profiles and Differences by Sex. Am J Prev Med 2022:S0749-3797(22)00290-2. [PMID: 35773102 DOI: 10.1016/j.amepre.2022.04.028] [Reference Citation Analysis]
331 Okunev IM, Kochergina AM, Kashtalap VV. Chronic and acute decompensated heart failure: topical issues. Kompleks probl serdečno-sosud zabol 2022;11:184-195. [DOI: 10.17802/2306-1278-2022-11-2-184-195] [Reference Citation Analysis]
332 Feng J, Wu Y. Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis. Int Immunopharmacol 2022;110:108938. [PMID: 35759811 DOI: 10.1016/j.intimp.2022.108938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Lönn A, Kallings LV, Börjesson M, Ekblom Ö, Ekström M. Convergent validity of commonly used questions assessing physical activity and sedentary time in Swedish patients after myocardial infarction. BMC Sports Sci Med Rehabil 2022;14:117. [PMID: 35751097 DOI: 10.1186/s13102-022-00509-y] [Reference Citation Analysis]
334 Guagliumi G, Pellegrini D. Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis. EuroIntervention 2022;18:190-1. [PMID: 35747953 DOI: 10.4244/EIJ-E-22-00013] [Reference Citation Analysis]
335 Susilo H, Pikir BS, Thaha M, Alsagaff MY, Suryantoro SD, Wungu CDK, Wafa IA, Pakpahan C, Oceandy D. The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. Genes 2022;13:1121. [DOI: 10.3390/genes13071121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Antoniou V, Xanthopoulos A, Giamouzis G, Davos C, Batalik L, Stavrou V, Gourgoulianis KI, Kapreli E, Skoularigis J, Pepera G. Efficacy, efficiency and safety of a cardiac telerehabilitation programme using wearable sensors in patients with coronary heart disease: the TELEWEAR-CR study protocol. BMJ Open 2022;12:e059945. [PMID: 35738643 DOI: 10.1136/bmjopen-2021-059945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Miklík R, Jiravský O. Acetylsalicylic acid in primary prevention of cardiovascular disease. Vnitr Lek 2022;68:240-245. [DOI: 10.36290/vnl.2022.050] [Reference Citation Analysis]
338 Merino-ribas A, Araujo R, Pereira L, Campos J, Barreiros L, Segundo MA, Silva N, Costa CFFA, Quelhas-santos J, Trindade F, Falcão-pires I, Alencastre I, Dumitrescu IB, Sampaio-maia B. Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study. Biomolecules 2022;12:867. [DOI: 10.3390/biom12070867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Barrios V, Escobar C, Suarez C, Garcia-Moll X, Lozano F. Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study. J Clin Med 2022;11:3554. [PMID: 35743622 DOI: 10.3390/jcm11123554] [Reference Citation Analysis]
340 Shishkova VN. Cognitive and emotional disorders in patients with chronic heart failure: prospects for detection and correction. RJTAO 2022;14:87-93. [DOI: 10.14412/2074-2711-2022-3-87-93] [Reference Citation Analysis]
341 Koskinas KC, Dendale P, Halle M, Caselli S, Cornelissen V, Kavousi M, Kurpas D, Osto E, Raupach T, Semb AG, Pedretti RF. Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2022:zwac118. [PMID: 35708728 DOI: 10.1093/eurjpc/zwac118] [Reference Citation Analysis]
342 Piechota W, Krzesiński P, Piotrowicz K, Gielerak G, Kurpaska M, Rączka A, Woźniak-Kosek A. Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome. J Clin Med 2022;11:3471. [PMID: 35743540 DOI: 10.3390/jcm11123471] [Reference Citation Analysis]
343 Spacek M, Vacha J, Precek J, Hutyra M, Nykl R, Sluka M, Taborsky M. Complete revascularization of multivessel coronary artery disease in patients with ST elevation acute coronary syndrome - for whom and when? A comprehensive review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2022. [PMID: 35703363 DOI: 10.5507/bp.2022.024] [Reference Citation Analysis]
344 Merzel Šabović EK, Starbek Zorko M, Janić M. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time. Int J Mol Sci 2022;23:6648. [PMID: 35743091 DOI: 10.3390/ijms23126648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Dixon D, Patel J, Spence R, Talasaz A, Abbate A, Wiggins BS. Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review. Am Heart J 2022:S0002-8703(22)00126-0. [PMID: 35714680 DOI: 10.1016/j.ahj.2022.06.002] [Reference Citation Analysis]
346 François C, Willems AM, Van Calster L, Germonpré E, De Sutter J. Changes in lipid lowering medication and lipid levels over time in patients with stable coronary artery disease. Acta Clin Belg 2022;:1-5. [PMID: 35695418 DOI: 10.1080/17843286.2022.2084948] [Reference Citation Analysis]
347 Bapir M, Campagnolo P, Rodriguez-mateos A, Skene SS, Heiss C. Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials. Front Nutr 2022;9:886597. [DOI: 10.3389/fnut.2022.886597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Romero-Trevejo JL, Fernández-Romero L, Delgado J, Muñoz-García E, Sánchez-Pérez A, Murri M, Gutiérrez-Bedmar M, Jiménez-Navarro MF. Choroidal thickness and granulocyte colony-stimulating factor in tears improve the prediction model for coronary artery disease. Cardiovasc Diabetol 2022;21:103. [PMID: 35681222 DOI: 10.1186/s12933-022-01538-0] [Reference Citation Analysis]
349 Hasebe T, Hasebe N. Impact of risk factors related to metabolic syndrome on acute myocardial infarction in younger patients. Hypertens Res 2022. [PMID: 35681042 DOI: 10.1038/s41440-022-00951-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
350 Lopina N, Dmytrenko I, Hamov D, Lopin D, Dyagil I. A New Paradigm of Cardio-Hematological Monitoring in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors. Cureus. [DOI: 10.7759/cureus.25766] [Reference Citation Analysis]
351 Cuomo G, Cioffi G, Di Lorenzo A, Iannone FP, Cudemo G, Iannicelli AM, Pacileo M, D’andrea A, Vigorito C, Iannuzzo G, Giallauria F. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients. JCM 2022;11:3247. [DOI: 10.3390/jcm11113247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Lin J, Tseng W, Lee P, Lee C, Tseng S, Chen P, Chang H, Chao T. A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease. JPM 2022;12:938. [DOI: 10.3390/jpm12060938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Grinshtein YI, Shabalin VV, Ruf RR, Shalnova SA, Drapkina OM. Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes. Cardiovasc Ther Prev 2022;21:3176. [DOI: 10.15829/1728-8800-2022-3176] [Reference Citation Analysis]
354 Wong CKH, Lau KTK, Tang EHM, Lee CH, Lee CYY, Woo YC, Au ICH, Tan KCB, Lui DTW. Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. Cardiovasc Diabetol 2022;21. [DOI: 10.1186/s12933-022-01520-w] [Reference Citation Analysis]
355 Rossignol P, Silva-Cardoso J, Kosiborod MN, Brandenburg 5th, Cleland JG, Hadimeri H, Hullin R, Makela S, Mörtl D, Paoletti E, Pollock C, Vogt L, Jadoul M, Butler J. Pragmatic Diagnostic and Therapeutic Algorithms to Optimize New Potassium Binder use in Cardiorenal Disease. Pharmacol Res 2022;:106277. [PMID: 35662631 DOI: 10.1016/j.phrs.2022.106277] [Reference Citation Analysis]
356 Li X, Li L, Na S, Santilli F, Shi Z, Blaha M. Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100363] [Reference Citation Analysis]
357 Bongarth CM. Kardiologische Rehabilitation nach herzchirurgischen Eingriffen. Z Herz- Thorax- Gefäßchir 2022;36:137-147. [DOI: 10.1007/s00398-022-00505-x] [Reference Citation Analysis]
358 Trimaille A. Les outils d'estimation du risque cardiovasculaire, le Score2 de l'ESC. Revue Francophone des Laboratoires 2022;2022:35-42. [DOI: 10.1016/s1773-035x(22)00213-1] [Reference Citation Analysis]
359 van Veelen A, Henriques JP, Claessen BE. Residual Inflammatory Risk After Percutaneous Coronary Intervention. JACC: Asia 2022;2:338-340. [DOI: 10.1016/j.jacasi.2021.12.003] [Reference Citation Analysis]
360 Mesa A, Giménez M, Pueyo I, Perea V, Viñals C, Blanco J, Vinagre I, Serés-Noriega T, Boswell L, Esmatjes E, Conget I, Amor AJ. HYPERGLYCEMIA AND HYPOGLYCEMIA EXPOSURE ARE DIFFERENTIALLY ASSOCIATED WITH MICRO- AND MACROVASCULAR COMPLICATIONS IN ADULTS WITH TYPE 1 DIABETES. Diabetes Res Clin Pract 2022;:109938. [PMID: 35662616 DOI: 10.1016/j.diabres.2022.109938] [Reference Citation Analysis]
361 Thérond P. Place des marqueurs lipidiques dans la stratification du risque cardiovasculaire : LDL cholestérol, HDL cholestérol, triglycérides, apolipoprotéine B. Revue Francophone des Laboratoires 2022;2022:51-56. [DOI: 10.1016/s1773-035x(22)00215-5] [Reference Citation Analysis]
362 Strandberg TE, Kivimäki M, Urtamo A, Jyväkorpi S, Laaksonen R. Plasma ceramides independently predict all-cause mortality in men aged 85. Age Ageing 2022;51:afac136. [PMID: 35716045 DOI: 10.1093/ageing/afac136] [Reference Citation Analysis]
363 Brotons C, Camafort M, Castellanos MDM, Clarà A, Cortés O, Diaz Rodríguez Á, Elosua R, Gorostidi M, Hernández AM, Herranz M, Justo S, Lahoz C, Niño P, Pallarés-carratalá V, Pedro-botet J, Pérez Pérez A, Royo-bordonada MÁ, Santamaría R, Tresserras R, Zamora A, Zuza I, Armario P. Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021. Nefrología 2022. [DOI: 10.1016/j.nefro.2022.05.003] [Reference Citation Analysis]
364 Castilla-guerra L, Fernandez-moreno M, Jiménez-hernández M, Rico-corral M. Colchicina en prevención del ictus. ¿Es hora de cambiar nuestra práctica clínica? Neurología 2022. [DOI: 10.1016/j.nrl.2022.03.001] [Reference Citation Analysis]
365 Sun W, Wang Y, Zhang H, Sheng Y, Fan J, Gu M, Tian Y, Zhang Y, Ma H, Yin X, Sun K, Ding Z, Hu Z, Chen L, Kong X; eHypertension Cohort Study. eHypertension: A prospective longitudinal multi‐omics essential hypertension cohort. iMeta 2022;1. [DOI: 10.1002/imt2.22] [Reference Citation Analysis]
366 Blockhaus C, Guelker J, Feyen L, Bufe A, Seyfarth M, Shin D. Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure. JCDD 2022;9:175. [DOI: 10.3390/jcdd9060175] [Reference Citation Analysis]
367 Scicchitano P, Marzullo A, Santoro A, Zito A, Cortese F, Galeandro C, Ciccone AS, Angiletta D, Manca F, Pulli R, Navarese EP, Gurbel PA, Ciccone MM. The Prognostic Role of ST2L and sST2 in Patients Who Underwent Carotid Plaque Endarterectomy: A Five-Year Follow-Up Study. J Clin Med 2022;11:3142. [PMID: 35683529 DOI: 10.3390/jcm11113142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
368 Drapkina OM, Begrambekova YL, Orlov DO, Shepel RN, Samojlov TV. Determination of factors influencing the desire and possibilities of prevention of inactivity and other behavi­oral risk factors by primary care physicians (REFLECTION). The results of a one-time survey. Kardiologiia 2022;62:9-17. [DOI: 10.18087/cardio.2022.5.n2022] [Reference Citation Analysis]
369 Achim A, Kákonyi K, Nagy F, Jambrik Z, Varga A, Nemes A, Chan JSK, Toth GG, Ruzsa Z, Meng F. Radial Artery Calcification in Predicting Coronary Calcification and Atherosclerosis Burden. Cardiology Research and Practice 2022;2022:1-8. [DOI: 10.1155/2022/5108389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
370 Gallo G, Migliarino S, Cotugno M, Stanzione R, Burocchi S, Bianchi F, Marchitti S, Autore C, Volpe M, Rubattu S. Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.921244] [Reference Citation Analysis]
371 Bonanad C, Fernández-Olmo R, García-Blas S, Alarcon JA, Díez-Villanueva P, Mansilla CR, García-Pardo H, Toledo P, Ayesta A, Pereira E, Carol A, Castro-Conde A, de Pablo-Zarzoso C, Martínez-Sellés M, Arrarte V, Campuzano R, Ariza-Solé A. Cardiovascular prevention in elderly patients. J Geriatr Cardiol 2022;19:377-92. [PMID: 35722032 DOI: 10.11909/j.issn.1671-5411.2022.05.004] [Reference Citation Analysis]
372 Pivato CA, Chandiramani R, Petrovic M, Nicolas J, Spirito A, Cao D, Mehran R. Depression and ischemic heart disease. Int J Cardiol 2022:S0167-5273(22)00767-7. [PMID: 35643217 DOI: 10.1016/j.ijcard.2022.05.056] [Reference Citation Analysis]
373 Sinnadurai S, Sowa P, Jankowski P, Gasior Z, Kosior DA, Haberka M, Czarnecka D, Pajak A, Setny M, Jamiolkowski J, Sawicka-śmiarowska E, Kaminski K. Recollection of Physician Information about Risk Factor and Lifestyle Changes in Chronic Coronary Syndrome Patients. IJERPH 2022;19:6416. [DOI: 10.3390/ijerph19116416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Rao A, DiGiacomo M, Phillips JL, Hickman LD. Health professionals' perspectives of integrating meditation into cardiovascular care: A descriptive qualitative study. Health Soc Care Community 2022. [PMID: 35611693 DOI: 10.1111/hsc.13849] [Reference Citation Analysis]
375 Ibanez B, García-Lunar I, Fuster V. The Intima-Media Thickness Age Is Over: The Time of Multiterritorial Subclinical Plaque Quantification Has Come. J Am Coll Cardiol 2022;79:1983-5. [PMID: 35589159 DOI: 10.1016/j.jacc.2022.03.361] [Reference Citation Analysis]
376 Ties D, van Dorp P, Pundziute G, Lipsic E, van der Aalst CM, Oudkerk M, de Koning HJ, Vliegenthart R, van der Harst P. Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time? J Clin Med 2022;11:2965. [PMID: 35683356 DOI: 10.3390/jcm11112965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Wernly S, Semmler G, Völkerer A, Rezar R, Datz L, Radzikowski K, Stickel F, Aigner E, Niederseer D, Wernly B, Datz C. Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality. JPM 2022;12:848. [DOI: 10.3390/jpm12050848] [Reference Citation Analysis]
378 Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis 2022:izac100. [PMID: 35590447 DOI: 10.1093/ibd/izac100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Kirresh A, White L, Mitchell A, Ahmad S, Obika B, Davis S, Ahmad M, Candilio L. Radiation-induced coronary artery disease: a difficult clinical conundrum. Clin Med (Lond) 2022;22:251-6. [PMID: 35584837 DOI: 10.7861/clinmed.2021-0600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
380 Kielb J, Weber J, Shahjerdi K, Saffak S, Baensch L, Glugla S, Polzin A, Zeus T, Kelm M, Dannenberg L. Untapped Potential for Female Patients? Comment on Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176. J Clin Med 2022;11:2862. [PMID: 35628988 DOI: 10.3390/jcm11102862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
381 Fonseca A, Lima TM, Fernandez-Llimos F, Castel-Branco MM, Figueiredo IV. Evaluation of Cardiovascular Pharmacotherapy Guideline Adherence and Risk Factor Control in Portuguese Community Pharmacy Patients. Int J Environ Res Public Health 2022;19:6170. [PMID: 35627707 DOI: 10.3390/ijerph19106170] [Reference Citation Analysis]
382 Chen S, Li N, Gao Y, Jiang H, Shen Y. Prevalence and risk factors for vascular calcification based on the ankle-brachial index in the general population: a cross-sectional study. BMC Cardiovasc Disord 2022;22:227. [PMID: 35585487 DOI: 10.1186/s12872-022-02668-9] [Reference Citation Analysis]
383 Baranowska J, Törngren C, Nielsen SJ, Lindgren M, Björklund E, Ravn-fischer A, Skoglund K, Jeppsson A, Martinsson A. Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry. European Heart Journal - Cardiovascular Pharmacotherapy 2022. [DOI: 10.1093/ehjcvp/pvac034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Duarte Lau F, Giugliano RP. Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. JAMA Cardiol 2022. [PMID: 35583875 DOI: 10.1001/jamacardio.2022.0987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
385 Kobayashi Frisk M, Hedner J, Grote L, Ekblom Ö, Arvidsson D, Bergström G, Börjesson M, Zou D. Eveningness is associated with sedentary behavior and increased 10-year risk of cardiovascular disease: the SCAPIS pilot cohort. Sci Rep 2022;12:8203. [PMID: 35581309 DOI: 10.1038/s41598-022-12267-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Wang M, Yu H, Li Z, Gong D, Liu X. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis. Am J Cardiovasc Drugs 2022. [PMID: 35570250 DOI: 10.1007/s40256-022-00537-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Arcoraci V, Squadrito F, Rottura M, Barbieri MA, Pallio G, Irrera N, Nobili A, Natoli G, Argano C, Squadrito G, Corrao S. Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register. Front Cardiovasc Med 2022;9:876693. [DOI: 10.3389/fcvm.2022.876693] [Reference Citation Analysis]
388 Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol 2022;21:74. [PMID: 35568946 DOI: 10.1186/s12933-022-01516-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
389 Tyurina AV, Afanas’eva OI, Klesareva EA, Tmoyan NA, Razova OA, Ezhov MV, Pokrovsky SN. Association of various lipid parameters with premature coronary artery disease in men. Russ J Cardiol 2022;27:5058. [DOI: 10.15829/1560-4071-2022-5058] [Reference Citation Analysis]
390 Cattaneo M, Halasz G, Cattaneo MM, Younes A, Gallino C, Sudano I, Gallino A. The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina. Front Cardiovasc Med 2022;9:896042. [DOI: 10.3389/fcvm.2022.896042] [Reference Citation Analysis]
391 Smirnova MD, Pogorelova OA, Fofanova TV, Svirida ON, Blankova ZN, Tripoten MI, Tamaeva BM, Yarovaya EB, Ageev FT, Balakhonova TV. Prognostic value of subclinical atherosclerosis in patients with a SCORE risk <5%: data from a 10-year follow-up. Russ J Cardiol 2022;27:5057. [DOI: 10.15829/1560-4071-2022-5057] [Reference Citation Analysis]
392 Vassalle C, Gaggini M. Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options. Antioxidants 2022;11:953. [DOI: 10.3390/antiox11050953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
393 Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J Clin Med 2022;11:2704. [PMID: 35628831 DOI: 10.3390/jcm11102704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
394 Svatun ÅL, Løchen ML, Thelle DS, Wilsgaard T. Association between espresso coffee and serum total cholesterol: the Tromsø Study 2015-2016. Open Heart 2022;9:e001946. [PMID: 35537850 DOI: 10.1136/openhrt-2021-001946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Zakharova IN, Osmanov IM, Pshenichnikova II, Skorobogatova EV, Koba YV, Kuznetsova IS. The role of ω3-polyunsaturated fatty acids in the prevention of atherogenic cardiovascular diseases starting in childhood. Pediatr Con Med 2022. [DOI: 10.26442/26586630.2022.1.201434] [Reference Citation Analysis]
396 Yang Y, Li Y, Zheng Y, Zhang L, Ma W, Shi L, Kong J, Liu X, Yu H. The Effect of Acupuncture Combined with Aerobic Exercise for Coronary Heart Disease as Cardiac Rehabilitation. J Healthc Eng 2022;2022:4903265. [PMID: 35340225 DOI: 10.1155/2022/4903265] [Reference Citation Analysis]
397 Bär S, Räber I, Koskinas KC, Schlapbach C, Räber L. Transient injection site reaction to alirocumab during immune system activation: a case series. European Heart Journal - Case Reports 2022;6. [DOI: 10.1093/ehjcr/ytac187] [Reference Citation Analysis]
398 Martin A, Lang S, Goeser T, Demir M, Steffen HM, Kasper P. Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. Curr Atheroscler Rep 2022. [PMID: 35507279 DOI: 10.1007/s11883-022-01028-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Khan SU, Yedlapati SH, Lone AN, Hao Q, Guyatt G, Delvaux N, Bekkering GET, Vandvik PO, Riaz IB, Li S, Aertgeerts B, Rodondi N. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ 2022;377:e069116. [PMID: 35508321 DOI: 10.1136/bmj-2021-069116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
400 Płaczkowska S, Sołkiewicz K, Bednarz-Misa I, Kratz EM. Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins. Int J Mol Sci 2022;23:5089. [PMID: 35563477 DOI: 10.3390/ijms23095089] [Reference Citation Analysis]
401 Nidorf SM, Layland J, Robinson PC, Patel S, Psaltis PJ, Thompson PL. Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease. Medical Journal of Australia 2022;216:385-387. [DOI: 10.5694/mja2.51488] [Reference Citation Analysis]
402 González-juanatey JR, Cordero A, Castellano JM, Masana L, Dalmau R, Ruiz E, Sicras-mainar A, Fuster V. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.05.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
403 Juárez Olmos V, Severo Sánchez A, Zamora Auñón P, López-fernández T. Cardio-oncología en la actualidad: un reto pendiente. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2022.04.006] [Reference Citation Analysis]
404 Ruiz-garcía A, Pallarés-carratalá V, Serrano-cumplido A, Escobar-cervantes C, Barquilla-garcía A, Divisón-garrote J, Turégano-yedro M, Prieto-díaz M, Cinza-sanjurjo S, Alonso-moreno F, Beato-fernández P, García-matarín L, Rey-aldana D, Martín-rioboó E, Moyá-amengual A, Crespo-sabarís R, Piera-carbonell A, Romero-vigara J, Carrasco-carrasco E, Velilla-zancada S, Seoane-vicente M, Górriz-teruel J, Polo-garcía J, Barrios V. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review. Medicina de Familia SEMERGEN 2022;48:275-292. [DOI: 10.1016/j.semerg.2021.12.002] [Reference Citation Analysis]
405 SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) 2022;75:364-9. [PMID: 35165071 DOI: 10.1016/j.rec.2021.10.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
406 Weintraub WS. Revascularization for stable ischemic heart disease: the beat goes on. Cardiovascular Revascularization Medicine 2022. [DOI: 10.1016/j.carrev.2022.04.017] [Reference Citation Analysis]
407 . Comentarios a la guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022;75:364-9. [DOI: 10.1016/j.recesp.2021.10.015] [Reference Citation Analysis]
408 Nasir K, Cainzos-achirica M, Valero-elizondo J, Ali SS, Havistin R, Lakshman S, Blaha MJ, Blankstein R, Shapiro MD, Arias L, Saxena A, Feldman T, Budoff MJ, Ziffer JA, Fialkow J, Cury RC. Coronary Atherosclerosis in an Asymptomatic U.S. Population. JACC: Cardiovascular Imaging 2022. [DOI: 10.1016/j.jcmg.2022.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
409 Mostaza J, Pintó X, Armario P, Masana L, Real J, Valdivielso P, Arrobas-velilla T, Baeza-trinidad R, Calmarza P, Cebollada J, Civera-andrés M, Cuende Melero J, Díaz-díaz J, Fernández Pardo J, Guijarro C, Jericó C, Laclaustra M, Lahoz C, López-miranda J, Martínez-hervás S, Muñiz-grijalvo O, Páramo J, Pascual V, Pedro-botet J, Pérez-martínez P, Plana N, Puzo J, Sánchez Chaparro M, Vila L. SEA 2022 standards for the comprehensive control of cardiovascular risk. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:130-179. [DOI: 10.1016/j.artere.2022.06.002] [Reference Citation Analysis]
410 Marquina C, Talic S, Zomer E, Vargas-torres S, Petrova M, Wolfe R, Abushanab D, Lybrand S, Thomson D, Stratton G, Ofori-asenso R, Liew D, Ademi Z. Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.05.002] [Reference Citation Analysis]
411 Shafi BH, Bøttcher M, Ejupi A, Jensen G, Osler M, Lange T, Prescott E. Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.05.020] [Reference Citation Analysis]
412 Benincasa G, Coscioni E, Napoli C. Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for primary prevention. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
413 Mostaza JM, Pintó X, Armario P, Masana L, Real JT, Valdivielso P, Arrobas-Velilla T, Baeza-Trinidad R, Calmarza P, Cebollada J, Civera-Andrés M, Cuende Melero JI, Díaz-Díaz JL, Fernández Pardo J, Guijarro C, Jericó C, Laclaustra M, Lahoz C, López-Miranda J, Martínez-Hervás S, Muñiz-Grijalvo O, Páramo JA, Pascual V, Pedro-Botet J, Pérez-Martínez P, Plana N, Puzo J, Sánchez Chaparro MÁ, Vila L. SEA 2022 Standards for Global Control of Cardiovascular Risk. Clin Investig Arterioscler 2022;34:130-79. [PMID: 35090775 DOI: 10.1016/j.arteri.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Wilding JPH, Evans M, Fernando K, Gorriz JL, Cebrian A, Diggle J, Hicks D, James J, Newland-Jones P, Ali A, Bain S, Da Porto A, Patel D, Viljoen A, Wheeler DC, Del Prato S. The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review. Diabetes Ther 2022;13:847-72. [PMID: 35307801 DOI: 10.1007/s13300-022-01228-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
415 Girkantaite Z, Laucyte-cibulskiene A, Ryliskyte L, Juceviciene A, Badariene J. Laser Doppler flowmetry evaluation of skin microvascular endothelial function in patients with metabolic syndrome. Microvascular Research 2022. [DOI: 10.1016/j.mvr.2022.104373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
416 Banegas J, Gijón-conde T. Hypertension: The most common chronic health problem in Spain. A call to action. Hipertensión y Riesgo Vascular 2022. [DOI: 10.1016/j.hipert.2022.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Granata A, Pesce F, Iacoviello M, Anzaldi M, Amico F, Catalano M, Leonardi G, Gatta C, Costanza G, Corrao S, Gesualdo L. SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.867075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Xiao X, Luo Y, Peng D. Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism. Front Cardiovasc Med 2022;9:879355. [DOI: 10.3389/fcvm.2022.879355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
419 Sydorchuk A. Risks’ Stratification of Metabolic Disorders and Arterial Hypertension Depending on the NOS3 (RS2070744) and GNB3 (RS5443) Genes’ Allelic State. FM 2022. [DOI: 10.30841/2307-5112.1-2.2022.260501] [Reference Citation Analysis]
420 Liang J, Li W, Liu H, Li X, Yuan C, Zou W, Qu L. Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Front Pharmacol 2022;13:857092. [DOI: 10.3389/fphar.2022.857092] [Reference Citation Analysis]
421 Zubair M, Bown MJ, Armstrong N. Introducing multi-component cardiovascular health screening into existing Abdominal Aortic Aneurysm (AAA) screening programmes in the UK: a qualitative study of programme staff views. BMC Health Serv Res 2022;22:569. [PMID: 35477458 DOI: 10.1186/s12913-022-07975-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Limpijankit T, Jongjirasiri S, Unwanatham N, Rattanasiri S, Thakkinstian A, Laothamatas J. Causal Relationship of Coronary Artery Calcium on Myocardial Infarction and Preventive Effect of Antiplatelet Therapy. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.871267] [Reference Citation Analysis]
423 Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Peláez C, Pentieva K, Thies F, Tsabouri S, Vinceti M, Bresson JL, Siani A; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific advice related to nutrient profiling for the development of harmonised mandatory front-of-pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods. EFSA J 2022;20:e07259. [PMID: 35464873 DOI: 10.2903/j.efsa.2022.7259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
424 Mora S, Shufelt CL, Manson JE. Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma. JAMA Intern Med 2022. [PMID: 35471410 DOI: 10.1001/jamainternmed.2022.1365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Achenbach S. [Cardiac computed tomography - Current diagnostic role in cardiology]. Dtsch Med Wochenschr 2022;147:549-56. [PMID: 35468636 DOI: 10.1055/a-1554-8450] [Reference Citation Analysis]
426 Nussbaumerová B. Hypertension and dyslipidemia treament in stroke. Vnitr Lek 2022;68:172-177. [DOI: 10.36290/vnl.2022.034] [Reference Citation Analysis]
427 Wei W, Liu J, Chen S, Xu X, Guo D, He Y, Huang Z, Wang B, Huang H, Li Q, Chen J, Chen H, Tan N, Liu Y. Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis. Front Endocrinol (Lausanne) 2022;13:850836. [PMID: 35330914 DOI: 10.3389/fendo.2022.850836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
428 Soška V. Dyslipidemia and PCSK9 inhibitors - practical focused update of indication and reimbursement criteria. Vnitr Lek 2022;68:191-194. [DOI: 10.36290/vnl.2022.038] [Reference Citation Analysis]
429 Blaum C, Arnold N, Waldeyer C. Kosten-Nutzen-Analyse neuer Lipidsenker. Herz. [DOI: 10.1007/s00059-022-05116-8] [Reference Citation Analysis]
430 von Ehr A, Bode C, Hilgendorf I. Macrophages in Atheromatous Plaque Developmental Stages. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.865367] [Reference Citation Analysis]
431 Gynnild MN, Hageman SHJ, Spigset O, Lydersen S, Saltvedt I, Dorresteijn JAN, Visseren FLJ, Ellekjær H. Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment. Open Heart 2022;9:e001972. [PMID: 35459718 DOI: 10.1136/openhrt-2022-001972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Caracciolo A, Scalise RFM, Ceresa F, Bagnato G, Versace AG, Licordari R, Perfetti S, Lofrumento F, Irrera N, Santoro D, Patanè F, Di Bella G, Costa F, Micari A. Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease. JCM 2022;11:2380. [DOI: 10.3390/jcm11092380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
433 Tünnemann-Tarr A, Katzmann JL, Thiery J, Laufs U. [Lipoprotein apheresis : State of the art and case report of the longest HELP treatment worldwide]. Herz 2022. [PMID: 35451597 DOI: 10.1007/s00059-022-05115-9] [Reference Citation Analysis]
434 Nakai M, Iwanaga Y, Sumita Y, Wada S, Hiramatsu H, Iihara K, Kohro T, Komuro I, Kuroda T, Matoba T, Nakayama M, Nishimura K, Noguchi T, Takemura T, Tominaga T, Toyoda K, Tsujita K, Yasuda S, Miyamoto Y, Ogawa H. Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset. PLoS One 2022;17:e0264390. [PMID: 35275919 DOI: 10.1371/journal.pone.0264390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
435 Jakše B, Lipošek S, Zenić N, Šajber D. Olympic Cycle Comparison of the Nutritional and Cardiovascular Health Status of an Elite-Level Female Swimmer: Case Study Report from Slovenia. Sports 2022;10:63. [DOI: 10.3390/sports10050063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Drapkina OM, Kontsevaya AV, Kalinina AM, Avdeev SM, Agaltsov MV, Alexandrova LM, Antsiferova AA, Aronov DM, Akhmedzhanov NM, Balanova YA, Balakhonova TV, Berns SA, Bochkarev MV, Bochkareva EV, Bubnova MV, Budnevsky AV, Gambaryan MG, Gorbunov VM, Gorny BE, Gorshkov AY, Gumanova NG, Dadaeva VA, Drozdova LY, Egorov VA, Eliashevich SO, Ershova AI, Ivanova ES, Imaeva AE, Ipatov PV, Kaprin AD, Karamnova NS, Kobalava ZD, Konradi AO, Kopylova OV, Korostovtseva LS, Kotova MB, Kulikova MS, Lavrenova EA, Lischenko OV, Lopatina MV, Lukina YV, Lukyanov MM, Mayev IV, Mamedov MN, Markelova SV, Martsevich SY, Metelskaya VA, Meshkov AN, Milushkina OY, Mukaneeva DK, Myrzamatova AO, Nebieridze DV, Orlov DO, Poddubskaya EA, Popovich MV, Popovkina OE, Potievskaya VI, Prozorova GG, Rakovskaya YS, Rotar OP, Rybakov IA, Sviryaev YV, Skripnikova IA, Skoblina NA, Smirnova MI, Starinsky VV, Tolpygina SN, Usova EV, Khailova ZV, Shalnova SA, Shepel RN, Shishkova VN, Yavelov IS. 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines. Cardiovasc Ther Prev 2022;21:3235. [DOI: 10.15829/1728-8800-2022-3235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
437 Zhang X, Liu Q, Zhang H, Tan C, Zhu Q, Chen S, Du Y, Yang H, Li Q, Xu C, Wu C, Wang QK. Hyperlipidemia patients carrying LDLR splicing mutation c.1187-2A>G respond favorably to rosuvastatin and PCSK9 inhibitor evolocumab. Mol Genet Genomics 2022. [PMID: 35441343 DOI: 10.1007/s00438-022-01892-4] [Reference Citation Analysis]
438 Karczewska-Kupczewska M, Nikołajuk A, Kondraciuk M, Stachurska Z, Dubatówka M, Szpakowicz A, Strączkowski M, Kowalska I, Kamiński K. The relationships between FLAIS, a novel insulin sensitivity index, and cardiovascular risk factors in a population-based study. Cardiovasc Diabetol 2022;21:55. [PMID: 35439985 DOI: 10.1186/s12933-022-01491-y] [Reference Citation Analysis]
439 Erina AM, Usoltsev DA, Boyarinova MA, Kolesova EP, Moguchaya EV, Tolkunova KM, Alieva AS, Rotar OP, Artemov NN, Shalnova SA, Konradi AO, Drapkina OM, Boytsov SA, Shlyakhto EV. Appointment of lipid-lowering therapy in the Russian population: comparison of SCORE and SCORE2 (according to the ESSE-RF study). Russ J Cardiol 2022;27:5006. [DOI: 10.15829/1560-4071-2022-5006] [Reference Citation Analysis]
440 Sonmez A, Sabbour H, Echtay A, Rahmah AM, Alhozali AM, Sabaan FS, Haddad FH, Iraqi H, Elebrashy I, Assaad SN, Bayat Z, Osar Siva Z, Hassanein M. Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations. Journal of Diabetes. [DOI: 10.1111/1753-0407.13266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
441 Chou P, Wu P, Wu P, Huang T, Huang J, Chen S, Lee S, Kuo M, Chiu Y, Hsu Y, Chang J, Hwang S. Investigation of the Relationship between Cardiovascular Biomarkers and Brachial–Ankle Pulse Wave Velocity in Hemodialysis Patients. JPM 2022;12:636. [DOI: 10.3390/jpm12040636] [Reference Citation Analysis]
442 Cheng X, Ma T, Ouyang F, Zhang G, Bai Y. Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999-2018. Int J Environ Res Public Health 2022;19:4726. [PMID: 35457593 DOI: 10.3390/ijerph19084726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Paraskevas KI, Mikhailidis DP, Antignani PL, Ascher E, Baradaran H, Bokkers RPH, Cambria RP, Comerota AJ, Dardik A, Davies AH, Eckstein HH, Faggioli G, Fernandes E Fernandes J, Fraedrich G, Geroulakos G, Gloviczki P, Golledge J, Gupta A, Jezovnik MK, Kakkos SK, Katsiki N, Knoflach M, Eline Kooi M, Lanza G, Lavenson GS Jr, Liapis CD, Loftus IM, Mansilha A, Millon A, Nicolaides AN, Pini R, Poredos P, Proczka RM, Ricco JB, Riles TS, Ringleb PA, Rundek T, Saba L, Schlachetzki F, Silvestrini M, Spinelli F, Stilo F, Sultan S, Suri JS, Svetlikov AV, Zeebregts CJ, Chaturvedi S. Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis. Angiology 2022;:33197221081914. [PMID: 35412377 DOI: 10.1177/00033197221081914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Imaz Aristimuño N, Rodriguez Agirretxe I, San Vicente Blanco R, Rotaeche Del Campo R, Mendicute Del Barrio J. Comparison of Cardiovascular Risk and Events among Spanish Patients with and without Ocular Pseudoexfoliation. J Clin Med 2022;11:2153. [PMID: 35456246 DOI: 10.3390/jcm11082153] [Reference Citation Analysis]
445 Tanaka A, Toyoda S, Kato T, Yoshida H, Hamasaki S, Watarai M, Ishizu T, Ueda S, Inoue T, Node K. Association between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trial. RMD Open 2022;8:e002226. [DOI: 10.1136/rmdopen-2022-002226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
446 Masiliūnas R, Vilionskis A, Bornstein NM, Rastenytė D, Jatužis D. The impact of a comprehensive national policy on improving acute stroke patient care in Lithuania. European Stroke Journal. [DOI: 10.1177/23969873221089158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
447 Haudum CW, Kolesnik E, Colantonio C, Mursic I, Url-Michitsch M, Tomaschitz A, Glantschnig T, Hutz B, Lind A, Schweighofer N, Reiter C, Ablasser K, Wallner M, Tripolt NJ, Pieske-Kraigher E, Madl T, Springer A, Seidel G, Wedrich A, Zirlik A, Krahn T, Stauber R, Pieske B, Pieber TR, Verheyen N, Obermayer-Pietsch B, Schmidt A. Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases. BMJ Open 2022;12:e058890. [PMID: 35393327 DOI: 10.1136/bmjopen-2021-058890] [Reference Citation Analysis]
448 Gallo A, Mszar R, Miname MH. Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia. Curr Atheroscler Rep 2022. [PMID: 35386094 DOI: 10.1007/s11883-022-01017-7] [Reference Citation Analysis]
449 Eikelboom JW, Bosch J, Connolly SJ, Tyrwitt J, Fox KAA, Muehlhofer E, Neumann C, Tasto C, Bangdiwala SI, Diaz R, Alings M, Dagenais GR, Leong DP, Lonn EM, Avezum A, Piegas LS, Widimsky P, Parkhomenko AN, Bhatt DL, Branch KRH, Probstfield JL, Lopez-jaramillo P, Rydén L, Pogosova N, Keltai K, Keltai M, Ertl G, Stoerk S, Dans AL, Lanas F, Liang Y, Zhu J, Torp-pedersen C, Maggioni AP, Commerford PJ, Guzik TJ, Vanassche T, Verhamme P, O'donnell M, Tonkin AM, Varigos JD, Vinereanu D, Felix C, Kim J, Ibrahim KS, Lewis BS, Metsarinne KP, Aboyans V, Steg PG, Hori M, Kakkar A, Anand SS, Lamy A, Sharma M, Yusuf S. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European Heart Journal - Cardiovascular Pharmacotherapy 2022. [DOI: 10.1093/ehjcvp/pvac023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 Andersen RM, Skou ST, Clausen MB, Jäger M, Zangger G, Grøntved A, Brønd JC, Soja AMB, Tang LH. Maintenance of physical activity after cardiac rehabilitation (FAIR): study protocol for a feasibility trial. BMJ Open 2022;12:e060157. [PMID: 35383088 DOI: 10.1136/bmjopen-2021-060157] [Reference Citation Analysis]
451 Arsyad DS, Westerink J, Cramer MJ, Ansar J, Wahiduddin, Visseren FLJ, Doevendans PA, Ansariadi. Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research. BMC Public Health 2022;22:660. [PMID: 35382783 DOI: 10.1186/s12889-022-13104-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
452 Altschmiedova T, Todorovova V, Vrablik M, Ceska R. Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics. Front Genet 2022;13:849267. [PMID: 35368707 DOI: 10.3389/fgene.2022.849267] [Reference Citation Analysis]
453 Rosolová H. Prediabetes. Vnitr Lek 2022;68:82-84. [DOI: 10.36290/vnl.2022.016] [Reference Citation Analysis]
454 Gebhardt P, Caldarone F, Westhoff-bleck M, Olsson KM, Hoeper MM, Park D, Stapel B, Breitner MH, Werth O, Heitland I, Kahl KG. Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events. Front Psychiatry 2022;13:812807. [DOI: 10.3389/fpsyt.2022.812807] [Reference Citation Analysis]
455 Putot A, Putot S, Chagué F, Cottin Y, Zeller M, Manckoundia P. New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease. Age Ageing 2022;51:afac085. [PMID: 35397160 DOI: 10.1093/ageing/afac085] [Reference Citation Analysis]
456 Arnesen EK, Retterstøl K. Secular trends in serum lipid profiles in young adults in Norway, 2001-19. Atherosclerosis Plus 2022;48:60-67. [DOI: 10.1016/j.athplu.2022.03.006] [Reference Citation Analysis]
457 Zhou L, Zhang W, Wang J. Recent advances in the study of modified cellulose in meat products: Modification method of cellulose, meat quality improvement and safety concern. Trends in Food Science & Technology 2022;122:140-56. [DOI: 10.1016/j.tifs.2022.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
458 Fegers-wustrow I, Gianos E, Halle M, Yang E. Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology 2022;79:1304-13. [DOI: 10.1016/j.jacc.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
459 Chen X, Zhang M, Wang L, Huang Z, Zhang W, Wu J. Association between physical activity energy expenditure and cardiometabolic risk factor clustering among Chinese adults in 2015. Sports Medicine and Health Science 2022. [DOI: 10.1016/j.smhs.2022.04.002] [Reference Citation Analysis]
460 Poredoš P, Cífková R, Marie Maier JA, Nemcsik J, Šabovič M, Jug B, Ježovnik MK, Schernthaner GH, Antignani PL, Catalano M, Fras Z, Höbaus C, Nicolaides AN, Paraskevas KI, Reiner Ž, Wohlfahrt P, Poredoš P, Blinc A. Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events? Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
461 Berger JS. Aspirin for Primary Prevention-Time to Rethink Our Approach. JAMA Netw Open 2022;5:e2210144. [PMID: 35471577 DOI: 10.1001/jamanetworkopen.2022.10144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Gupta R, Misra A. Hyperlipidemia management in diabetes: First line or supportive therapy? Diabetes Metab Syndr 2022;16:102470. [PMID: 35378385 DOI: 10.1016/j.dsx.2022.102470] [Reference Citation Analysis]
463 Wang C(, Liblik K, Haseeb S, Lopez-santi R, Baranchuk A. Women and Alcohol: Limitations in the Cardiovascular Guidelines. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101200] [Reference Citation Analysis]
464 Di Lisi D, Madaudo C, Alagna G, Santoro M, Rossetto L, Siragusa S, Novo G. The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity. ESC Heart Fail 2022. [PMID: 35355425 DOI: 10.1002/ehf2.13897] [Reference Citation Analysis]
465 Kim S, Choi SY, Lee H, Kim JJ, Park HE. Sex and Age Differences in the Impact of Metabolic Syndrome and Its Components including A Body Shape Index on Arterial Stiffness in the General Population. J Atheroscler Thromb 2022. [PMID: 35354700 DOI: 10.5551/jat.63371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
466 Tajiri K, Sekine I. Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patients. Japanese Journal of Clinical Oncology 2022. [DOI: 10.1093/jjco/hyac041] [Reference Citation Analysis]
467 Balint EM, Angerer P, Guendel H, Marten-Mittag B, Jarczok MN. Stress Management Intervention for Leaders Increases Nighttime SDANN: Results from a Randomized Controlled Trial. Int J Environ Res Public Health 2022;19:3841. [PMID: 35409525 DOI: 10.3390/ijerph19073841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
468 Falter M, Scherrenberg M, Kindermans H, Kizilkilic S, Kaihara T, Dendale P. Willingness to participate in cardiac telerehabilitation: results from semi-structured interviews. European Heart Journal - Digital Health 2022;3:67-76. [DOI: 10.1093/ehjdh/ztab091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
469 Brouwers RWM, Brini A, Kuijpers RWFH, Kraal JJ, Kemps HMC. Predictors of non-participation in a cardiac telerehabilitation programme: a prospective analysis. European Heart Journal - Digital Health 2022;3:81-89. [DOI: 10.1093/ehjdh/ztab105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Novotný V. Triple combination, double meaning. Intervencni a akutni kardiologie 2022;21:41-44. [DOI: 10.36290/kar.2022.002] [Reference Citation Analysis]
471 Matiashova LM, L T Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine. 2 а, Lyubovi Maloy Ave., Kharkiv 61039, Ukraine. The Effect of Acute Intermittent Fasting on Blood Pressure, Inflammation Markers and Metabolic Parameters. Ukr ž med bìol sportu 2022;7:131-136. [DOI: 10.26693/jmbs07.01.131] [Reference Citation Analysis]
472 Papageorgiou M, Merminod F, Ferrari S, Rizzoli R, Biver E. Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium Intake. Nutrients 2022;14:1314. [PMID: 35334971 DOI: 10.3390/nu14061314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Brotons C, Camafort M, Del Mar Castellanos M, Clarà A, Cortés O, Diaz Rodriguez A, Elosua R, Gorostidi M, Hernández AM, Herranz M, Justo S, Lahoz C, Niño P, Pallarés-Carratalá V, Pedro-Botet J, Pérez Pérez A, Royo-Bordonada MA, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention]. Hipertens Riesgo Vasc 2022:S1889-1837(22)00023-X. [PMID: 35331672 DOI: 10.1016/j.hipert.2022.02.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Ferraro RA, Leucker T, Martin SS, Banach M, Jones SR, Toth PP. Contemporary Management of Dyslipidemia. Drugs 2022. [PMID: 35303294 DOI: 10.1007/s40265-022-01691-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
475 Groenland EH, Vendeville JP, Bots ML, de Borst GJ, Nathoe HM, Ruigrok YM, Blankestijn PJ, Visseren FLJ, Spiering W; UCC-SMART Study Group. The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease. PLoS One 2022;17:e0265429. [PMID: 35298524 DOI: 10.1371/journal.pone.0265429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
476 Cheburkin YV, Sonin DL, Polozov AS, Mateikovich PA, Savochkina EV, Galagudza MM. The role of membrane and circulating forms of ACE 2 in pathological processes in COVID-19 infection. Arter gipertenz 2022;27:608-616. [DOI: 10.18705/1607-419x-2021-27-6-608-616] [Reference Citation Analysis]
477 Chapman MJ, Zamorano JL, Parhofer KG. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Pharmacol Ther 2022;237:108172. [PMID: 35304222 DOI: 10.1016/j.pharmthera.2022.108172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
478 Yagensky V, Schirmer M. Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study. Front Med (Lausanne) 2022;9:786776. [PMID: 35280915 DOI: 10.3389/fmed.2022.786776] [Reference Citation Analysis]
479 Nowak-lis A, Nowak Z, Gabrys T, Szmatlan-gabrys U, Batalik L, Knappova V. The Use of Vibration Training in Men after Myocardial Infarction. IJERPH 2022;19:3326. [DOI: 10.3390/ijerph19063326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
480 Sepehri Shamloo A, Dilk P, Dagres N. Prävention des plötzlichen Herztods. Herz. [DOI: 10.1007/s00059-022-05106-w] [Reference Citation Analysis]
481 Corianò M, Tona F. Strategies for Sudden Cardiac Death Prevention. Biomedicines 2022;10:639. [DOI: 10.3390/biomedicines10030639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
482 Nowak BM, Kamiński M, Owczarek B, Szulińska M, Bogdański P. Availability of Cardiodiabetological Drugs in Poland during the First Year of COVID-19 Pandemic: Retrospective Study. BioMed 2022;2:117-126. [DOI: 10.3390/biomed2010013] [Reference Citation Analysis]
483 Maștaleru A, Cojocariu SA, Oancea A, Constantin MML, Roca M, Zota IM, Abdulan I, Rusu C, Popescu R, Antoci LM, Ciobanu CG, Costache AD, Cojocaru E, Mitu F. Genetic Polymorphisms in a Familial Hypercholesterolemia Population from North-Eastern Europe. JPM 2022;12:429. [DOI: 10.3390/jpm12030429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
484 Krieger J, Mccann N, Bluhm M, Zuhl M. Exercise Prescription and Progression Practices among US Cardiac Rehabilitation Clinics. Clinics and Practice 2022;12:194-203. [DOI: 10.3390/clinpract12020023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Gili S, Giuliani M, Santagostino Baldi G, Teruzzi G, Pravettoni G, Montorsi P, Trabattoni D. Early Detection of Cardiovascular Risk Factors and Definition of Psychosocial Profile in Women Through a Systematic Approach: The Monzino Women Heart Center's Experience. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.844563] [Reference Citation Analysis]
486 Chazova IE, Ageev FT, Aksenova AV, Vicenya MV, Gilyarov MY, Martynyuk TV, Panchenko EP, Poltavskaya MG, Potievskaya VI, Trofimova OP, Fedotkina YA. Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022). Evrazijskij kardiologičeskij žurnal 2022. [DOI: 10.38109/2225-1685-2022-1-6-79] [Reference Citation Analysis]
487 Zaffino P, Spadea MF, Indolfi C, De Rosa S. CoroFinder: A New Tool for Real Time Detection and Tracking of Coronary Arteries in Contrast-Free Cine-Angiography. JPM 2022;12:411. [DOI: 10.3390/jpm12030411] [Reference Citation Analysis]
488 Del Bianco-rondeau M, Robert-halabi M, Bloom S, Rabasa-lhoret R, Tardif J, Lordkipanidzé M, Marquis-gravel G. Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities. Thromb Haemost. [DOI: 10.1055/s-0042-1743469] [Reference Citation Analysis]
489 Martsevich SY, Lukina YV, Kutishenko NP, Zagrebelnyy AV, Tolpygina SN, Voronina VP, Dmitrieva NA, Lerman OV, Nekoshnova ES, Budaeva IV, Blagodatskikh SV, Aslanova BB. Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data). Racionalʹnaâ farmakoterapiâ v kardiologii 2022;18:73-8. [DOI: 10.20996/1819-6446-2022-02-02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
490 Kanaoka K, Iwanaga Y, Nakai M, Nishioka Y, Myojin T, Kubo S, Okada K, Soeda T, Noda T, Sakata Y, Miyamoto Y, Saito Y, Imamura T. Outpatient cardiac rehabilitation dose after acute coronary syndrome in a nationwide cohort. Heart 2022:heartjnl-2021-320434. [PMID: 35241624 DOI: 10.1136/heartjnl-2021-320434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Verdecchia P, Cavallini C, Angeli F. Advances in the Treatment Strategies in Hypertension: Present and Future. JCDD 2022;9:72. [DOI: 10.3390/jcdd9030072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
492 Dawkes S. Supporting mental health in people with cardiovascular disease. British Journal of Cardiac Nursing 2022;17:1-5. [DOI: 10.12968/bjca.2022.0022] [Reference Citation Analysis]
493 Groenland EH, Heidemann BE, van der Laan SW, van Setten J, Koopal C, Bots ML, Asselbergs FW, Visseren FL, Spiering W. Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Gollmer J, Zirlik A, Bugger H. SOP Der herzkranke Diabetespatient. Kardiologie up2date 2022;18:13-18. [DOI: 10.1055/a-1224-0954] [Reference Citation Analysis]
495 Casey A, Quinn S, McAdam B, Kennedy M, Sheahan R. Colchicine-regeneration of an old drug. Ir J Med Sci 2022. [PMID: 35230596 DOI: 10.1007/s11845-022-02938-7] [Reference Citation Analysis]
496 Shui X, Chen Z, Wen Z, Tang L, Tang W, Liao Y, Wu Z, Chen L. Association of Atherogenic Index of Plasma With Angiographic Progression in Patients With Suspected Coronary Artery Disease. Angiology 2022;:33197221080911. [PMID: 35229661 DOI: 10.1177/00033197221080911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Koch S, Esch T, Werdecker L. Effects of a Yoga-Based Stress Intervention Program on the Blood Pressure of Young Police Officers: A Randomized Controlled Trial. J Integr Complement Med 2022;28:234-40. [PMID: 35294298 DOI: 10.1089/jicm.2021.0294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 Cardoso R, Abovich A, Boden WE, Arbab-zadeh A, Blankstein R, Blumenthal RS. The 2021 AHA/ACC/SCAI Coronary Artery Revascularization Recommendations. JACC: Advances 2022;1:100006. [DOI: 10.1016/j.jacadv.2022.100006] [Reference Citation Analysis]
499 Christensen DM, Strange JE, Phelps M, Schjerning AM, Sehested TS, Gerds T, Gislason G. Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
500 Belardo D, Michos ED, Blankstein R, Blumenthal RS, Ferdinand KC, Hall K, Klatt K, Natajaran P, Ostfeld RJ, Reddy K, Rodriguez R, Sriram U, Tobias DK, Gulati M. Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society for Preventive Cardiology Clinical Practice Statement. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
501 Rossignol P, Bhandari S, Kalra PA, Selwood J, Hinchliffe W, Maxfield D. Managing persistent hyperkalaemia with next-generation potassium binders. Journal of Kidney Care 2022;7:S1-S18. [DOI: 10.12968/jokc.2022.7.sup2.s1] [Reference Citation Analysis]
502 Wong ND, Budoff MJ, Ferdinand K, Graham IM, Michos ED, Reddy T, Shapiro M, Toth PP. ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK ASSESSMENT: An American Society for Preventive Cardiology Clinical Practice Statement. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
503 Obrova J, Sovova E, Ivanova K, Furstova J, Taborsky M. Let It Beat: How Lifestyle and Psychosocial Factors Affect the Risk of Sudden Cardiac Death-A 10-Year Follow-Up Study. Int J Environ Res Public Health 2022;19:2627. [PMID: 35270315 DOI: 10.3390/ijerph19052627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
504 Lu X, Liu Z, Cui Q, Liu F, Li J, Niu X, Shen C, Hu D, Huang K, Chen J, Xing X, Zhao Y, Lu F, Liu X, Cao J, Chen S, Ma H, Yu L, Wu X, Wu X, Li Y, Zhang H, Mo X, Zhao L, Huang J, Wang L, Wen W, Shu XO, Takeuchi F, Koh WP, Tai ES, Cheng CY, Wong TY, Chang X, Chan MY, Gao W, Zheng H, Chen K, Chen J, He J, Tang CS, Lam KSL, Tse HF, Cheung CYY, Takahashi A, Kubo M, Kato N, Terao C, Kamatani Y, Sham PC, Heng CK, Hu Z, Chen YE, Wu T, Shen H, Willer CJ, Gu D. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J 2022:ehac093. [PMID: 35195259 DOI: 10.1093/eurheartj/ehac093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
505 Krajčoviechová A. Treatment of arterial hypertension in 2022. Med Pro Praxi 2022;19:74-76. [DOI: 10.36290/med.2022.011] [Reference Citation Analysis]
506 Lucà F, Abrignani MG, Parrini I, Di Fusco SA, Giubilato S, Rao CM, Piccioni L, Cipolletta L, Passaretti B, Giallauria F, Leone A, Francese GM, Riccio C, Gelsomino S, Colivicchi F, Gulizia MM. Update on Management of Cardiovascular Diseases in Women. J Clin Med 2022;11:1176. [PMID: 35268267 DOI: 10.3390/jcm11051176] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
507 Bogdanov DY, Nevzorova VA, Shestopalov EY. Comparative assessment of cardiovascular risk in European and Korean ethnic groups in the Russian population using the SCORE and SCORE2. Cardiovasc Ther Prev 2022;21:3128. [DOI: 10.15829/1728-8800-2022-3128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
508 Zhang Y, Zhao X, Ding X, Chen H, Li H, Li W. Association of Prior Statin Therapy With Cardiovascular Outcomes in Patients With Initial Diagnosis of OCAD and LDL-C Below 1.8 mmol/L. Angiology 2022;:33197221075861. [PMID: 35191328 DOI: 10.1177/00033197221075861] [Reference Citation Analysis]
509 Adamski P, Barańska M, Ostrowska M, Kuliczkowski W, Buszko K, Kościelska-Kasprzak K, Karolko B, Mysiak A, Kubica J. Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor. J Clin Med 2022;11:1124. [PMID: 35207396 DOI: 10.3390/jcm11041124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Di Raimondo D, Musiari G, Rizzo G, Pirera E, Signorelli SS. New Insights in Prevention and Treatment of Cardiovascular Disease. Int J Environ Res Public Health 2022;19:2475. [PMID: 35206661 DOI: 10.3390/ijerph19042475] [Reference Citation Analysis]
511 Janjusevic M, Fluca AL, Gagno G, Pierri A, Padoan L, Sorrentino A, Beltrami AP, Sinagra G, Aleksova A. Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis. Int J Mol Sci 2022;23:2336. [PMID: 35216451 DOI: 10.3390/ijms23042336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
512 Peiró ÓM, Ferrero M, Romeu A, Carrasquer A, Bonet G, Mohandes M, Pernigotti A, Bardají A. Performance of Coronary Angiography in the Detection of Coronary Artery Disease in Patients with Systolic Left Ventricular Dysfunction and No Prior Ischemic Heart Disease. JCM 2022;11:1097. [DOI: 10.3390/jcm11041097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Nordén KR, Dagfinrud H, Semb AG, Hisdal J, Viktil KK, Sexton J, Fongen C, Skandsen J, Blanck T, Metsios GS, Tveter AT. Effect of high-intensity exercise on cardiorespiratory fitness, cardiovascular disease risk and disease activity in patients with inflammatory joint disease: protocol for the ExeHeart randomised controlled trial. BMJ Open 2022;12:e058634. [PMID: 35177467 DOI: 10.1136/bmjopen-2021-058634] [Reference Citation Analysis]
514 Maisch B, Dörr R. [Guidelines 2021-is retrospective also a perspective?]. Herz 2022;47:1-3. [PMID: 35166858 DOI: 10.1007/s00059-021-05092-5] [Reference Citation Analysis]
515 Vekic J, Zeljkovic A, Cicero AFG, Janez A, Stoian AP, Sonmez A, Rizzo M. Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL. Medicina 2022;58:299. [DOI: 10.3390/medicina58020299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
516 Mikolaitytė J, Badarienė J, Puronaitė R, Čypienė A, Rutkauskienė I, Dadonienė J, Laucevičius A. Which Clusters of Metabolic Syndrome Are the Most Associated with Serum Uric Acid? Medicina 2022;58:297. [DOI: 10.3390/medicina58020297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
517 Giosuè A, Calabrese I, Vitale M, Riccardi G, Vaccaro O. Consumption of Dairy Foods and Cardiovascular Disease: A Systematic Review. Nutrients 2022;14:831. [PMID: 35215479 DOI: 10.3390/nu14040831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
518 Santamaría Olmo R, Pendón Ruiz de Mier MV, Rodelo Haad C. Chronic kidney disease and vascular risk - what's new? Hipertens Riesgo Vasc 2022;39:3-7. [PMID: 35152979 DOI: 10.1016/j.hipert.2022.01.001] [Reference Citation Analysis]
519 Oliveira GMMD, Wenger NK. Considerações Especiais na Prevenção de Doenças Cardiovasculares nas Mulheres. Arquivos Brasileiros de Cardiologia 2022;118:374-7. [DOI: 10.36660/abc.20220028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
520 Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. 'Myocardial Ischemia-Reperfusion Injury and the Influence of Inflammation. Trends Cardiovasc Med 2022:S1050-1738(22)00029-9. [PMID: 35181472 DOI: 10.1016/j.tcm.2022.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
521 Falsetti L, Viticchi G, Zaccone V, Guerrieri E, Moroncini G, Luzzi S, Silvestrini M. Shared Molecular Mechanisms among Alzheimer’s Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review. Biomedicines 2022;10:439. [DOI: 10.3390/biomedicines10020439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
522 Norberg H, Sjölander M, Glader E, Gustafsson M. Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study. Eur J Clin Pharmacol. [DOI: 10.1007/s00228-022-03284-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 Soška V. Cholesterol measurement and current guidelines. Vnitr Lek 2022;68:54-57. [DOI: 10.36290/vnl.2022.007] [Reference Citation Analysis]
524 Bertolone DT, Gallinoro E, Esposito G, Paolisso P, Bermpeis K, De Colle C, Fabbricatore D, Mileva N, Valeriano C, Munhoz D, Belmonte M, Vanderheyden M, Bartunek J, Sonck J, Wyffels E, Collet C, Mancusi C, Morisco C, De Luca N, De Bruyne B, Barbato E. Contemporary Management of Stable Coronary Artery Disease. High Blood Press Cardiovasc Prev 2022. [PMID: 35147890 DOI: 10.1007/s40292-021-00497-z] [Reference Citation Analysis]
525 Czerniuk MR, Surma S, Romańczyk M, Nowak JM, Wojtowicz A, Filipiak KJ. Unexpected Relationships: Periodontal Diseases: Atherosclerosis-Plaque Destabilization? From the Teeth to a Coronary Event. Biology (Basel) 2022;11:272. [PMID: 35205138 DOI: 10.3390/biology11020272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
526 Usova EI, Ionov MV, Alieva AS, Avdonina NG, Orbeladze NV, Khodyreva АA, Yakovlev AN, Zvartau NE. An integrated approach for very high cardiovascular risk patients. Intermediate results. Russ J Cardiol 2022;27:4839. [DOI: 10.15829/1560-4071-2022-4839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
527 Kott KA, Bishop M, Yang CHJ, Plasto TM, Cheng DC, Kaplan AI, Cullen L, Celermajer DS, Meikle PJ, Vernon ST, Figtree GA. Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells 2022;11:588. [PMID: 35159397 DOI: 10.3390/cells11030588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Salzmann S, Salzmann-djufri M, Euteneuer F. Childhood Emotional Neglect and Cardiovascular Disease: A Narrative Review. Front Cardiovasc Med 2022;9:815508. [DOI: 10.3389/fcvm.2022.815508] [Reference Citation Analysis]
529 Ma H, Lin Y, Dai L, Lin C, Huang Y, Liu S. Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis.. [DOI: 10.1101/2022.02.06.22270446] [Reference Citation Analysis]
530 Gencer B, Tessitore E. 2021 European guidelines on cardiovascular prevention: Challenges for an evidence-based patient care. Eur J Clin Invest 2022;52:e13752. [PMID: 35118645 DOI: 10.1111/eci.13752] [Reference Citation Analysis]
531 Kim M, Sung J, Jin M, Jang E, Yu HT, Kim T, Pak H, Lee M, Lip GYH, Yang P, Joung B. Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease. Front Cardiovasc Med 2022;9:811058. [DOI: 10.3389/fcvm.2022.811058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Abdelhamid M, Kandil H, Hassanin M, Shaheen S, Sobhy M, ElEtreby A, Hasan-Ali H, Mahfouz H, Nasr G, Shawky I, Emil S, ElSetiha M, Hasssan M, Sadek Y, Karim MA, Asham A, Ghaleb M, Samir A, Shokry K. Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fraction. ESC Heart Fail 2022. [PMID: 35118822 DOI: 10.1002/ehf2.13811] [Reference Citation Analysis]
533 Vynckier P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators. Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry. Int J Cardiol 2022:S0167-5273(22)00185-1. [PMID: 35122913 DOI: 10.1016/j.ijcard.2022.01.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
534 Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, Boumpas DT, Brodin N, Bruce IN, González-Gay MÁ, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C, Ramos-Casals M, Sattar N, Schreiber K, Sciascia S, Svenungsson E, Szekanecz Z, Tausche AK, Tyndall A, van Halm V, Voskuyl A, Macfarlane GJ, Ward MM, Nurmohamed MT, Tektonidou MG. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 2022:annrheumdis-2021-221733. [PMID: 35110331 DOI: 10.1136/annrheumdis-2021-221733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
535 Reimers AK, Marzi I, Beck F, Engels E, Renninger D, Buttazzoni A, Krieger C, Demetriou Y. Active travel behaviour in the family environment: protocol for the mixed-methods cross-sectional ARRIVE study. BMJ Open 2022;12:e056383. [PMID: 35105596 DOI: 10.1136/bmjopen-2021-056383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
536 Núñez E, Fuster V, Gómez-Serrano M, Valdivielso JM, Fernández-Alvira JM, Martínez-López D, Rodríguez JM, Bonzon-Kulichenko E, Calvo E, Alfayate A, Bermudez-Lopez M, Escola-Gil JC, Fernández-Friera L, Cerro-Pardo I, Mendiguren JM, Sánchez-Cabo F, Sanz J, Ordovás JM, Blanco-Colio LM, García-Ruiz JM, Ibáñez B, Lara-Pezzi E, Fernández-Ortiz A, Martín-Ventura JL, Vázquez J. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis. EBioMedicine 2022;76:103874. [PMID: 35152150 DOI: 10.1016/j.ebiom.2022.103874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
537 Katsiki N, Raggi P, Korosoglou G. Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women? Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.02.019] [Reference Citation Analysis]
538 Córdoba-soriano JG, Gutiérrez-díez A, Del Blanco BG, Núñez J, Amat-santos IJ, Oteo JF, Romaguera R, Gallardo-lópez A, Lozano Ruíz-poveda F, Baello P, Aguar P, Jerez-valero M, Jiménez-díaz VA, Serra B, Cascon JD, Morales-ponce FJ, Portero-portaz JJ, Melehi El Assali D, Cerrato-garcía P, Jiménez-mazuecos J. Bioactive or Drug Eluting Stents in 75 years or older patients: The BIODES-75 Registry. Cardiovascular Revascularization Medicine 2022. [DOI: 10.1016/j.carrev.2022.02.001] [Reference Citation Analysis]
539 Bruninx A, Scheenstra B, Dekker A, Maessen J, van 't Hof A, Kietselaer B, Bermejo I. Using clinical prediction models to personalise lifestyle interventions for cardiovascular disease prevention: A systematic literature review. Preventive Medicine Reports 2022;25:101672. [DOI: 10.1016/j.pmedr.2021.101672] [Reference Citation Analysis]
540 Moraru CA, Dr. Iacob Czihac Military Emergency Hospital, Iași, Romania, Năfureanu ED, Proca A, Zavadovschi I, Floria M, Popescu DM, "1 Dr. Iacob Czihac Military Emergency Hospital, Iași, Romania 2 Grigore T. Popa University of Medicine and Pharmacy, Iași, Romania", "1 Dr. Iacob Czihac Military Emergency Hospital, Iași, Romania 2 Grigore T. Popa University of Medicine and Pharmacy, Iași, Romania", Dr. Iacob Czihac Military Emergency Hospital, Iași, Romania, "1 Dr. Iacob Czihac Military Emergency Hospital, Iași, Romania 2 Grigore T. Popa University of Medicine and Pharmacy, Iași, Romania", University of Medicine and Pharmacy, Craiova, Romania. Post-traumatic stress disorder and cardiovascular disease. RJMM 2022;125:97-111. [DOI: 10.55453/rjmm.2022.125.1.13] [Reference Citation Analysis]
541 Ziegler O. Variabilité de la triglycéridémie : impact métabolique. De la dysfonction du tissu adipeux à l’adiposité viscérale et à la stéatopathie métabolique, les chemins de l’insulino-résistance. Médecine des Maladies Métaboliques 2022;16:54-68. [DOI: 10.1016/j.mmm.2021.12.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 de la Fuente-Mancera JC, Forado-Bentar I, Farrero M. Management of long-term cardiovascular risk factors post organ transplant. Curr Opin Organ Transplant 2022;27:29-35. [PMID: 34939962 DOI: 10.1097/MOT.0000000000000950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
543 Cainzos-achirica M, Nasir K. Debates in Cardiac CT: The Force of Data Is with CAC — And It’s Rock Solid. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.02.002] [Reference Citation Analysis]
544 Keleszade E, Kolida S, Costabile A. The cholesterol lowering efficacy of Lactobacillus plantarum ECGC 13110402 in hypercholesterolemic adults: a double-blind, randomized, placebo controlled, pilot human intervention study. Journal of Functional Foods 2022;89:104939. [DOI: 10.1016/j.jff.2022.104939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
545 Nargesi AA, Clark C, Chen L, Liu M, Reddy A, Amodeo S, Oikonomou EK, Suchard MA, Mcguire DK, Lin Z, Inzucchi S, Khera R. Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States.. [DOI: 10.1101/2022.01.31.22270187] [Reference Citation Analysis]
546 Leonetti S, Tricò D, Nesti L, Baldi S, Kozakova M, Goncalves I, Nilsson J, Shore A, Khan F, Natali A. Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk. Atherosclerosis 2022;343:1-9. [DOI: 10.1016/j.atherosclerosis.2022.01.003] [Reference Citation Analysis]
547 Chan NC, Xu K, de Vries TA, Eikelboom JW, Hirsh J. Inflammation as a mechanism and therapeutic target in peripheral artery disease. Can J Cardiol 2022:S0828-282X(22)00076-9. [PMID: 35114347 DOI: 10.1016/j.cjca.2022.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Casula M, Catapano AL, Magni P. Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet). Nutrients 2022;14:606. [DOI: 10.3390/nu14030606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
549 Sauer F, Riou M, Charles A, Meyer A, Andres E, Geny B, Talha S. Pathophysiology of Heart Failure: A Role for Peripheral Blood Mononuclear Cells Mitochondrial Dysfunction? JCM 2022;11:741. [DOI: 10.3390/jcm11030741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
550 Agnello F, Capodanno D. Anti-inflammatory strategies for atherosclerotic artery disease. Expert Opinion on Drug Safety. [DOI: 10.1080/14740338.2022.2036717] [Reference Citation Analysis]
551 Xie Y, Xing Z, Wei J, Sun X, Zhao B, Chen Y, Geng Y, Jia Z, Zou H, M.a B. Levosimendan Postconditioning Attenuates Cardiomyocyte Apoptosis after Myocardial Infarction. Journal of Healthcare Engineering 2022;2022:1-9. [DOI: 10.1155/2022/2988756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
552 Mauersberger C, Hinterdobler J, Schunkert H, Kessler T, Sager HB. Where the Action Is-Leukocyte Recruitment in Atherosclerosis. Front Cardiovasc Med 2021;8:813984. [PMID: 35087886 DOI: 10.3389/fcvm.2021.813984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
553 Shalnova SA. Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice. Cardiovasc Ther Prev 2022;21:3171. [DOI: 10.15829/1728-8800-2022-3171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
554 Cinque F, Cespiati A, Lombardi R, Costantino A, Maffi G, Alletto F, Colavolpe L, Francione P, Oberti G, Fatta E, Bertelli C, Sigon G, Dongiovanni P, Vecchi M, Fargion S, Fracanzani AL. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. Nutrients 2022;14:556. [PMID: 35276911 DOI: 10.3390/nu14030556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
555 Daponte-Codina A, Knox EC, Mateo-Rodriguez I, Seims A, Regitz-Zagrosek V, Maas AHEM, White A, Barnhoorn F, Rosell-Ortiz F. Gender and Social Inequalities in Awareness of Coronary Artery Disease in European Countries. Int J Environ Res Public Health 2022;19:1388. [PMID: 35162415 DOI: 10.3390/ijerph19031388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
556 Hageman S, Pennells L, Ojeda F, Kaptoge S, Dorresteijn J, Di Angelantonio E, for the SCORE2 working group and ESC Cardiovascular Risk Collaboration. SCORE2 models allow consideration of sex-specific cardiovascular disease risks by region. European Heart Journal 2022;43:241-242. [DOI: 10.1093/eurheartj/ehab761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
557 Carballo D, Visseren FLJ, Mach F, Smulders Y. The 'ten commandments' for the 2021 ESC Guidelines on CVD prevention. Eur Heart J 2022;43:174-6. [PMID: 35080240 DOI: 10.1093/eurheartj/ehab742] [Reference Citation Analysis]
558 Vekic J, Zeljkovic A, Al Rasadi K, Cesur M, Silva-nunes J, Stoian AP, Rizzo M. A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies. Metabolites 2022;12:108. [DOI: 10.3390/metabo12020108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
559 Kotlyarov S, Kotlyarova A. Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis. Int J Mol Sci 2022;23:1308. [PMID: 35163232 DOI: 10.3390/ijms23031308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
560 Yavelo IS. Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction. Aterotromboz 2022;11:18-28. [DOI: 10.21518/2307-1109-2021-11-2-18-28] [Reference Citation Analysis]
561 Viladés-Medel D, Dégano IR, Subirana I, Descalzo M, Padilla M, Mundet X, Carreras Costa F, Alomar Serrallach X, Camps A, Elosua R, Marrugat J, Leta Petracca R. Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries). J Clin Med 2022;11:533. [PMID: 35159985 DOI: 10.3390/jcm11030533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
562 Lehtisalo J, Rusanen M, Solomon A, Antikainen R, Laatikainen T, Peltonen M, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M, Ngandu T. Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial. Eur Heart J 2022:ehab922. [PMID: 35051281 DOI: 10.1093/eurheartj/ehab922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
563 Liu C, Zhao Q, Ma X, Cheng Y, Sun Y, Zhang D, Liu X, Zhou Y. Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol 2022;21. [DOI: 10.1186/s12933-022-01446-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
564 Baggiano A, Italiano G, Guglielmo M, Fusini L, Guaricci AI, Maragna R, Giacari CM, Mushtaq S, Conte E, Annoni AD, Formenti A, Mancini ME, Andreini D, Rabbat M, Pepi M, Pontone G. Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging. JCM 2022;11:477. [DOI: 10.3390/jcm11030477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
565 Masson W, Barbagelata L, Lavalle-Cobo A, Lobo M, Masson G, Nogueira JP, Vergès B. Low-doses aspirin in the primary prevention of cardiovascular disease in patients with diabetes: Meta-analysis stratified by baseline cardiovascular risk. Diabetes Metab Syndr 2022;16:102391. [PMID: 35030453 DOI: 10.1016/j.dsx.2022.102391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
566 Paschou SA, Bletsa E, Stampouloglou PK, Tsigkou V, Valatsou A, Stefanaki K, Kazakou P, Spartalis M, Spartalis E, Oikonomou E, Siasos G. Thyroid disorders and cardiovascular manifestations: an update. Endocrine 2022. [PMID: 35032315 DOI: 10.1007/s12020-022-02982-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
567 Susekov AV. Topical issues concerning modern lipid-lowering therapy. Consilium Medicum 2022;24:20-7. [DOI: 10.26442/20751753.2022.1.201484] [Reference Citation Analysis]
568 Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G; Members of the Board of the Italian Society of Cardiovascular Prevention. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention. High Blood Press Cardiovasc Prev 2022. [PMID: 35025091 DOI: 10.1007/s40292-021-00503-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
569 Zanchin C, Ledwoch S, Bär S, Ueki Y, Otsuka T, Häner JD, Zanchin T, Praz F, Hunziker L, Stortecky S, Pilgrim T, Losdat S, Windecker S, Räber L, Siontis GCM. Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions. Int J Cardiol 2022:S0167-5273(22)00065-1. [PMID: 35033577 DOI: 10.1016/j.ijcard.2022.01.018] [Reference Citation Analysis]
570 Dias P, Pourová J, Vopršalová M, Nejmanová I, Mladěnka P. 3-Hydroxyphenylacetic Acid: A Blood Pressure-Reducing Flavonoid Metabolite. Nutrients 2022;14:328. [PMID: 35057508 DOI: 10.3390/nu14020328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
571 Busnatu SS, Salmen T, Pana MA, Rizzo M, Stallone T, Papanas N, Popovic D, Tanasescu D, Serban D, Stoian AP. The Role of Fructose as a Cardiovascular Risk Factor: An Update. Metabolites 2022;12:67. [PMID: 35050189 DOI: 10.3390/metabo12010067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
572 Leosdottir M, Wärjerstam S, Michelsen HÖ, Schlyter M, Hag E, Wallert J, Larsson M. Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods. Sci Rep 2022;12:642. [PMID: 35022490 DOI: 10.1038/s41598-021-04634-5] [Reference Citation Analysis]
573 Boytsov SA, Piradov MA, Tanashyan MM, Voznjouk IA, Ezhov MV, Oschepkova EV, Sergienko IV, Shamalov NA, Yanishevskiy SN. Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;17:927-30. [DOI: 10.20996/1819-6446-2021-12-10] [Reference Citation Analysis]
574 Martins AMA, Paiva MUB, Paiva DVN, de Oliveira RM, Machado HL, Alves LJSR, Picossi CRC, Faccio AT, Tavares MFM, Barbas C, Giraldez VZR, Santos RD, Monte GU, Atik FA. Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies. Front Cardiovasc Med 2021;8:788062. [PMID: 35004898 DOI: 10.3389/fcvm.2021.788062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Wu P, Mamas MA, Gulati M. Health Care Professional's Knowledge of Pregnancy Complications and Women's Cardiovascular Health: An International Study Utilizing Social Media. J Womens Health (Larchmt) 2022. [PMID: 35006000 DOI: 10.1089/jwh.2021.0298] [Reference Citation Analysis]
576 Katsi V, Papakonstantinou IP, Soulaidopoulos S, Katsiki N, Tsioufis K. Chrononutrition in Cardiometabolic Health. J Clin Med 2022;11:296. [PMID: 35053991 DOI: 10.3390/jcm11020296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Kasper P, Lang S, Demir M, Steffen HM. Optimising the management of cardiovascular comorbidities in NAFLD patients: it's time to (re-) act! Gut 2022:gutjnl-2021-326662. [PMID: 34992133 DOI: 10.1136/gutjnl-2021-326662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
578 Grassi G, Del Pinto R, Agabiti Rosei C, Agnoletti D, Borghi C, Cicero AFG, De Ciuceis C, Desideri G, Grassi D, Muiesan ML, Paini A, Salvetti M, Tocci G, Veglio F, Volpe M, Ferri C. Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension. High Blood Press Cardiovasc Prev 2022. [PMID: 34978703 DOI: 10.1007/s40292-021-00501-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
579 Cosentino F, Bhatt DL, Marx N, Verma S. The year in cardiovascular medicine 2021: diabetes and metabolic disorders. Eur Heart J 2022:ehab876. [PMID: 34974614 DOI: 10.1093/eurheartj/ehab876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
580 Tokgozoglu L, Orringer C, Ginsberg HN, Catapano AL. The year in cardiovascular medicine 2021: dyslipidaemia. Eur Heart J 2022:ehab875. [PMID: 34974612 DOI: 10.1093/eurheartj/ehab875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
581 Dale CE, Takhar R, Carragher R, Torabi F, Katsoulis M, Duffield S, Kent S, Mueller T, Kurdi A, Mctaggart S, Abbasizanjani H, Hollings S, Scourfield A, Lyons R, Griffiths R, Lyons J, Davies G, Harris D, Handy A, Mizani MA, Tomlinson C, Ashworth M, Denaxas S, Banerjee A, Sterne J, Lovibond K, Brown P, Bullard I, Priedon R, Mamas MA, Slee A, Lorgelly P, Pirmohamed M, Khunti K, Sattar N, Morris A, Sudlow C, Akbari A, Bennie M, Sofat R. The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data.. [DOI: 10.1101/2021.12.31.21268587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
582 Budzyński J, Szukay B. BMI as a Biomarker in Patients’ Nutritional Assessment. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-031-07389-2_36] [Reference Citation Analysis]
583 Colak A, Akin Y. Effectiveness of statin treatment in reducing red cell distribution width and mean platelet volume in patients with stable coronary artery disease: A retrospective study. Int J Cardiovasc Acad 2022;8:110. [DOI: 10.4103/ijca.ijca_21_22] [Reference Citation Analysis]
584 Cawley C, Mcevoy JW. European Guidelines for Risk Assessment in the Primary Prevention of Cardiovascular Disease. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-030-98824-1_3] [Reference Citation Analysis]
585 Gupta R, Singhal S. Dietary issues in coronary heart disease prevention. Reference Module in Food Science 2022. [DOI: 10.1016/b978-0-12-821848-8.00078-0] [Reference Citation Analysis]
586 Shishkova V, Imamgayazova K, Kapustina L. Correction of psychoemotional disorders and short-term prognosis in patients with COVID-19. Z nevrol psikhiatr im S S Korsakova 2022;122:63. [DOI: 10.17116/jnevro202212205163] [Reference Citation Analysis]
587 Bae JH. Opposing View: A Blind Faith in Meta-Analyses in Academia Could Be a Threat to Public Health. J Lipid Atheroscler 2022;11:308. [DOI: 10.12997/jla.2022.11.3.308] [Reference Citation Analysis]
588 Halle M, Wimbauer F, Esefeld K, Fegers-wustrow I. Herz und Sport. Klinische Kardiologie 2022. [DOI: 10.1007/978-3-662-62939-0_38-1] [Reference Citation Analysis]
589 . Kardialer Check-up. Facharztprüfung Kardiologie 2022. [DOI: 10.1016/b978-3-437-21115-7.00008-1] [Reference Citation Analysis]
590 Sionis A, Hidalgo R. Escenario II. Optimización del control lipídico después de un síndrome coronario agudo: la transición entre el servicio de cardiología y atención primaria. Revista Española de Cardiología Suplementos 2022;22:7-10. [DOI: 10.1016/s1131-3587(22)00010-3] [Reference Citation Analysis]
591 Budzyński J, Szukay B. BMI as a Biomarker in Patients’ Nutritional Assessment. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-030-81304-8_36-1] [Reference Citation Analysis]
592 Stangl V, Lueg J. Kardiale Erkrankungen bei Frauen. Klinische Kardiologie 2022. [DOI: 10.1007/978-3-662-62939-0_43-1] [Reference Citation Analysis]
593 Berkelmans G, Read S, Gudbjörnsdottir S, Wild S, Franzen S, van der Graaf Y, Eliasson B, Visseren F, Paynter N, Dorresteijn J. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. Journal of Clinical Epidemiology 2022. [DOI: 10.1016/j.jclinepi.2022.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
594 Park CS. Reclassification of Cardiovascular Risk Based on the Presence of Carotid Plaque Regarding Statin Eligibility in Low to Moderate Risk Patients. Korean Circ J 2022;52. [DOI: 10.4070/kcj.2022.0302] [Reference Citation Analysis]
595 Taha MB, Ahuja D, Patel KV, Cainzos-achirica M, Nasir K. Coronary Artery Calcium. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-030-98824-1_22] [Reference Citation Analysis]
596 Alexander S, Li S, Tracy M. Cardiac rehabilitation - The answer for the second chance. American Heart Journal Plus: Cardiology Research and Practice 2022;13:100108. [DOI: 10.1016/j.ahjo.2022.100108] [Reference Citation Analysis]
597 de Terwangne C, Sorgente A, Macovei S, Preumont T, Chierchia G, de Asmundis C, de Meester A, Hanotier P. Association between atrial fibrillation, frailty, and geriatric syndromes in the late elderly in a south Belgian outpatient and inpatient setting. American Heart Journal Plus: Cardiology Research and Practice 2022;13:100106. [DOI: 10.1016/j.ahjo.2022.100106] [Reference Citation Analysis]
598 Bochkareva E, Butina E, Bayramkulova N, Drapkina O, Ipatov P. Association of breast arterial calcifications and coronary calcification: implications for the prevention of cardiovascular diseases in women. Profil med 2022;25:89. [DOI: 10.17116/profmed20222506189] [Reference Citation Analysis]
599 Arutyunov G, Amelin A, Voznyuk I, Kulesh A, Maximova M, Mkrtchyan V, Putilina M, Sorokoumov V, Fonyakin A, Khasanova D. COMPASS study results as a foundation for new treatment approach for neurological patients. Opinion of the expert council of december 18, 2021. Z nevrol psikhiatr im S S Korsakova 2022;122:94. [DOI: 10.17116/jnevro202212204194] [Reference Citation Analysis]
600 Baltă MD. Cardiovascular risk in women. Medic ro 2022;5:32. [DOI: 10.26416/med.149.5.2022.7121] [Reference Citation Analysis]
601 Cimaglia P, Bernucci D, Cardelli LS, Carone A, Scavone G, Manfrini M, Censi S, Calvi S, Ferrari R, Campo G, Paola LD. Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions. J Cardiovasc Pharmacol Ther 2022;27:10742484221101980. [PMID: 35593201 DOI: 10.1177/10742484221101980] [Reference Citation Analysis]
602 Kochergina A, Batluk T, Benimetskaya K, Vishnyak D, Gavrilova E, Gubareva E, Efremova E, Izmozherova N, Ionin V, Isaeva A, Martirosyan K, Rubanenko O, Safyanik E, Semenova E, Tolmacheva A, Fadeeva E. Issues of catering for students of medical universities in Russia. Results of the first multicenter study. Profil med 2022;25:12. [DOI: 10.17116/profmed20222506112] [Reference Citation Analysis]
603 . Leitsymptom Dyspnoe, Leistungsschwäche. Facharztprüfung Kardiologie 2022. [DOI: 10.1016/b978-3-437-21115-7.00003-2] [Reference Citation Analysis]
604 Campuzano Ruiz R, Arrarte Esteban V, Fernández Olmo R, Castro Conde A, Mazón Ramos P, Boraita Pérez A, Palau Sampio P, Sandín Rollán M. Selección de lo mejor del año 2021 en riesgo vascular y rehabilitación cardiaca. REC: CardioClinics 2022;57:S29-S35. [DOI: 10.1016/j.rccl.2021.10.001] [Reference Citation Analysis]
605 Escobar C, Castro A, Gómez Cerezo JF, Luis Górriz J, Obaya Rebollar JC, Villar-taibo R. Abordaje práctico de la semaglutida en el paciente con diabetes tipo 2. Revista Española de Cardiología Suplementos 2022;22:1-9. [DOI: 10.1016/s1131-3587(22)00013-9] [Reference Citation Analysis]
606 Rizzoni D, Agabiti-rosei C, de Ciuceis C. Exercise and Microcirculation in Hypertension. Exercise, Sports and Hypertension 2022. [DOI: 10.1007/978-3-031-07958-0_5] [Reference Citation Analysis]
607 Kris-etherton PM, Sanders L, Lawler O, Riley T, Maki K. Hyperlipidemia. Reference Module in Food Science 2022. [DOI: 10.1016/b978-0-12-821848-8.00175-x] [Reference Citation Analysis]
608 Alarcón JA, Bonanad C. Escenario I. Mejoras en la ruta asistencial para pacientes derivados al alta a la unidad de rehabilitación cardiaca. Revista Española de Cardiología Suplementos 2022;22:4-6. [DOI: 10.1016/s1131-3587(22)00009-7] [Reference Citation Analysis]
609 Skybchyk O, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Chevtchik O, Solomenchuk T, Martovlos (Hodovana) O, Department Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh,UK, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. ASSESSMENT OF LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE AND GENERALIZED PERIODONTITIS. PSSS MS 2021;65. [DOI: 10.25040/ntsh2021.02.09] [Reference Citation Analysis]
610 Calderone D, Ingala S, Mauro MS, Angiolillo DJ, Capodanno D. Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events. Expert Rev Cardiovasc Ther 2021;:1-21. [PMID: 34915778 DOI: 10.1080/14779072.2021.2020100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
611 Kashirin AK, Kachkovsky MA, Brylyakova SN, Artischev VP, Berezhnov ID. Organization of treatment and health resort rehabilitation of elderly and long-living patients with cardiovascular diseases in hospital for war veterans. vmirvz 2021. [DOI: 10.20340/vmi-rvz.2022.1.clin.6] [Reference Citation Analysis]
612 Şimşek MA, Türer Cabbar A, Özveren O, Koca Ç, Durmuş E, Değertekin M. Factors Affecting The Change in Agatson Score in Follow Up Multislice Coronary Ct Angiograms. Harran Üniversitesi Tıp Fakültesi Dergisi 2021. [DOI: 10.35440/hutfd.997349] [Reference Citation Analysis]
613 Chen W, Li H, Lu Z, Guo Q, Liu X, Sun R, Zhang J, Huang J, Chen Q, Wang J, Shen J, Zhang Y. The ratio of the max-to-mean coronary artery calcium score in the most calcified vessel is associated with the presence of coronary artery disease. Eur J Radiol 2021;147:110134. [PMID: 34979296 DOI: 10.1016/j.ejrad.2021.110134] [Reference Citation Analysis]
614 Kashirin AK, Kachkovsky MA, Brylyakova SN, Artischev VP, Berezhnov ID. Organization of treatment and health resort rehabilitation of elderly and long-living patients with cardiovascular diseases in hospital for war veterans. vmirvz 2021. [DOI: 10.20340/vmirvz.2022.1.clin.6] [Reference Citation Analysis]
615 Gruca M, Zamojska J, Niewiadomska-jarosik K, Wosiak A, Smolewska E. Evaluation of Health-Promoting Behaviors in the Prevention of Cardiovascular Diseases in the Preschool Children of Polish Health Care Professionals. IJERPH 2021;19:308. [DOI: 10.3390/ijerph19010308] [Reference Citation Analysis]
616 Ferrari F, Scheffel RS, Martins VM, Santos RD, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. Am J Cardiovasc Drugs 2021. [PMID: 34958423 DOI: 10.1007/s40256-021-00515-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
617 Rymar OD, Shchetinina AO, Mustafina SV, Simonova GI, Shcherbakova LV, Kuntseviсh AK. Base mucronutrients and food groups consumption, associations with the risk of fatal cardiovascular disease development in people with type 2 diabetes: a prospective cohort study. Sibirskij nauchnyj medicinskij zhurnal 2021;41:91-100. [DOI: 10.18699/ssmj20210611] [Reference Citation Analysis]
618 Gaffney B, Jacobsen AP, Pallippattu AW, Leahy N, McEvoy JW. The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease. Integr Blood Press Control 2021;14:179-87. [PMID: 34938115 DOI: 10.2147/IBPC.S286957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
619 Ding M, Wennberg A, Ek S, Santoni G, Gigante B, Walldius G, Hammar N, Modig K. The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age. Sci Rep 2021;11:24440. [PMID: 34952923 DOI: 10.1038/s41598-021-03959-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
620 Langslet G, Holven KB, Bogsrud MP. Treatment goals in familial hypercholesterolemia - time to consider LDL-cholesterol burden. Eur J Prev Cardiol 2021:zwab228. [PMID: 34935933 DOI: 10.1093/eurjpc/zwab228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
621 Wannamethee SG. Frailty and increased risk of cardiovascular disease: are we at a crossroad to include frailty in cardiovascular risk assessment in older adults? Eur Heart J 2021:ehab818. [PMID: 34935046 DOI: 10.1093/eurheartj/ehab818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
622 Barbero U, Ajassa M, Gaglioti CM, Piga A, Ferrero GB, Longo F. The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients. J Cardiovasc Dev Dis 2021;9:3. [PMID: 35050213 DOI: 10.3390/jcdd9010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
623 Rolles B, Wessels I, Doukas P, Kotelis D, Rink L, Vieri M, Beier F, Jacobs M, Gombert A. Retrospective observational study evaluating zinc plasma level in patients undergoing thoracoabdominal aortic aneurysm repair and its correlation with outcome. Sci Rep 2021;11:24348. [PMID: 34934131 DOI: 10.1038/s41598-021-03877-6] [Reference Citation Analysis]
624 Beltrán Romero LM, Vallejo-Vaz AJ, Muñiz Grijalvo O. Cerebrovascular Disease and Statins. Front Cardiovasc Med 2021;8:778740. [PMID: 34926626 DOI: 10.3389/fcvm.2021.778740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
625 Bolla E, Tentolouris N, Sfikakis PP, Tektonidou MG. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus. Lupus Sci Med 2021;8:e000579. [PMID: 34921093 DOI: 10.1136/lupus-2021-000579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
626 Mills GB, Ratcovich H, Adams-hall J, Beska B, Kirkup E, Raharjo DE, Veerasamy M, Wilkinson C, Kunadian V, Banach M. Is the contemporary care of the older persons with acute coronary syndrome evidence-based? European Heart Journal Open 2022;2:oeab044. [DOI: 10.1093/ehjopen/oeab044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
627 Shan Y, Bai Y, Zhang J, Lu Y, Yu S, Song C, Liu J, Jian M, Xu J, Xiong Z, Huang X. Urinary sodium excretion is not associated with the incidence of end-stage kidney disease and kidney-related death: results from the UK Biobank.. [DOI: 10.1101/2021.12.14.21267572] [Reference Citation Analysis]
628 Plakht Y, Gilutz H, Shiyovich A. When More Means Less: The Prognosis of Recurrent Acute Myocardial Infarctions. J Clin Med 2021;10:5889. [PMID: 34945184 DOI: 10.3390/jcm10245889] [Reference Citation Analysis]
629 Kuznetsova OY, Degtyareva LN, Moiseeva IE. Results of the all-russian conference with international participation “The place and role of a general practitioner in a changing world”. Rossiĭskiĭ semeĭnyĭ vrach 2021;25:37-46. [DOI: 10.17816/rfd84048] [Reference Citation Analysis]
630 Doi T, Langsted A, Nordestgaard BG. Mineral oil and icosapent ethyl may jointly explain the between arm difference of cardiovascular risk in REDUCE-IT. Eur Heart J 2021;42:4867-8. [PMID: 34734260 DOI: 10.1093/eurheartj/ehab764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
631 Weschenfelder C, Kris-etherton PM. Abdominal Subcutaneous Adipose Tissue, Diet, and Risk of Cardiovascular Disease: What do we Know? International Journal of Cardiovascular Sciences 2021;35:46-7. [DOI: 10.36660/ijcs.20210233] [Reference Citation Analysis]
632 Crea F. An update on triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular disease. Eur Heart J 2021;42:4777-80. [PMID: 34905602 DOI: 10.1093/eurheartj/ehab844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
633 Guedes MR, Klein MRST. Cardiovascular Benefits of Plant-Based Diets. International Journal of Cardiovascular Sciences 2021;35:11-3. [DOI: 10.36660/ijcs.20210262] [Reference Citation Analysis]
634 Tsaban G. Statins and lipoprotein(a); facing the residual risk. Eur J Prev Cardiol 2021:zwab178. [PMID: 34904162 DOI: 10.1093/eurjpc/zwab178] [Reference Citation Analysis]
635 Delabays B, Cavassini M, Damas J, Beuret H, Calmy A, Hasse B, Bucher HC, Frischknecht M, Müller O, Méan M, Vollenweider P, Marques-Vidal P, Vaucher J. Cardiovascular risk assessment in people living with HIV compared to the general population. Eur J Prev Cardiol 2021:zwab201. [PMID: 34893801 DOI: 10.1093/eurjpc/zwab201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
636 . Major cholesterol study reveals benefits of examining diverse populations. Nature 2021. [PMID: 34887580 DOI: 10.1038/d41586-021-02998-2] [Reference Citation Analysis]
637 Thompson B, McEvoy JW. Establishing target systolic and diastolic blood pressure in diabetic patients with hypertension: what do we need to consider? Expert Rev Cardiovasc Ther 2021;19:993-1003. [PMID: 34878361 DOI: 10.1080/14779072.2021.2013814] [Reference Citation Analysis]
638 Prokšelj K, Brida M. Pre-term birth: a novel risk factor for cardiovascular disease in women? Eur Heart J 2021:ehab838. [PMID: 34888648 DOI: 10.1093/eurheartj/ehab838] [Reference Citation Analysis]
639 Mattioli AV, Coppi F, Manenti A, Farinetti A. Subclinical Vascular Damage: Current Insights and Future Potential. Vasc Health Risk Manag 2021;17:729-38. [PMID: 34866906 DOI: 10.2147/VHRM.S242636] [Reference Citation Analysis]
640 Catapano AL, Ray KK, Tokgözoglu L. Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future. Atherosclerosis 2022;340:51-2. [PMID: 34863532 DOI: 10.1016/j.atherosclerosis.2021.11.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
641 Editorial A. High cardiovascular risk patient — focus on results. Treatment of dyslipidemia in the clinical practice of a cardiologist, pediatrician, neurologist and endocrinologist. Russ J Cardiol 2021;26:4798. [DOI: 10.15829/1560-4071-2021-4798] [Reference Citation Analysis]
642 Ocenasek H, Kuzdas-sallaberger M. Ambulante Rehabilitation. J Gastroenterol Hepatol Erkr 2021;19:89-97. [DOI: 10.1007/s41971-021-00111-y] [Reference Citation Analysis]
643 Fawzy AM, Lip GY. Cardiovascular disease prevention: Risk factor modification at the heart of the matter. The Lancet Regional Health - Western Pacific 2021;17:100291. [DOI: 10.1016/j.lanwpc.2021.100291] [Reference Citation Analysis]
644 Marazzato J, Masnaghetti S, De Ponti R, Verdecchia P, Blasi F, Ferrarese S, Trapasso M, Spanevello A, Angeli F. Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study. J Cardiovasc Dev Dis 2021;8:169. [PMID: 34940524 DOI: 10.3390/jcdd8120169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
645 Cebrian A, Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Manito N, Botana M, Alcázar R. Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk. Nefrología 2021. [DOI: 10.1016/j.nefro.2021.11.010] [Reference Citation Analysis]
646 von Knobelsdorff F. Kardiovaskuläre Risikoeinschätzung bei jungen Patienten: Hilft der koronare Kalk-Score? Kardiologe 2021;15:519-522. [DOI: 10.1007/s12181-021-00512-6] [Reference Citation Analysis]
647 Drapkina OM, Shepel RN, Dzhioeva ON. Natriuretic peptides: new challenges — new solutions. Cardiovasc Ther Prev 2021;20:3102. [DOI: 10.15829/1728-8800-2021-3102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
648 Kopylova OV, Ershova AI, Meshkov AN, Kontsevaya AV, Drapkina OM. Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age. Cardiovasc Ther Prev 2021;20:2991. [DOI: 10.15829/1728-8800-2021-2991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
649 Kharagjitsing HHS, van Vooren J, Brilman EG, Hendriksz TR, van Gelder T, van Bommel EFH. Abdominal aortic diameter and cardiovascular status in patients with idiopathic retroperitoneal fibrosis. Rheumatol Int 2021. [PMID: 34821970 DOI: 10.1007/s00296-021-05051-7] [Reference Citation Analysis]
650 Burlacu A, Brinza C, Popa IV, Covic A, Floria M. Influencing Cardiovascular Outcomes through Heart Rate Variability Modulation: A Systematic Review. Diagnostics (Basel) 2021;11:2198. [PMID: 34943435 DOI: 10.3390/diagnostics11122198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
651 Cimminiello C, Vlachopulos C, De Carlo M. The 2021 ESC guidelines on cardiovascular prevention: Whether the ends justify the means. Eur J Intern Med 2021:S0953-6205(21)00386-1. [PMID: 34823967 DOI: 10.1016/j.ejim.2021.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 Bálint G, Slezáková Z, Miklovičová E. Tobacco Profile and Evaluation of the DS14 Scale in Patients with Coronary Syndrome. Psych 2021;3:694-702. [DOI: 10.3390/psych3040044] [Reference Citation Analysis]
653 Dyrbuś K, Gąsior M, Penson PE, Banach M. Extreme cardiovascular risk-do we need a new risk category? Eur Heart J 2021:ehab771. [PMID: 34792106 DOI: 10.1093/eurheartj/ehab771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
654 Neiburga KD, Vilne B, Bauer S, Bongiovanni D, Ziegler T, Lachmann M, Wengert S, Hawe JS, Güldener U, Westerlund AM, Li L, Pang S, Yang C, Saar K, Huebner N, Maegdefessel L, DigiMed Bayern Consortium, Lange R, Krane M, Schunkert H, von Scheidt M. Vascular Tissue Specific miRNA Profiles Reveal Novel Correlations with Risk Factors in Coronary Artery Disease. Biomolecules 2021;11:1683. [PMID: 34827683 DOI: 10.3390/biom11111683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
655 Montgomery S, Miedema MD, Dodson JA. Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults. Heart 2021:heartjnl-2021-320154. [PMID: 34764212 DOI: 10.1136/heartjnl-2021-320154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
656 Druzhilov MA, Kuznetsova TY, Chumakova GA. Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity. Russ J Cardiol 2021;27:4755. [DOI: 10.15829/1560-4071-2022-4755] [Reference Citation Analysis]
657 Druzhilov MA, Kuznetsova TY, Chumakova GA. Multiagonists of the “incretin axis” as a promising tool for managing cardiometabolic risk in visceral obesity. Russ J Cardiol 2021;27:4755. [DOI: 10.15829/29/1560-4071-2022-4755] [Reference Citation Analysis]
658 Romaguera R, Salinas P, Gomez-Lara J, Brugaletta S, Gómez-Menchero A, Romero MA, García-Blas S, Ocaranza R, Bordes P, Kockar MJ, Salvatella N, Jiménez-Díaz VA, Alameda M, Trillo R, Lee DH, Martín P, López-Benito M, Freites A, Pascual-Tejerino V, Hernández-Hernández F, García Del Blanco B, Mohandes M, Bosa F, Pinar E, Roura G, Comin-Colet J, Fernández-Ortiz A, Macaya C, Rossello X, Sabate M, Pocock SJ, Gómez-Hospital JA; SUGAR trial Investigators . Amphilimus- versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease (SUGAR trial). Eur Heart J 2021:ehab790. [PMID: 34735004 DOI: 10.1093/eurheartj/ehab790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
659 Brunerová L, Urbanová J, Brož J. Metabolic and endocrine diseases - is our approach always rational? Vnitr Lek 2021;67:399-403. [DOI: 10.36290/vnl.2021.107] [Reference Citation Analysis]
660 Borghi C, Levy BI. Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis. Nutrition, Metabolism and Cardiovascular Diseases 2021. [DOI: 10.1016/j.numecd.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
661 Cai H, Cao P, Zhou W, Sun W, Zhang X, Li R, Shao W, Wang L, Zou L, Zheng Y. Effect of early cardiac rehabilitation on prognosis in patients with heart failure following acute myocardial infarction. BMC Sports Sci Med Rehabil 2021;13:139. [PMID: 34717743 DOI: 10.1186/s13102-021-00368-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
662 Rizvi AA, Stoian AP, Janez A, Rizzo M. Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. Biomedicines 2021;9:1579. [PMID: 34829807 DOI: 10.3390/biomedicines9111579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
663 Rivas Serna IM, Sitina M, Stokin GB, Medina-Inojosa JR, Lopez-Jimenez F, Gonzalez-Rivas JP, Vinciguerra M. Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health. Metabolites 2021;11:747. [PMID: 34822405 DOI: 10.3390/metabo11110747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
664 Escobedo A, Rivera-León EA, Luévano-Contreras C, Urías-Silvas JE, Luna-Vital DA, Morales-Hernández N, Mojica L. Common Bean Baked Snack Consumption Reduces Apolipoprotein B-100 Levels: A Randomized Crossover Trial. Nutrients 2021;13:3898. [PMID: 34836152 DOI: 10.3390/nu13113898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
665 Brinton EA. Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? Arterioscler Thromb Vasc Biol 2021;41:2798-801. [PMID: 34705475 DOI: 10.1161/ATVBAHA.121.316893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
666 Halle M. The ESC quality indicators for cardiovascular disease prevention: another puzzle piece in the strategy of preventive cardiology. Eur J Prev Cardiol 2021:zwab179. [PMID: 34718520 DOI: 10.1093/eurjpc/zwab179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
667 Khan SS, Navar AM. The Potential and Pitfalls of Coronary Artery Calcium Scoring. JAMA Cardiol 2021. [PMID: 34705021 DOI: 10.1001/jamacardio.2021.4413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
668 Ferat LR, Forrest R, Sehmi K, Santos RD, Stewart D, Boulton AJM, Jiménez BY, Riley P, Burger D, Jones ESW, Tomaszewski M, Milanese MR, Laffin P, Jha V, Borisch B, Moore M, Pinto FJ, Piñeiro D, Eiselé JL, Lackland DT, Whelton PK, Zhang XH, Stavdal A, Li D, Hobbs R, Pandian JD, Brainin M, Feigin V; Global Coalition for Circulatory Health. Preventing the Next Pandemic: The Case for Investing in Circulatory Health - A Global Coalition for Circulatory Health Position Paper. Glob Heart 2021;16:66. [PMID: 34692391 DOI: 10.5334/gh.1077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
669 Kotlyarov S. Diversity of Lipid Function in Atherogenesis: A Focus on Endothelial Mechanobiology. Int J Mol Sci 2021;22:11545. [PMID: 34768974 DOI: 10.3390/ijms222111545] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
670 Coleman CI, Kharat AA, Bookhart B, Baker WL. Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease. Curr Med Res Opin 2021;:1-8. [PMID: 34641745 DOI: 10.1080/03007995.2021.1991294] [Reference Citation Analysis]
671 Parums DV. Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD). Med Sci Monit 2021;27:e935172. [PMID: 34690345 DOI: 10.12659/MSM.935172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
672 Chipayo-Gonzales D, Ramakrishna H, Nuñez-Gil IJ. Score2: A New Updated Algorithm to Predict Cardiovascular Disease Risk in Europe. J Cardiothorac Vasc Anesth 2022;36:18-21. [PMID: 34686439 DOI: 10.1053/j.jvca.2021.09.033] [Reference Citation Analysis]
673 Aktaa S, Gencer B, Arbelo E, Davos CH, Désormais I, Hollander M, Abreu A, Ambrosetti M, Bäck M, Carballo D, Crawford C, Deaton C, Dendale P, Eijsvogels TMH, Galbraith M, Piepoli MF, Salzwedel A, Smulders Y, Wilhelm M, Biondi-Zoccai G, Mach F, Visseren FLJ, Gale CP. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 2021:zwab160. [PMID: 34687540 DOI: 10.1093/eurjpc/zwab160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
674 Taratukhin EO. Risk communication: ethics, psychology, law. Russ J Cardiol 2021;26:4678. [DOI: 10.15829/1560-4071-2021-4678] [Reference Citation Analysis]
675 Zamyatin KA, Nozdrachev DI, Solovieva MN. Mobile applications for anxiety and stress reduction: potential for preventing noncommunicable diseases. Russ J Cardiol 2021;26:4681. [DOI: 10.15829/1560-4071-2021-4681] [Reference Citation Analysis]
676 Theofilis P, Sagris M, Antonopoulos AS, Oikonomou E, Tsioufis C, Tousoulis D. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19. Int J Mol Sci 2021;22:11170. [PMID: 34681830 DOI: 10.3390/ijms222011170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
677 Calabria S, Ronconi G, Dondi L, Piccinni C, Cinconze E, Pedrini A, Esposito I, Addesi A, Martini N, Maggioni AP. Coronary Artery Disease in Patients Older than 35 and Eligible for Cardiovascular Secondary Prevention: An Italian Retrospective Observational Analysis of Healthcare Administrative Databases. J Clin Med 2021;10:4708. [PMID: 34682831 DOI: 10.3390/jcm10204708] [Reference Citation Analysis]
678 Calderone D, Greco A, Ingala S, Agnello F, Franchina G, Scalia L, Buccheri S, Capodanno D. Efficacy and Safety of Aspirin for Primary Cardiovascular Risk Prevention in Younger and Older Age: An Updated Systematic Review and Meta-analysis of 178,310 Subjects from 21 Randomized Studies. Thromb Haemost 2021. [PMID: 34638150 DOI: 10.1055/a-1667-7427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
679 Kabłak-Ziembicka A, Przewłocki T. Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients. J Clin Med 2021;10:4628. [PMID: 34682751 DOI: 10.3390/jcm10204628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
680 Rezuș E, Macovei LA, Burlui AM, Cardoneanu A, Rezuș C. Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background. Life (Basel) 2021;11:1042. [PMID: 34685413 DOI: 10.3390/life11101042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
681 Maranhao Neto GA, Pavlovska I, Polcrova A, Mechanick JI, Infante-Garcia MM, Hernandez JP, Araujo MA, Nieto-Martinez R, Gonzalez-Rivas JP. Prediction of Cardiorespiratory Fitness in Czech Adults: Normative Values and Association with Cardiometabolic Health. Int J Environ Res Public Health 2021;18:10251. [PMID: 34639552 DOI: 10.3390/ijerph181910251] [Reference Citation Analysis]
682 Kudaiberdieva G. On September 2021 issue, hot trials at ESC congress this year, and updates on pandemics. HVT 2021;5. [DOI: 10.24969/hvt.2021.272] [Reference Citation Analysis]
683 Marquis-Gravel G, Goodman SG, Anderson TJ, Bell AD, Bewick D, Cox J, Grégoire JC, Gupta A, Huynh T, Kertland H, Kouz S, L'Allier PL, Madan M, Mancini GBJ, McPherson R, So DYF, Welsh RC, Wong G, Tardif JC. Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians. Can J Cardiol 2021:S0828-282X(21)00654-1. [PMID: 34418482 DOI: 10.1016/j.cjca.2021.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
684 Escobar C, Barrios V, Ariza A, Campuzano R, Gámez JM, Mostaza JM. Empleo del ácido bempedoico en los pacientes con dislipemia. Una aproximación práctica. Revista Española de Cardiología Suplementos 2021;21:1-7. [DOI: 10.1016/s1131-3587(21)00005-4] [Reference Citation Analysis]